{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p0", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, [E1]C protein[/E1] was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of [E2]nucleocapsid protein[/E2] NP and phosphoprotein P, which were also detected with specific antisera.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C protein", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleocapsid protein", "entity_2_idx": [[148, 168]], "entity_2_idx_in_text_with_entity_marker": [161, 181], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p1", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of [E1]nucleocapsid protein[/E1] [E2]NP[/E2] and phosphoprotein P, which were also detected with specific antisera.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid protein", "entity_1_idx": [[148, 168]], "entity_1_idx_in_text_with_entity_marker": [152, 172], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "NP", "entity_2_idx": [[169, 171]], "entity_2_idx_in_text_with_entity_marker": [182, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p2", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of [E1]nucleocapsid protein[/E1] NP and [E2]phosphoprotein[/E2] P, which were also detected with specific antisera.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[148, 168]], "entity_1_idx_in_text_with_entity_marker": [152, 172], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "phosphoprotein", "entity_2_idx": [[176, 190]], "entity_2_idx_in_text_with_entity_marker": [189, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p3", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of [E1]nucleocapsid protein[/E1] NP and phosphoprotein [E2]P[/E2], which were also detected with specific antisera.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[148, 168]], "entity_1_idx_in_text_with_entity_marker": [152, 172], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "P", "entity_2_idx": [[191, 192]], "entity_2_idx_in_text_with_entity_marker": [204, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p4", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, [E1]C protein[/E1] was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein [E2]NP[/E2] and phosphoprotein P, which were also detected with specific antisera.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "C protein", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[169, 171]], "entity_2_idx_in_text_with_entity_marker": [182, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p5", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, [E1]C protein[/E1] was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and [E2]phosphoprotein[/E2] P, which were also detected with specific antisera.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "C protein", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[176, 190]], "entity_2_idx_in_text_with_entity_marker": [189, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p6", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, [E1]C protein[/E1] was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein [E2]P[/E2], which were also detected with specific antisera.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "C protein", "entity_1_idx": [[19, 28]], "entity_1_idx_in_text_with_entity_marker": [23, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[191, 192]], "entity_2_idx_in_text_with_entity_marker": [204, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p7", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein [E1]NP[/E1] and [E2]phosphoprotein[/E2] P, which were also detected with specific antisera.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[169, 171]], "entity_1_idx_in_text_with_entity_marker": [173, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[176, 190]], "entity_2_idx_in_text_with_entity_marker": [189, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p8", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein [E1]NP[/E1] and phosphoprotein [E2]P[/E2], which were also detected with specific antisera.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[169, 171]], "entity_1_idx_in_text_with_entity_marker": [173, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[191, 192]], "entity_2_idx_in_text_with_entity_marker": [204, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d344.s0_BioInfer.d344.s0.p9", "text": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and phosphoprotein P, which were also detected with specific antisera.", "text_with_entity_marker": "In infected cells, C protein was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of nucleocapsid protein NP and [E1]phosphoprotein[/E1] [E2]P[/E2], which were also detected with specific antisera.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "phosphoprotein", "entity_1_idx": [[176, 190]], "entity_1_idx_in_text_with_entity_marker": [180, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[191, 192]], "entity_2_idx_in_text_with_entity_marker": [204, 205], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p0", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, [E1]UL8[/E1], and [E2]UL52[/E2] genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[105, 108]], "entity_1_idx_in_text_with_entity_marker": [109, 112], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p1", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of the products of the UL5, [E2]UL8[/E2], and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[105, 108]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p2", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the [E1]UL5[/E1], [E2]UL8[/E2], and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL8", "entity_2_idx": [[105, 108]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p3", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of the products of the UL5, UL8, and [E2]UL52[/E2] genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p4", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the [E1]UL5[/E1], UL8, and [E2]UL52[/E2] genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[100, 103]], "entity_1_idx_in_text_with_entity_marker": [104, 107], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "UL52", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p5", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of the products of the [E2]UL5[/E2], UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d813.s0_BioInfer.d813.s0.p0", "text": "We have found that cofilin, a 21-kDa actin-binding protein, is a component of these rods.", "text_with_entity_marker": "We have found that [E1]cofilin[/E1], a 21-kDa [E2]actin-binding protein[/E2], is a component of these rods.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[19, 26]], "entity_1_idx_in_text_with_entity_marker": [23, 30], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[37, 58]], "entity_2_idx_in_text_with_entity_marker": [50, 71], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d138.s0_BioInfer.d138.s0.p0", "text": "Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.", "text_with_entity_marker": "Characterization of [E1]MLH1[/E1] and [E2]MSH2[/E2] DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p40", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and [E1]Arp3[/E1]; and five apparently novel proteins, [E2]p40[/E2], p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp3", "entity_1_idx": [[173, 177]], "entity_1_idx_in_text_with_entity_marker": [177, 181], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p40", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p41", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, Arp2 and [E2]Arp3[/E2]; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp3", "entity_2_idx": [[173, 177]], "entity_2_idx_in_text_with_entity_marker": [186, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p42", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two actin-related proteins, Arp2 and [E2]Arp3[/E2]; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Arp3", "entity_2_idx": [[173, 177]], "entity_2_idx_in_text_with_entity_marker": [186, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p43", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and [E1]Arp3[/E1]; and five apparently novel proteins, p40, p35, [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp3", "entity_1_idx": [[173, 177]], "entity_1_idx_in_text_with_entity_marker": [177, 181], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p44", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, [E1]Arp2[/E1] and [E2]Arp3[/E2]; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp3", "entity_2_idx": [[173, 177]], "entity_2_idx_in_text_with_entity_marker": [186, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p45", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two [E1]actin[/E1]-related proteins, Arp2 and Arp3; and five apparently novel proteins, [E2]p40[/E2], p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[140, 145]], "entity_1_idx_in_text_with_entity_marker": [144, 149], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p40", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p46", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, [E2]p40[/E2], p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p40", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p47", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, [E1]p40[/E1], p35, [E2]p19[/E2], p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p40", "entity_1_idx": [[215, 218]], "entity_1_idx_in_text_with_entity_marker": [219, 222], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p19", "entity_2_idx": [[225, 228]], "entity_2_idx_in_text_with_entity_marker": [238, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p48", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, [E1]Arp2[/E1] and Arp3; and five apparently novel proteins, [E2]p40[/E2], p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Arp2", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p40", "entity_2_idx": [[215, 218]], "entity_2_idx_in_text_with_entity_marker": [228, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d576.s0_BioInfer.d576.s0.p49", "text": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on profilin, consists of seven polypeptides; two actin-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "text_with_entity_marker": "The Arp2/3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on [E1]profilin[/E1], consists of seven polypeptides; two [E2]actin[/E2]-related proteins, Arp2 and Arp3; and five apparently novel proteins, p40, p35, p19, p18, and p14 (Machesky et al., 1994).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[94, 102]], "entity_1_idx_in_text_with_entity_marker": [98, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[140, 145]], "entity_2_idx_in_text_with_entity_marker": [153, 158], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p70", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, vimentin CD34, [E2]type IV collagen[/E2], smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "type IV collagen", "entity_2_idx": [[147, 163]], "entity_2_idx_in_text_with_entity_marker": [160, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p71", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, [E2]vimentin[/E2] CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vimentin", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p72", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, [E2]smooth muscle myosin heavy chain[/E2], calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle myosin heavy chain", "entity_2_idx": [[186, 218]], "entity_2_idx_in_text_with_entity_marker": [199, 231], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p73", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, vimentin CD34, type IV collagen, [E2]smooth muscle actin[/E2], smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smooth muscle actin", "entity_2_idx": [[165, 184]], "entity_2_idx_in_text_with_entity_marker": [178, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p74", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, vimentin [E2]CD34[/E2], type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD34", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p75", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [77, 79]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p76", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [70, 71]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p77", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), [E1]epithelial membrane antigen[/E1] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, [E2]calponin[/E2], and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "epithelial membrane antigen", "entity_1_idx": [[82, 109]], "entity_1_idx_in_text_with_entity_marker": [86, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calponin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p78", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of cytokeratins ([E1]CKs[/E1]) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CKs", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d294.s0_BioInfer.d294.s0.p79", "text": "Immunohistochemistry for a variety of cytokeratins (CKs) (8/18, 1/10, 7, and 20), epithelial membrane antigen (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "text_with_entity_marker": "Immunohistochemistry for a variety of [E1]cytokeratins[/E1] (CKs) (8/18, 1/10, 7, and 20), [E2]epithelial membrane antigen[/E2] (EMA), S-100 protein, vimentin CD34, type IV collagen, smooth muscle actin, smooth muscle myosin heavy chain, calponin, and glial fibrillary acid protein was performed.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytokeratins", "entity_1_idx": [[38, 50], [66, 68]], "entity_1_idx_in_text_with_entity_marker": [42, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epithelial membrane antigen", "entity_2_idx": [[82, 109]], "entity_2_idx_in_text_with_entity_marker": [95, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p20", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, [E2]type IV collagen[/E2], actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "type IV collagen", "entity_2_idx": [[171, 187]], "entity_2_idx_in_text_with_entity_marker": [184, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p21", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, [E1]type IV collagen[/E1], actin-binding protein [E2]cofilin[/E2], profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "type IV collagen", "entity_1_idx": [[171, 187]], "entity_1_idx_in_text_with_entity_marker": [175, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[211, 218]], "entity_2_idx_in_text_with_entity_marker": [224, 231], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p22", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase ([E1]PIMT[/E1]), ferritin heavy chain, [E2]type IV collagen[/E2], actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIMT", "entity_1_idx": [[142, 146]], "entity_1_idx_in_text_with_entity_marker": [146, 150], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "type IV collagen", "entity_2_idx": [[171, 187]], "entity_2_idx_in_text_with_entity_marker": [184, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p23", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, [E1]protein L-isoaspartyl methyltransferase[/E1] (PIMT), ferritin heavy chain, [E2]type IV collagen[/E2], actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein L-isoaspartyl methyltransferase", "entity_1_idx": [[101, 140]], "entity_1_idx_in_text_with_entity_marker": [105, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "type IV collagen", "entity_2_idx": [[171, 187]], "entity_2_idx_in_text_with_entity_marker": [184, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p24", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as [E1]embryonic alpha-tubulin[/E1], embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic alpha-tubulin", "entity_1_idx": [[45, 68]], "entity_1_idx_in_text_with_entity_marker": [49, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p25", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, [E1]hnRNP[/E1], protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "hnRNP", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p26", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, [E1]embryonic beta-tubulin[/E1], hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "embryonic beta-tubulin", "entity_1_idx": [[70, 92]], "entity_1_idx_in_text_with_entity_marker": [74, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p27", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein [E1]cofilin[/E1], [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[211, 218]], "entity_1_idx_in_text_with_entity_marker": [215, 222], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p28", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase ([E1]PIMT[/E1]), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PIMT", "entity_1_idx": [[142, 146]], "entity_1_idx_in_text_with_entity_marker": [146, 150], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d533.s0_BioInfer.d533.s0.p29", "text": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, protein L-isoaspartyl methyltransferase (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, profilin and nine novel sequences designated as A1-9.", "text_with_entity_marker": "Seventeen embryonic genes were identified as embryonic alpha-tubulin, embryonic beta-tubulin, hnRNP, [E1]protein L-isoaspartyl methyltransferase[/E1] (PIMT), ferritin heavy chain, type IV collagen, actin-binding protein cofilin, [E2]profilin[/E2] and nine novel sequences designated as A1-9.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "protein L-isoaspartyl methyltransferase", "entity_1_idx": [[101, 140]], "entity_1_idx_in_text_with_entity_marker": [105, 144], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "profilin", "entity_2_idx": [[220, 228]], "entity_2_idx_in_text_with_entity_marker": [233, 241], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p0", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another [E2]actin[/E2] and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[248, 253]], "entity_2_idx_in_text_with_entity_marker": [261, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p1", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with [E1]talin[/E1], another [E2]actin[/E2] and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[233, 238]], "entity_1_idx_in_text_with_entity_marker": [237, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[248, 253]], "entity_2_idx_in_text_with_entity_marker": [261, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p2", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and [E1]actin[/E1] bending stiffness which contrasts with our previous observations with talin, another [E2]actin[/E2] and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[248, 253]], "entity_2_idx_in_text_with_entity_marker": [261, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p3", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another [E1]actin[/E1] and [E2]vinculin[/E2]-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[248, 253]], "entity_1_idx_in_text_with_entity_marker": [252, 257], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p4", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal [E1]actin[/E1] filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another [E2]actin[/E2] and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[129, 134]], "entity_1_idx_in_text_with_entity_marker": [133, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[248, 253]], "entity_2_idx_in_text_with_entity_marker": [261, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p5", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with [E2]talin[/E2], another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[233, 238]], "entity_2_idx_in_text_with_entity_marker": [246, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p6", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal actin filament dynamics and [E2]actin[/E2] bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p7", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and [E2]vinculin[/E2]-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p8", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal [E2]actin[/E2] filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[129, 134]], "entity_2_idx_in_text_with_entity_marker": [142, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p9", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and [E1]actin[/E1] bending stiffness which contrasts with our previous observations with [E2]talin[/E2], another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[233, 238]], "entity_2_idx_in_text_with_entity_marker": [246, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p10", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with [E1]talin[/E1], another actin and [E2]vinculin[/E2]-binding protein from focal adhesions.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[233, 238]], "entity_1_idx_in_text_with_entity_marker": [237, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p11", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal [E1]actin[/E1] filament dynamics and actin bending stiffness which contrasts with our previous observations with [E2]talin[/E2], another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[129, 134]], "entity_1_idx_in_text_with_entity_marker": [133, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[233, 238]], "entity_2_idx_in_text_with_entity_marker": [246, 251], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p12", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and [E1]actin[/E1] bending stiffness which contrasts with our previous observations with talin, another actin and [E2]vinculin[/E2]-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p13", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal [E1]actin[/E1] filament dynamics and [E2]actin[/E2] bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[129, 134]], "entity_1_idx_in_text_with_entity_marker": [133, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p14", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal [E1]actin[/E1] filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and [E2]vinculin[/E2]-binding protein from focal adhesions.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[129, 134]], "entity_1_idx_in_text_with_entity_marker": [133, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p20", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of [E1]E-cadherin[/E1], alpha-catenin and beta-catenin, and the other of [E2]E-cadherin[/E2], alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[124, 134]], "entity_1_idx_in_text_with_entity_marker": [128, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[185, 195]], "entity_2_idx_in_text_with_entity_marker": [198, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p21", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, [E1]alpha-catenin[/E1] and beta-catenin, and the other of [E2]E-cadherin[/E2], alpha-catenin and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[136, 149]], "entity_1_idx_in_text_with_entity_marker": [140, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[185, 195]], "entity_2_idx_in_text_with_entity_marker": [198, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p22", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, [E1]alpha-catenin[/E1] and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[197, 210]], "entity_1_idx_in_text_with_entity_marker": [201, 214], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[215, 226]], "entity_2_idx_in_text_with_entity_marker": [228, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p23", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of [E1]E-cadherin[/E1], alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[124, 134]], "entity_1_idx_in_text_with_entity_marker": [128, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[215, 226]], "entity_2_idx_in_text_with_entity_marker": [228, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p24", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, [E1]alpha-catenin[/E1] and beta-catenin, and the other of E-cadherin, alpha-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[136, 149]], "entity_1_idx_in_text_with_entity_marker": [140, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[215, 226]], "entity_2_idx_in_text_with_entity_marker": [228, 239], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p25", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of [E1]E-cadherin[/E1], alpha-catenin and beta-catenin, and the other of E-cadherin, [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[124, 134]], "entity_1_idx_in_text_with_entity_marker": [128, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p26", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, [E1]alpha-catenin[/E1] and beta-catenin, and the other of E-cadherin, [E2]alpha-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[136, 149]], "entity_1_idx_in_text_with_entity_marker": [140, 153], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[197, 210]], "entity_2_idx_in_text_with_entity_marker": [210, 223], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d299.s0_BioInfer.d299.s0.p27", "text": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of E-cadherin, alpha-catenin and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "text_with_entity_marker": "Immunoprecipitations showed in both cell lines the presence of two different E-cadherin- catenin complexes, one composed of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and beta-catenin, and the other of E-cadherin, alpha-catenin and plakoglobin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[124, 134]], "entity_1_idx_in_text_with_entity_marker": [128, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[136, 149]], "entity_2_idx_in_text_with_entity_marker": [149, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p0", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin ([E2]alpha-SMA[/E2]), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-SMA", "entity_2_idx": [[213, 222]], "entity_2_idx_in_text_with_entity_marker": [226, 235], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p1", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), troponin I (TnI) isoforms, connexin 43 ([E2]Cx43[/E2]), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Cx43", "entity_2_idx": [[168, 172]], "entity_2_idx_in_text_with_entity_marker": [181, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p2", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), troponin I (TnI) isoforms, [E2]connexin 43[/E2] (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "connexin 43", "entity_2_idx": [[155, 166]], "entity_2_idx_in_text_with_entity_marker": [168, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p3", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain ([E1]MHC[/E1]), myosin light chain ([E2]MLC[/E2]), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[96, 99]], "entity_1_idx_in_text_with_entity_marker": [100, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MLC", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p4", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and [E2]alpha-smooth muscle actin[/E2] (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[186, 211]], "entity_2_idx_in_text_with_entity_marker": [199, 224], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p5", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), troponin I ([E2]TnI[/E2]) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[140, 143]], "entity_2_idx_in_text_with_entity_marker": [153, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p6", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of [E1]myosin heavy chain[/E1] (MHC), myosin light chain ([E2]MLC[/E2]), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[76, 94]], "entity_1_idx_in_text_with_entity_marker": [80, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MLC", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p7", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), [E2]troponin I[/E2] (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "troponin I", "entity_2_idx": [[128, 138]], "entity_2_idx_in_text_with_entity_marker": [141, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p8", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), [E1]myosin light chain[/E1] ([E2]MLC[/E2]), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin light chain", "entity_1_idx": [[102, 120]], "entity_1_idx_in_text_with_entity_marker": [106, 124], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MLC", "entity_2_idx": [[122, 125]], "entity_2_idx_in_text_with_entity_marker": [135, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d423.s0_BioInfer.d423.s0.p9", "text": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain (MLC), troponin I (TnI) isoforms, connexin 43 (Cx43), desmin and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "text_with_entity_marker": "METHODS: We have performed a detailed study of the pattern of expression of myosin heavy chain (MHC), myosin light chain ([E1]MLC[/E1]), troponin I (TnI) isoforms, connexin 43 (Cx43), [E2]desmin[/E2] and alpha-smooth muscle actin (alpha-SMA), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLC", "entity_1_idx": [[122, 125]], "entity_1_idx_in_text_with_entity_marker": [126, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "desmin", "entity_2_idx": [[175, 181]], "entity_2_idx_in_text_with_entity_marker": [188, 194], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p30", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p31", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p32", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E1]M[/E1] and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[280, 281]], "entity_1_idx_in_text_with_entity_marker": [284, 285], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p33", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and [E2]phosphoprotein[/E2] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[184, 198]], "entity_2_idx_in_text_with_entity_marker": [197, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p34", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p35", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p36", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] ([E2]P[/E2]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[200, 201]], "entity_2_idx_in_text_with_entity_marker": [213, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p37", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p38", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p39", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s0_BioInfer.d525.s0.p0", "text": "Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion.", "text_with_entity_marker": "Role of cofilin in [E1]epidermal growth factor[/E1]-stimulated [E2]actin[/E2] polymerization and lamellipod protrusion.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "epidermal growth factor", "entity_1_idx": [[19, 42]], "entity_1_idx_in_text_with_entity_marker": [23, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s0_BioInfer.d525.s0.p1", "text": "Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion.", "text_with_entity_marker": "Role of [E1]cofilin[/E1] in [E2]epidermal growth factor[/E2]-stimulated actin polymerization and lamellipod protrusion.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "epidermal growth factor", "entity_2_idx": [[19, 42]], "entity_2_idx_in_text_with_entity_marker": [32, 55], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s0_BioInfer.d525.s0.p2", "text": "Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion.", "text_with_entity_marker": "Role of [E1]cofilin[/E1] in epidermal growth factor-stimulated [E2]actin[/E2] polymerization and lamellipod protrusion.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s1_BioInfer.d525.s1.p0", "text": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "text_with_entity_marker": "These results support a model in which [E1]EGF[/E1] stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short [E2]actin[/E2] filaments with free barbed ends that participate in the nucleation of actin polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[169, 174]], "entity_2_idx_in_text_with_entity_marker": [182, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s1_BioInfer.d525.s1.p1", "text": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "text_with_entity_marker": "These results support a model in which [E1]EGF[/E1] stimulation recruits [E2]cofilin[/E2] to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EGF", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[64, 71]], "entity_2_idx_in_text_with_entity_marker": [77, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s1_BioInfer.d525.s1.p2", "text": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "text_with_entity_marker": "These results support a model in which [E1]EGF[/E1] stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EGF", "entity_1_idx": [[39, 42]], "entity_1_idx_in_text_with_entity_marker": [43, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s1_BioInfer.d525.s1.p3", "text": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "text_with_entity_marker": "These results support a model in which EGF stimulation recruits [E1]cofilin[/E1] to the leading edge where its severing activity is activated, leading to the generation of short [E2]actin[/E2] filaments with free barbed ends that participate in the nucleation of actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[169, 174]], "entity_2_idx_in_text_with_entity_marker": [182, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s1_BioInfer.d525.s1.p4", "text": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "text_with_entity_marker": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short [E1]actin[/E1] filaments with free barbed ends that participate in the nucleation of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[169, 174]], "entity_1_idx_in_text_with_entity_marker": [173, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s1_BioInfer.d525.s1.p5", "text": "These results support a model in which EGF stimulation recruits cofilin to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of actin polymerization.", "text_with_entity_marker": "These results support a model in which EGF stimulation recruits [E1]cofilin[/E1] to the leading edge where its severing activity is activated, leading to the generation of short actin filaments with free barbed ends that participate in the nucleation of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[64, 71]], "entity_1_idx_in_text_with_entity_marker": [68, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[245, 250]], "entity_2_idx_in_text_with_entity_marker": [258, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d525.s2_BioInfer.d525.s2.p0", "text": "To investigate the role of cofilin in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the actin dynamics by measuring the changes in the number of actin filaments.", "text_with_entity_marker": "To investigate the role of [E1]cofilin[/E1] in EGF-stimulated actin polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of cofilin relative to free barbed ends and characterized the [E2]actin[/E2] dynamics by measuring the changes in the number of actin filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p0", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue [E1]mgt1[/E1]delta O6 MeG DNA repair [E2]methyltransferase[/E2]-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "mgt1", "entity_1_idx": [[195, 199]], "entity_1_idx_in_text_with_entity_marker": [199, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "methyltransferase", "entity_2_idx": [[223, 240]], "entity_2_idx_in_text_with_entity_marker": [236, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p1", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, [E1]MSH6[/E1], and PMS1, did not rescue mgt1delta O6 MeG DNA repair [E2]methyltransferase[/E2]-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "methyltransferase", "entity_2_idx": [[223, 240]], "entity_2_idx_in_text_with_entity_marker": [236, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p2", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and [E1]PMS1[/E1], did not rescue mgt1delta O6 MeG DNA repair [E2]methyltransferase[/E2]-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PMS1", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "methyltransferase", "entity_2_idx": [[223, 240]], "entity_2_idx_in_text_with_entity_marker": [236, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p3", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair [E2]methyltransferase[/E2]-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "methyltransferase", "entity_2_idx": [[223, 240]], "entity_2_idx_in_text_with_entity_marker": [236, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p4", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, [E1]MSH3[/E1], MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair [E2]methyltransferase[/E2]-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "methyltransferase", "entity_2_idx": [[223, 240]], "entity_2_idx_in_text_with_entity_marker": [236, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p5", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair [E2]methyltransferase[/E2]-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "methyltransferase", "entity_2_idx": [[223, 240]], "entity_2_idx_in_text_with_entity_marker": [236, 253], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p6", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, [E1]MSH6[/E1], and PMS1, did not rescue [E2]mgt1[/E2]delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "mgt1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p7", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and [E1]PMS1[/E1], did not rescue [E2]mgt1[/E2]delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PMS1", "entity_1_idx": [[174, 178]], "entity_1_idx_in_text_with_entity_marker": [178, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "mgt1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p8", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], MSH3, MSH6, and PMS1, did not rescue [E2]mgt1[/E2]delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "mgt1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p9", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, [E1]MSH3[/E1], MSH6, and PMS1, did not rescue [E2]mgt1[/E2]delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "mgt1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p10", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, MSH6, and PMS1, did not rescue [E2]mgt1[/E2]delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "mgt1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p11", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, [E1]MSH6[/E1], and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH6", "entity_1_idx": [[164, 168]], "entity_1_idx_in_text_with_entity_marker": [168, 172], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p12", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], MSH3, [E2]MSH6[/E2], and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p13", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, [E1]MSH3[/E1], [E2]MSH6[/E2], and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p14", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, [E2]MSH6[/E2], and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[164, 168]], "entity_2_idx_in_text_with_entity_marker": [177, 181], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p15", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], MSH3, MSH6, and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p16", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, [E1]MSH3[/E1], MSH6, and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH3", "entity_1_idx": [[158, 162]], "entity_1_idx_in_text_with_entity_marker": [162, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p17", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, MSH3, MSH6, and [E2]PMS1[/E2], did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS1", "entity_2_idx": [[174, 178]], "entity_2_idx_in_text_with_entity_marker": [187, 191], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p18", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, [E1]MSH2[/E1], [E2]MSH3[/E2], MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MSH2", "entity_1_idx": [[152, 156]], "entity_1_idx_in_text_with_entity_marker": [156, 160], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p19", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], [E2]MSH2[/E2], MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d828.s0_BioInfer.d828.s0.p20", "text": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including MLH1, MSH2, MSH3, MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "text_with_entity_marker": "We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including [E1]MLH1[/E1], MSH2, [E2]MSH3[/E2], MSH6, and PMS1, did not rescue mgt1delta O6 MeG DNA repair methyltransferase-deficient cells from killing by MNNG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MLH1", "entity_1_idx": [[146, 150]], "entity_1_idx_in_text_with_entity_marker": [150, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[158, 162]], "entity_2_idx_in_text_with_entity_marker": [171, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p20", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], [E2]alpha 5[/E2] and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha 5", "entity_2_idx": [[27, 34], [46, 55]], "entity_2_idx_in_text_with_entity_marker": [40, 47], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p21", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, [E1]alpha 5[/E1] and beta 1 integrins, pp125 [E2]focal adhesion kinase[/E2], and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha 5", "entity_1_idx": [[27, 34], [46, 55]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "focal adhesion kinase", "entity_2_idx": [[63, 84]], "entity_2_idx_in_text_with_entity_marker": [76, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p22", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and [E1]beta 1 integrins[/E1], [E2]pp125[/E2] focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1 integrins", "entity_1_idx": [[39, 55]], "entity_1_idx_in_text_with_entity_marker": [43, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp125", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p23", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], alpha 5 and beta 1 integrins, [E2]pp125[/E2] focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "pp125", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p24", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and beta 1 integrins, [E1]pp125[/E1] [E2]focal adhesion kinase[/E2], and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "pp125", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "focal adhesion kinase", "entity_2_idx": [[63, 84]], "entity_2_idx_in_text_with_entity_marker": [76, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p25", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], alpha 5 and [E2]beta 1 integrins[/E2], pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1 integrins", "entity_2_idx": [[39, 55]], "entity_2_idx_in_text_with_entity_marker": [52, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p26", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, talin, alpha 5 and [E1]beta 1 integrins[/E1], pp125 [E2]focal adhesion kinase[/E2], and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta 1 integrins", "entity_1_idx": [[39, 55]], "entity_1_idx_in_text_with_entity_marker": [43, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "focal adhesion kinase", "entity_2_idx": [[63, 84]], "entity_2_idx_in_text_with_entity_marker": [76, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d4.s0_BioInfer.d4.s0.p27", "text": "Abundance of actin, talin, alpha 5 and beta 1 integrins, pp125 focal adhesion kinase, and alpha-catenin is not affected by the differential calreticulin expression.", "text_with_entity_marker": "Abundance of actin, [E1]talin[/E1], alpha 5 and beta 1 integrins, pp125 [E2]focal adhesion kinase[/E2], and alpha-catenin is not affected by the differential calreticulin expression.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "focal adhesion kinase", "entity_2_idx": [[63, 84]], "entity_2_idx_in_text_with_entity_marker": [76, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p52", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total [E2]H3[/E2] and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[69, 71]], "entity_2_idx_in_text_with_entity_marker": [82, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p53", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These [E1]histone[/E1] H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[6, 13]], "entity_1_idx_in_text_with_entity_marker": [10, 17], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d681.s1_BioInfer.d681.s1.p54", "text": "These histone H3 and H2a genes encode approximately 40% of the total H3 and H2a mRNA, whereas the histone H4 and histone H2b genes encode < 10% of the total H4 and H2b mRNA.", "text_with_entity_marker": "These histone H3 and H2a genes encode approximately 40% of the total [E1]H3[/E1] and H2a mRNA, whereas the histone H4 and [E2]histone[/E2] H2b genes encode < 10% of the total H4 and H2b mRNA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[69, 71]], "entity_1_idx_in_text_with_entity_marker": [73, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[113, 120]], "entity_2_idx_in_text_with_entity_marker": [126, 133], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d571.s0_BioInfer.d571.s0.p0", "text": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "text_with_entity_marker": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as [E1]vinculin[/E1] and [E2]talin[/E2], and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[170, 178]], "entity_1_idx_in_text_with_entity_marker": [174, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[183, 188]], "entity_2_idx_in_text_with_entity_marker": [196, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d571.s0_BioInfer.d571.s0.p1", "text": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "text_with_entity_marker": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two [E1]actin[/E1]-associated proteins of the adherens junctions, such as [E2]vinculin[/E2] and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[170, 178]], "entity_2_idx_in_text_with_entity_marker": [183, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d571.s0_BioInfer.d571.s0.p2", "text": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two actin-associated proteins of the adherens junctions, such as vinculin and talin, and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "text_with_entity_marker": "The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two [E1]actin[/E1]-associated proteins of the adherens junctions, such as vinculin and [E2]talin[/E2], and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[183, 188]], "entity_2_idx_in_text_with_entity_marker": [196, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p30", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p31", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p32", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p33", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p34", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p35", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E1]H2A.Z[/E1], histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.Z", "entity_1_idx": [[280, 285]], "entity_1_idx_in_text_with_entity_marker": [284, 289], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p36", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone [E1]H2A.X[/E1], histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.X", "entity_1_idx": [[265, 270]], "entity_1_idx_in_text_with_entity_marker": [269, 274], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p37", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone [E1]H2A.2[/E1], histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[250, 255]], "entity_1_idx_in_text_with_entity_marker": [254, 259], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p38", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three [E2]histone[/E2] H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[306, 313]], "entity_2_idx_in_text_with_entity_marker": [319, 326], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p39", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: [E1]histone[/E1] H1(0), four histone H1 subfractions, histone H2A.1, [E2]histone[/E2] H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[158, 165]], "entity_1_idx_in_text_with_entity_marker": [162, 169], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[218, 225]], "entity_2_idx_in_text_with_entity_marker": [231, 238], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p180", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized [E1]histone[/E1] [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[242, 249]], "entity_1_idx_in_text_with_entity_marker": [246, 253], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p181", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone [E1]H2A.2[/E1], oxidized [E2]histone[/E2] H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.2", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[242, 249]], "entity_2_idx_in_text_with_entity_marker": [255, 262], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p182", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone [E1]H1[/E1] subfractions, histone [E2]H2A.1[/E2], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[186, 188]], "entity_1_idx_in_text_with_entity_marker": [190, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.1", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p183", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone H1 subfractions, histone [E2]H2A.1[/E2], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.1", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p184", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified [E1]histones[/E1] were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E2]H2A.1[/E2], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[100, 108]], "entity_1_idx_in_text_with_entity_marker": [104, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "H2A.1", "entity_2_idx": [[211, 216]], "entity_2_idx_in_text_with_entity_marker": [224, 229], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p185", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone [E2]H2A.Z[/E2], histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.Z", "entity_2_idx": [[280, 285]], "entity_2_idx_in_text_with_entity_marker": [293, 298], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p186", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone H2A.2, histone [E2]H2A.X[/E2], histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.X", "entity_2_idx": [[265, 270]], "entity_2_idx_in_text_with_entity_marker": [278, 283], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p187", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone H2A.2, oxidized histone [E2]H2A.2[/E2], histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[250, 255]], "entity_2_idx_in_text_with_entity_marker": [263, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p188", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone [E1]H2A.1[/E1], histone [E2]H2A.2[/E2], oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A.1", "entity_1_idx": [[211, 216]], "entity_1_idx_in_text_with_entity_marker": [215, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A.2", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d31.s0_BioInfer.d31.s0.p189", "text": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone H1(0), four histone H1 subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "text_with_entity_marker": "After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified histones were identified by HPLC and gel electrophoresis: histone [E1]H1(0)[/E1], four histone [E2]H1[/E2] subfractions, histone H2A.1, histone H2A.2, oxidized histone H2A.2, histone H2A.X, histone H2A.Z, histone H2B, three histone H3 variants and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1(0)", "entity_1_idx": [[166, 171]], "entity_1_idx_in_text_with_entity_marker": [170, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H1", "entity_2_idx": [[186, 188]], "entity_2_idx_in_text_with_entity_marker": [199, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p0", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human [E1]dystrophin related protein[/E1] ([E2]DRP[/E2] or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin related protein", "entity_1_idx": [[71, 97]], "entity_1_idx_in_text_with_entity_marker": [75, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DRP", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p1", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein ([E1]DRP[/E1] or utrophin) and the [E2]87K postsynaptic protein[/E2] from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DRP", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K postsynaptic protein", "entity_2_idx": [[124, 148]], "entity_2_idx_in_text_with_entity_marker": [137, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p2", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein ([E1]DRP[/E1] or [E2]utrophin[/E2]) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DRP", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[106, 114]], "entity_2_idx_in_text_with_entity_marker": [119, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p3", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein ([E1]DRP[/E1] or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated [E2]beta 1-syntrophin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "DRP", "entity_1_idx": [[99, 102]], "entity_1_idx_in_text_with_entity_marker": [103, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1-syntrophin", "entity_2_idx": [[202, 219]], "entity_2_idx_in_text_with_entity_marker": [215, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p4", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the [E1]dystrophin[/E1] relatives, human dystrophin related protein ([E2]DRP[/E2] or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dystrophin", "entity_1_idx": [[43, 53]], "entity_1_idx_in_text_with_entity_marker": [47, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DRP", "entity_2_idx": [[99, 102]], "entity_2_idx_in_text_with_entity_marker": [112, 115], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p5", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human [E1]dystrophin related protein[/E1] (DRP or utrophin) and the [E2]87K postsynaptic protein[/E2] from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin related protein", "entity_1_idx": [[71, 97]], "entity_1_idx_in_text_with_entity_marker": [75, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K postsynaptic protein", "entity_2_idx": [[124, 148]], "entity_2_idx_in_text_with_entity_marker": [137, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p6", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human [E1]dystrophin related protein[/E1] (DRP or [E2]utrophin[/E2]) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin related protein", "entity_1_idx": [[71, 97]], "entity_1_idx_in_text_with_entity_marker": [75, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[106, 114]], "entity_2_idx_in_text_with_entity_marker": [119, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p7", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human [E1]dystrophin related protein[/E1] (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated [E2]beta 1-syntrophin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dystrophin related protein", "entity_1_idx": [[71, 97]], "entity_1_idx_in_text_with_entity_marker": [75, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1-syntrophin", "entity_2_idx": [[202, 219]], "entity_2_idx_in_text_with_entity_marker": [215, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p8", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the [E1]dystrophin[/E1] relatives, human [E2]dystrophin related protein[/E2] (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dystrophin", "entity_1_idx": [[43, 53]], "entity_1_idx_in_text_with_entity_marker": [47, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "dystrophin related protein", "entity_2_idx": [[71, 97]], "entity_2_idx_in_text_with_entity_marker": [84, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p9", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or [E1]utrophin[/E1]) and the [E2]87K postsynaptic protein[/E2] from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "utrophin", "entity_1_idx": [[106, 114]], "entity_1_idx_in_text_with_entity_marker": [110, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K postsynaptic protein", "entity_2_idx": [[124, 148]], "entity_2_idx_in_text_with_entity_marker": [137, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p10", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the [E1]87K postsynaptic protein[/E1] from Torpedo electric organ, also bind to translated [E2]beta 1-syntrophin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "87K postsynaptic protein", "entity_1_idx": [[124, 148]], "entity_1_idx_in_text_with_entity_marker": [128, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1-syntrophin", "entity_2_idx": [[202, 219]], "entity_2_idx_in_text_with_entity_marker": [215, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p11", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the [E1]dystrophin[/E1] relatives, human dystrophin related protein (DRP or utrophin) and the [E2]87K postsynaptic protein[/E2] from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dystrophin", "entity_1_idx": [[43, 53]], "entity_1_idx_in_text_with_entity_marker": [47, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "87K postsynaptic protein", "entity_2_idx": [[124, 148]], "entity_2_idx_in_text_with_entity_marker": [137, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p12", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or [E1]utrophin[/E1]) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated [E2]beta 1-syntrophin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "utrophin", "entity_1_idx": [[106, 114]], "entity_1_idx_in_text_with_entity_marker": [110, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1-syntrophin", "entity_2_idx": [[202, 219]], "entity_2_idx_in_text_with_entity_marker": [215, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p13", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the [E1]dystrophin[/E1] relatives, human dystrophin related protein (DRP or [E2]utrophin[/E2]) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "dystrophin", "entity_1_idx": [[43, 53]], "entity_1_idx_in_text_with_entity_marker": [47, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[106, 114]], "entity_2_idx_in_text_with_entity_marker": [119, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d376.s0_BioInfer.d376.s0.p14", "text": "In this recombinant expression system, the dystrophin relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated beta 1-syntrophin.", "text_with_entity_marker": "In this recombinant expression system, the [E1]dystrophin[/E1] relatives, human dystrophin related protein (DRP or utrophin) and the 87K postsynaptic protein from Torpedo electric organ, also bind to translated [E2]beta 1-syntrophin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dystrophin", "entity_1_idx": [[43, 53]], "entity_1_idx_in_text_with_entity_marker": [47, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta 1-syntrophin", "entity_2_idx": [[202, 219]], "entity_2_idx_in_text_with_entity_marker": [215, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p30", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p31", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p32", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p33", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p34", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p35", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p36", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p37", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p38", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p39", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p90", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E1]BUB3[/E1], and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BUB3", "entity_1_idx": [[196, 200]], "entity_1_idx_in_text_with_entity_marker": [200, 204], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p0", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of [E1]talin[/E1] thus binds to [E2]integrins[/E2] to form a link to the actin cytoskeleton and can thus regulate integrin function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[39, 48]], "entity_2_idx_in_text_with_entity_marker": [52, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p1", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of talin thus binds to [E1]integrins[/E1] to form a link to the actin cytoskeleton and can thus regulate [E2]integrin[/E2] function.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[39, 48]], "entity_1_idx_in_text_with_entity_marker": [43, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p2", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of talin thus binds to [E1]integrins[/E1] to form a link to the [E2]actin[/E2] cytoskeleton and can thus regulate integrin function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[39, 48]], "entity_1_idx_in_text_with_entity_marker": [43, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p3", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of [E1]talin[/E1] thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate [E2]integrin[/E2] function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p4", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of [E1]talin[/E1] thus binds to integrins to form a link to the [E2]actin[/E2] cytoskeleton and can thus regulate integrin function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[19, 24]], "entity_1_idx_in_text_with_entity_marker": [23, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d617.s0_BioInfer.d617.s0.p5", "text": "The head domain of talin thus binds to integrins to form a link to the actin cytoskeleton and can thus regulate integrin function.", "text_with_entity_marker": "The head domain of talin thus binds to integrins to form a link to the [E1]actin[/E1] cytoskeleton and can thus regulate [E2]integrin[/E2] function.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[112, 120]], "entity_2_idx_in_text_with_entity_marker": [125, 133], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d146.s0_BioInfer.d146.s0.p0", "text": "Cofilin and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "text_with_entity_marker": "Cofilin and [E1]profilin[/E1] may also be involved in the redistribution of [E2]actin[/E2] during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d146.s0_BioInfer.d146.s0.p1", "text": "Cofilin and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "text_with_entity_marker": "Cofilin and [E1]profilin[/E1] may also be involved in the redistribution of actin during myofibrillogenesis and in the process of [E2]actin[/E2] disassembly in degenerating muscles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d146.s0_BioInfer.d146.s0.p2", "text": "Cofilin and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "text_with_entity_marker": "[E1]Cofilin[/E1] and [E2]profilin[/E2] may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Cofilin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[12, 20]], "entity_2_idx_in_text_with_entity_marker": [25, 33], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d146.s0_BioInfer.d146.s0.p3", "text": "Cofilin and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "text_with_entity_marker": "Cofilin and profilin may also be involved in the redistribution of [E1]actin[/E1] during myofibrillogenesis and in the process of [E2]actin[/E2] disassembly in degenerating muscles.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[67, 72]], "entity_1_idx_in_text_with_entity_marker": [71, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d146.s0_BioInfer.d146.s0.p4", "text": "Cofilin and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "text_with_entity_marker": "[E1]Cofilin[/E1] and profilin may also be involved in the redistribution of [E2]actin[/E2] during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cofilin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d146.s0_BioInfer.d146.s0.p5", "text": "Cofilin and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of actin disassembly in degenerating muscles.", "text_with_entity_marker": "[E1]Cofilin[/E1] and profilin may also be involved in the redistribution of actin during myofibrillogenesis and in the process of [E2]actin[/E2] disassembly in degenerating muscles.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Cofilin", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[121, 126]], "entity_2_idx_in_text_with_entity_marker": [134, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d219.s0_BioInfer.d219.s0.p0", "text": "From these we have isolated eight viable and lethal alleles of the muscle myosin heavy chain gene, and seven viable alleles of the indirect flight muscle (IFM)-specific Act88F actin gene.", "text_with_entity_marker": "From these we have isolated eight viable and lethal alleles of the [E1]muscle myosin heavy chain[/E1] gene, and seven viable alleles of the indirect flight muscle (IFM)-specific [E2]Act88F[/E2] actin gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscle myosin heavy chain", "entity_1_idx": [[67, 92]], "entity_1_idx_in_text_with_entity_marker": [71, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Act88F", "entity_2_idx": [[169, 175]], "entity_2_idx_in_text_with_entity_marker": [182, 188], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d219.s0_BioInfer.d219.s0.p1", "text": "From these we have isolated eight viable and lethal alleles of the muscle myosin heavy chain gene, and seven viable alleles of the indirect flight muscle (IFM)-specific Act88F actin gene.", "text_with_entity_marker": "From these we have isolated eight viable and lethal alleles of the [E1]muscle myosin heavy chain[/E1] gene, and seven viable alleles of the indirect flight muscle (IFM)-specific Act88F [E2]actin[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscle myosin heavy chain", "entity_1_idx": [[67, 92]], "entity_1_idx_in_text_with_entity_marker": [71, 96], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d219.s0_BioInfer.d219.s0.p2", "text": "From these we have isolated eight viable and lethal alleles of the muscle myosin heavy chain gene, and seven viable alleles of the indirect flight muscle (IFM)-specific Act88F actin gene.", "text_with_entity_marker": "From these we have isolated eight viable and lethal alleles of the muscle myosin heavy chain gene, and seven viable alleles of the indirect flight muscle (IFM)-specific [E1]Act88F[/E1] [E2]actin[/E2] gene.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Act88F", "entity_1_idx": [[169, 175]], "entity_1_idx_in_text_with_entity_marker": [173, 179], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[176, 181]], "entity_2_idx_in_text_with_entity_marker": [189, 194], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s0_BioInfer.d47.s0.p0", "text": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "text_with_entity_marker": "Although the chemical basis of these results is not known, they indicate that [E1]profilin[/E1] can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for [E2]actin[/E2] may be under metabolic control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s0_BioInfer.d47.s0.p1", "text": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "text_with_entity_marker": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester [E1]actin[/E1] monomers and support the earlier suggestion that the affinity of profilin for [E2]actin[/E2] may be under metabolic control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s0_BioInfer.d47.s0.p2", "text": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "text_with_entity_marker": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of [E1]profilin[/E1] for [E2]actin[/E2] may be under metabolic control.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[180, 188]], "entity_1_idx_in_text_with_entity_marker": [184, 192], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[193, 198]], "entity_2_idx_in_text_with_entity_marker": [206, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s0_BioInfer.d47.s0.p3", "text": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "text_with_entity_marker": "Although the chemical basis of these results is not known, they indicate that [E1]profilin[/E1] can tightly sequester [E2]actin[/E2] monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[109, 114]], "entity_2_idx_in_text_with_entity_marker": [122, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s0_BioInfer.d47.s0.p4", "text": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "text_with_entity_marker": "Although the chemical basis of these results is not known, they indicate that [E1]profilin[/E1] can tightly sequester actin monomers and support the earlier suggestion that the affinity of [E2]profilin[/E2] for actin may be under metabolic control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[78, 86]], "entity_1_idx_in_text_with_entity_marker": [82, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[180, 188]], "entity_2_idx_in_text_with_entity_marker": [193, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s0_BioInfer.d47.s0.p5", "text": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester actin monomers and support the earlier suggestion that the affinity of profilin for actin may be under metabolic control.", "text_with_entity_marker": "Although the chemical basis of these results is not known, they indicate that profilin can tightly sequester [E1]actin[/E1] monomers and support the earlier suggestion that the affinity of [E2]profilin[/E2] for actin may be under metabolic control.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[109, 114]], "entity_1_idx_in_text_with_entity_marker": [113, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[180, 188]], "entity_2_idx_in_text_with_entity_marker": [193, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p0", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of [E1]actin[/E1] has led some to question whether profilin is ever truly an [E2]actin[/E2] monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p1", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of [E1]actin[/E1] has led some to question whether [E2]profilin[/E2] is ever truly an actin monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[130, 138]], "entity_2_idx_in_text_with_entity_marker": [143, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p2", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that [E1]profilin[/E1] inhibits phospholipase C and enhances nucleotide exchange of [E2]actin[/E2] has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p3", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that profilin inhibits [E1]phospholipase C[/E1] and enhances nucleotide exchange of [E2]actin[/E2] has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[39, 54]], "entity_1_idx_in_text_with_entity_marker": [43, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p4", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether [E1]profilin[/E1] is ever truly an [E2]actin[/E2] monomer sequestering agent.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[130, 138]], "entity_1_idx_in_text_with_entity_marker": [134, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p5", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that [E1]profilin[/E1] inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an [E2]actin[/E2] monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p6", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that profilin inhibits [E1]phospholipase C[/E1] and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an [E2]actin[/E2] monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[39, 54]], "entity_1_idx_in_text_with_entity_marker": [43, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[156, 161]], "entity_2_idx_in_text_with_entity_marker": [169, 174], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p7", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that [E1]profilin[/E1] inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether [E2]profilin[/E2] is ever truly an actin monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[130, 138]], "entity_2_idx_in_text_with_entity_marker": [143, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p8", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that profilin inhibits [E1]phospholipase C[/E1] and enhances nucleotide exchange of actin has led some to question whether [E2]profilin[/E2] is ever truly an actin monomer sequestering agent.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phospholipase C", "entity_1_idx": [[39, 54]], "entity_1_idx_in_text_with_entity_marker": [43, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[130, 138]], "entity_2_idx_in_text_with_entity_marker": [143, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d47.s1_BioInfer.d47.s1.p9", "text": "Recent evidence that profilin inhibits phospholipase C and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "text_with_entity_marker": "Recent evidence that [E1]profilin[/E1] inhibits [E2]phospholipase C[/E2] and enhances nucleotide exchange of actin has led some to question whether profilin is ever truly an actin monomer sequestering agent.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[21, 29]], "entity_1_idx_in_text_with_entity_marker": [25, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[39, 54]], "entity_2_idx_in_text_with_entity_marker": [52, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p60", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; [E2]4a[/E2] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "4a", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p61", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-[E1]4b[/E1]-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4b", "entity_1_idx": [[41, 43]], "entity_1_idx_in_text_with_entity_marker": [45, 47], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p62", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-[E1]N[/E1]-4a-4b-[E2]M[/E2]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "N", "entity_1_idx": [[36, 37]], "entity_1_idx_in_text_with_entity_marker": [40, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[44, 45]], "entity_2_idx_in_text_with_entity_marker": [57, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p63", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-[E1]4a[/E1]-4b-[E2]M[/E2]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[38, 40]], "entity_1_idx_in_text_with_entity_marker": [42, 44], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[44, 45]], "entity_2_idx_in_text_with_entity_marker": [57, 58], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p64", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; [E2]G[/E2] is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "G", "entity_2_idx": [[271, 272]], "entity_2_idx_in_text_with_entity_marker": [284, 285], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p65", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and [E2]L[/E2] is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[312, 313]], "entity_2_idx_in_text_with_entity_marker": [325, 326], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p66", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where [E2]N[/E2] is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "N", "entity_2_idx": [[60, 61]], "entity_2_idx_in_text_with_entity_marker": [73, 74], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p67", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p68", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p69", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-[E1]M[/E1]-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[44, 45]], "entity_1_idx_in_text_with_entity_marker": [48, 49], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p130", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E1]4a[/E1] and 4b are two genes, one of which codes for the proposed phosphoprotein [E2]P[/E2] and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "4a", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "P", "entity_2_idx": [[172, 173]], "entity_2_idx_in_text_with_entity_marker": [185, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p131", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein [E1]P[/E1] and the other for a putative protein of unknown function; M is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[172, 173]], "entity_1_idx_in_text_with_entity_marker": [176, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p132", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E1]M[/E1] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[232, 233]], "entity_1_idx_in_text_with_entity_marker": [236, 237], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p133", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E1]M[/E1] is the proposed matrix protein gene; G is the proposed [E2]glycoprotein[/E2] gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[232, 233]], "entity_1_idx_in_text_with_entity_marker": [236, 237], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "glycoprotein", "entity_2_idx": [[289, 301]], "entity_2_idx_in_text_with_entity_marker": [302, 314], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p134", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p135", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed [E1]phosphoprotein[/E1] P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[157, 171]], "entity_1_idx_in_text_with_entity_marker": [161, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p136", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; [E1]4a[/E1] and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E2]M[/E2] is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "4a", "entity_1_idx": [[96, 98]], "entity_1_idx_in_text_with_entity_marker": [100, 102], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[232, 233]], "entity_2_idx_in_text_with_entity_marker": [245, 246], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p137", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; [E1]M[/E1] is the proposed [E2]matrix protein[/E2] gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[232, 233]], "entity_1_idx_in_text_with_entity_marker": [236, 237], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "matrix protein", "entity_2_idx": [[250, 264]], "entity_2_idx_in_text_with_entity_marker": [263, 277], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p138", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed [E1]glycoprotein[/E1] gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycoprotein", "entity_1_idx": [[289, 301]], "entity_1_idx_in_text_with_entity_marker": [293, 305], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d672.s0_BioInfer.d672.s0.p139", "text": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the nucleocapsid protein gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed transcriptase gene.", "text_with_entity_marker": "The proposed LNYV genomic map is 3'-N-4a-4b-M-G-L-5', where N is the [E1]nucleocapsid protein[/E1] gene; 4a and 4b are two genes, one of which codes for the proposed phosphoprotein P and the other for a putative protein of unknown function; M is the proposed matrix protein gene; G is the proposed glycoprotein gene; and L is the proposed [E2]transcriptase[/E2] gene.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid protein", "entity_1_idx": [[69, 89]], "entity_1_idx_in_text_with_entity_marker": [73, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "transcriptase", "entity_2_idx": [[330, 343]], "entity_2_idx_in_text_with_entity_marker": [343, 356], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p0", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 [E1]cyclin-dependent kinase inhibitor[/E1] ([E2]CKI[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[241, 274]], "entity_1_idx_in_text_with_entity_marker": [245, 278], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p1", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with [E1]Myc[/E1] allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 [E2]cyclin-dependent kinase inhibitor[/E2] (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myc", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[241, 274]], "entity_2_idx_in_text_with_entity_marker": [254, 287], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p2", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of [E1]Ras[/E1] with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 [E2]cyclin-dependent kinase inhibitor[/E2] (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[241, 274]], "entity_2_idx_in_text_with_entity_marker": [254, 287], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p3", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 [E1]CDK[/E1] activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 [E2]cyclin-dependent kinase inhibitor[/E2] (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[241, 274]], "entity_2_idx_in_text_with_entity_marker": [254, 287], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p4", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of [E1]Ras[/E1] alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 [E2]cyclin-dependent kinase inhibitor[/E2] (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[241, 274]], "entity_2_idx_in_text_with_entity_marker": [254, 287], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p5", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the [E1]p27[/E1] [E2]cyclin-dependent kinase inhibitor[/E2] (CKI).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[237, 240]], "entity_1_idx_in_text_with_entity_marker": [241, 244], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[241, 274]], "entity_2_idx_in_text_with_entity_marker": [254, 287], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p6", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of [E1]cyclin E-dependent kinase[/E1] activity and the induction of S phase, coincident with the loss of the p27 [E2]cyclin-dependent kinase inhibitor[/E2] (CKI).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E-dependent kinase", "entity_1_idx": [[140, 165]], "entity_1_idx_in_text_with_entity_marker": [144, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin-dependent kinase inhibitor", "entity_2_idx": [[241, 274]], "entity_2_idx_in_text_with_entity_marker": [254, 287], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p7", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with [E1]Myc[/E1] allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor ([E2]CKI[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myc", "entity_1_idx": [[111, 114]], "entity_1_idx_in_text_with_entity_marker": [115, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p8", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of [E1]Ras[/E1] with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor ([E2]CKI[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Ras", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d266.s0_BioInfer.d266.s0.p9", "text": "However, although expression of Ras alone will not induce G1 CDK activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor (CKI).", "text_with_entity_marker": "However, although expression of Ras alone will not induce G1 [E1]CDK[/E1] activity or S phase, coexpression of Ras with Myc allows the generation of cyclin E-dependent kinase activity and the induction of S phase, coincident with the loss of the p27 cyclin-dependent kinase inhibitor ([E2]CKI[/E2]).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDK", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CKI", "entity_2_idx": [[276, 279]], "entity_2_idx_in_text_with_entity_marker": [289, 292], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p10", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/[E1]cofilin[/E1]-like actin-regulatory domains, but no specific actin structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p11", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/[E1]cofilin[/E1]-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p12", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/[E1]cofilin[/E1]-like [E2]actin[/E2]-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p13", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/[E1]cofilin[/E1]-like actin-regulatory domains, but no specific [E2]actin[/E2] structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p14", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the [E1]Rho GTPase[/E1] CDC42Hs as well as verprolin/[E2]cofilin[/E2]-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho GTPase", "entity_1_idx": [[38, 48]], "entity_1_idx_in_text_with_entity_marker": [42, 52], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p15", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "[E1]WASp[/E1] contains a binding motif for the Rho GTPase [E2]CDC42Hs[/E2] as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "WASp", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[49, 56]], "entity_2_idx_in_text_with_entity_marker": [62, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p16", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase [E1]CDC42Hs[/E1] as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by [E2]CDC42Hs[/E2]-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC42Hs", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CDC42Hs", "entity_2_idx": [[162, 169]], "entity_2_idx_in_text_with_entity_marker": [175, 182], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p17", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase [E1]CDC42Hs[/E1] as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-[E2]WASp[/E2] has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC42Hs", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WASp", "entity_2_idx": [[170, 174]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p18", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase [E1]CDC42Hs[/E1] as well as verprolin/cofilin-like [E2]actin[/E2]-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC42Hs", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d795.s0_BioInfer.d795.s0.p19", "text": "WASp contains a binding motif for the Rho GTPase CDC42Hs as well as verprolin/cofilin-like actin-regulatory domains, but no specific actin structure regulated by CDC42Hs-WASp has been identified.", "text_with_entity_marker": "WASp contains a binding motif for the Rho GTPase [E1]CDC42Hs[/E1] as well as verprolin/cofilin-like actin-regulatory domains, but no specific [E2]actin[/E2] structure regulated by CDC42Hs-WASp has been identified.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC42Hs", "entity_1_idx": [[49, 56]], "entity_1_idx_in_text_with_entity_marker": [53, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[133, 138]], "entity_2_idx_in_text_with_entity_marker": [146, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p10", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the [E1]Rho[/E1] family small GTP-binding proteins and bind to an actin-binding protein, [E2]profilin[/E2], at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p11", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the [E1]Rho[/E1] family small GTP-binding proteins and bind to an [E2]actin-binding protein[/E2], profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rho", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[133, 154]], "entity_2_idx_in_text_with_entity_marker": [146, 167], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p12", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] Bni1p and Bnr1p are potential targets of the [E2]Rho[/E2] family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Rho", "entity_2_idx": [[80, 83]], "entity_2_idx_in_text_with_entity_marker": [93, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p13", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and [E1]Bnr1p[/E1] are potential targets of the Rho family [E2]small GTP-binding proteins[/E2] and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bnr1p", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small GTP-binding proteins", "entity_2_idx": [[91, 117]], "entity_2_idx_in_text_with_entity_marker": [104, 130], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p14", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins [E1]Bni1p[/E1] and [E2]Bnr1p[/E2] are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Bni1p", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Bnr1p", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p15", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and [E1]Bnr1p[/E1] are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, [E2]profilin[/E2], at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bnr1p", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p16", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and [E1]Bnr1p[/E1] are potential targets of the Rho family small GTP-binding proteins and bind to an [E2]actin-binding protein[/E2], profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Bnr1p", "entity_1_idx": [[45, 50]], "entity_1_idx_in_text_with_entity_marker": [49, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[133, 154]], "entity_2_idx_in_text_with_entity_marker": [146, 167], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p17", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the [E1]FH proteins[/E1] Bni1p and [E2]Bnr1p[/E2] are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FH proteins", "entity_1_idx": [[23, 34]], "entity_1_idx_in_text_with_entity_marker": [27, 38], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Bnr1p", "entity_2_idx": [[45, 50]], "entity_2_idx_in_text_with_entity_marker": [58, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p18", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins [E1]Bni1p[/E1] and Bnr1p are potential targets of the Rho family [E2]small GTP-binding proteins[/E2] and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Bni1p", "entity_1_idx": [[35, 40]], "entity_1_idx_in_text_with_entity_marker": [39, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "small GTP-binding proteins", "entity_2_idx": [[91, 117]], "entity_2_idx_in_text_with_entity_marker": [104, 130], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d814.s0_BioInfer.d814.s0.p19", "text": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family small GTP-binding proteins and bind to an actin-binding protein, profilin, at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "text_with_entity_marker": "We have shown that the FH proteins Bni1p and Bnr1p are potential targets of the Rho family [E1]small GTP-binding proteins[/E1] and bind to an actin-binding protein, [E2]profilin[/E2], at their proline-rich FH1 domains to regulate reorganization of the actin cytoskeleton in the yeast Saccharomyces cerevisiae.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "small GTP-binding proteins", "entity_1_idx": [[91, 117]], "entity_1_idx_in_text_with_entity_marker": [95, 121], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p10", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and Rac families, the translational regulator RAFT1, and [E2]actin-binding proteins[/E2] like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p11", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between [E1]gephyrin[/E1], exchange factors for [E2]G proteins[/E2] of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gephyrin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G proteins", "entity_2_idx": [[68, 78]], "entity_2_idx_in_text_with_entity_marker": [81, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p12", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and [E2]Rac[/E2] families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rac", "entity_2_idx": [[94, 97]], "entity_2_idx_in_text_with_entity_marker": [107, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p13", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and Rac families, the translational regulator [E2]RAFT1[/E2], and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RAFT1", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p14", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like [E2]profilin[/E2] might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p15", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and Rac families, the translational regulator RAFT1, and [E2]actin-binding proteins[/E2] like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p16", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between [E1]gephyrin[/E1], exchange factors for [E2]G proteins[/E2] of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gephyrin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "G proteins", "entity_2_idx": [[68, 78]], "entity_2_idx_in_text_with_entity_marker": [81, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p17", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for [E1]G proteins[/E1] of the Rho and [E2]Rac[/E2] families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "G proteins", "entity_1_idx": [[68, 78]], "entity_1_idx_in_text_with_entity_marker": [72, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Rac", "entity_2_idx": [[94, 97]], "entity_2_idx_in_text_with_entity_marker": [107, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p18", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator [E1]RAFT1[/E1], and actin-binding proteins like [E2]profilin[/E2] might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAFT1", "entity_1_idx": [[136, 141]], "entity_1_idx_in_text_with_entity_marker": [140, 145], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[175, 183]], "entity_2_idx_in_text_with_entity_marker": [188, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d451.s0_BioInfer.d451.s0.p19", "text": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator RAFT1, and actin-binding proteins like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "text_with_entity_marker": "Newly disclosed interactions between gephyrin, exchange factors for G proteins of the Rho and Rac families, the translational regulator [E1]RAFT1[/E1], and [E2]actin-binding proteins[/E2] like profilin might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAFT1", "entity_1_idx": [[136, 141]], "entity_1_idx_in_text_with_entity_marker": [140, 145], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[147, 169]], "entity_2_idx_in_text_with_entity_marker": [160, 182], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s0_BioInfer.d87.s0.p0", "text": "A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "text_with_entity_marker": "A truncated [E1]beta-catenin[/E1] disrupts the interaction between [E2]E-cadherin[/E2] and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[58, 68]], "entity_2_idx_in_text_with_entity_marker": [71, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s0_BioInfer.d87.s0.p1", "text": "A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "text_with_entity_marker": "A truncated beta-catenin disrupts the interaction between [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2]: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s0_BioInfer.d87.s0.p2", "text": "A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "text_with_entity_marker": "A truncated [E1]beta-catenin[/E1] disrupts the interaction between E-cadherin and [E2]alpha-catenin[/E2]: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s1_BioInfer.d87.s1.p0", "text": "However, the recombinant fusion protein containing wild-type beta-catenin precipitated alpha-catenin from these cells.", "text_with_entity_marker": "However, the recombinant fusion protein containing wild-type [E1]beta-catenin[/E1] precipitated [E2]alpha-catenin[/E2] from these cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[61, 73]], "entity_1_idx_in_text_with_entity_marker": [65, 77], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[87, 100]], "entity_2_idx_in_text_with_entity_marker": [100, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s2_BioInfer.d87.s2.p0", "text": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.", "text_with_entity_marker": "These results suggest that the dysfunction of [E1]E-cadherin[/E1] in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[46, 56]], "entity_1_idx_in_text_with_entity_marker": [50, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[191, 203]], "entity_2_idx_in_text_with_entity_marker": [204, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s2_BioInfer.d87.s2.p1", "text": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.", "text_with_entity_marker": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with [E1]alpha-catenin[/E1], and that this defect results from the mutation in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[126, 139]], "entity_1_idx_in_text_with_entity_marker": [130, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[191, 203]], "entity_2_idx_in_text_with_entity_marker": [204, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s2_BioInfer.d87.s2.p2", "text": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.", "text_with_entity_marker": "These results suggest that the dysfunction of [E1]E-cadherin[/E1] in these cell lines is due primarily to its failure to interact with [E2]alpha-catenin[/E2], and that this defect results from the mutation in beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[46, 56]], "entity_1_idx_in_text_with_entity_marker": [50, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p0", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[53, 63]], "entity_1_idx_in_text_with_entity_marker": [57, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[68, 81]], "entity_2_idx_in_text_with_entity_marker": [81, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p1", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between E-cadherin and [E1]alpha-catenin[/E1] is mediated by [E2]beta-catenin[/E2], and that this process is blocked by NH2-terminal deletion in beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p2", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between E-cadherin and [E1]alpha-catenin[/E1] is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p3", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between [E1]E-cadherin[/E1] and alpha-catenin is mediated by [E2]beta-catenin[/E2], and that this process is blocked by NH2-terminal deletion in beta-catenin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[53, 63]], "entity_1_idx_in_text_with_entity_marker": [57, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p4", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between [E1]E-cadherin[/E1] and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[53, 63]], "entity_1_idx_in_text_with_entity_marker": [57, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p5", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by [E1]beta-catenin[/E1], and that this process is blocked by NH2-terminal deletion in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[97, 109]], "entity_1_idx_in_text_with_entity_marker": [101, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s4_BioInfer.d87.s4.p0", "text": "While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.", "text_with_entity_marker": "While [E1]alpha-catenin[/E1] has been demonstrated to be crucial for [E2]cadherin[/E2] function, the role of beta-catenin is not yet fully understood.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[6, 19]], "entity_1_idx_in_text_with_entity_marker": [10, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s4_BioInfer.d87.s4.p1", "text": "While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.", "text_with_entity_marker": "While alpha-catenin has been demonstrated to be crucial for [E1]cadherin[/E1] function, the role of [E2]beta-catenin[/E2] is not yet fully understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[60, 68]], "entity_1_idx_in_text_with_entity_marker": [64, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[91, 103]], "entity_2_idx_in_text_with_entity_marker": [104, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s4_BioInfer.d87.s4.p2", "text": "While alpha-catenin has been demonstrated to be crucial for cadherin function, the role of beta-catenin is not yet fully understood.", "text_with_entity_marker": "While [E1]alpha-catenin[/E1] has been demonstrated to be crucial for cadherin function, the role of [E2]beta-catenin[/E2] is not yet fully understood.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[6, 19]], "entity_1_idx_in_text_with_entity_marker": [10, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[91, 103]], "entity_2_idx_in_text_with_entity_marker": [104, 116], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d323.s0_BioInfer.d323.s0.p0", "text": "In cells lacking the myosin-II heavy chain, the bundles, which were induced by an over-expression of cofilin, shortened and became straight following hyperosmotic stress, forming a polygonal structure.", "text_with_entity_marker": "In cells lacking the [E1]myosin-II heavy chain[/E1], the bundles, which were induced by an over-expression of [E2]cofilin[/E2], shortened and became straight following hyperosmotic stress, forming a polygonal structure.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin-II heavy chain", "entity_1_idx": [[21, 42]], "entity_1_idx_in_text_with_entity_marker": [25, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[101, 108]], "entity_2_idx_in_text_with_entity_marker": [114, 121], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d808.s0_BioInfer.d808.s0.p0", "text": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "text_with_entity_marker": "We have characterized the interaction and nuclear localization of the nucleocapsid ([E1]N[/E1]) protein and [E2]phosphoprotein[/E2] (P) of sonchus yellow net nucleorhabdovirus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N", "entity_1_idx": [[84, 85]], "entity_1_idx_in_text_with_entity_marker": [88, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[99, 113]], "entity_2_idx_in_text_with_entity_marker": [112, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d808.s0_BioInfer.d808.s0.p1", "text": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "text_with_entity_marker": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and [E1]phosphoprotein[/E1] ([E2]P[/E2]) of sonchus yellow net nucleorhabdovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "phosphoprotein", "entity_1_idx": [[99, 113]], "entity_1_idx_in_text_with_entity_marker": [103, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[115, 116]], "entity_2_idx_in_text_with_entity_marker": [128, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d808.s0_BioInfer.d808.s0.p2", "text": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "text_with_entity_marker": "We have characterized the interaction and nuclear localization of the [E1]nucleocapsid[/E1] (N) protein and [E2]phosphoprotein[/E2] (P) of sonchus yellow net nucleorhabdovirus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid", "entity_1_idx": [[70, 82], [87, 94]], "entity_1_idx_in_text_with_entity_marker": [74, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[99, 113]], "entity_2_idx_in_text_with_entity_marker": [112, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d808.s0_BioInfer.d808.s0.p3", "text": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "text_with_entity_marker": "We have characterized the interaction and nuclear localization of the nucleocapsid ([E1]N[/E1]) protein and phosphoprotein ([E2]P[/E2]) of sonchus yellow net nucleorhabdovirus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "N", "entity_1_idx": [[84, 85]], "entity_1_idx_in_text_with_entity_marker": [88, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[115, 116]], "entity_2_idx_in_text_with_entity_marker": [128, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d808.s0_BioInfer.d808.s0.p4", "text": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "text_with_entity_marker": "We have characterized the interaction and nuclear localization of the [E1]nucleocapsid[/E1] ([E2]N[/E2]) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nucleocapsid", "entity_1_idx": [[70, 82], [87, 94]], "entity_1_idx_in_text_with_entity_marker": [74, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "N", "entity_2_idx": [[84, 85]], "entity_2_idx_in_text_with_entity_marker": [97, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d808.s0_BioInfer.d808.s0.p5", "text": "We have characterized the interaction and nuclear localization of the nucleocapsid (N) protein and phosphoprotein (P) of sonchus yellow net nucleorhabdovirus.", "text_with_entity_marker": "We have characterized the interaction and nuclear localization of the [E1]nucleocapsid[/E1] (N) protein and phosphoprotein ([E2]P[/E2]) of sonchus yellow net nucleorhabdovirus.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "nucleocapsid", "entity_1_idx": [[70, 82], [87, 94]], "entity_1_idx_in_text_with_entity_marker": [74, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[115, 116]], "entity_2_idx_in_text_with_entity_marker": [128, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s0_BioInfer.d226.s0.p0", "text": "Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "text_with_entity_marker": "Further, we show that talin, a high molecular weight structural protein that links [E1]integrins[/E1] to the [E2]actin[/E2] cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "integrins", "entity_1_idx": [[83, 92]], "entity_1_idx_in_text_with_entity_marker": [87, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s0_BioInfer.d226.s0.p1", "text": "Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "text_with_entity_marker": "Further, we show that [E1]talin[/E1], a high molecular weight structural protein that links [E2]integrins[/E2] to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[83, 92]], "entity_2_idx_in_text_with_entity_marker": [96, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s0_BioInfer.d226.s0.p2", "text": "Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "text_with_entity_marker": "Further, we show that [E1]talin[/E1], a high molecular weight structural protein that links integrins to the [E2]actin[/E2] cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p0", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and [E1]vinculin[/E1] at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "vinculin", "entity_1_idx": [[107, 115]], "entity_1_idx_in_text_with_entity_marker": [111, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p1", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on [E1]fibronectin[/E1] confirmed the presence of paxillin, talin, and vinculin at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[48, 59]], "entity_1_idx_in_text_with_entity_marker": [52, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p2", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of [E1]paxillin[/E1], talin, and vinculin at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "paxillin", "entity_1_idx": [[86, 94]], "entity_1_idx_in_text_with_entity_marker": [90, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p3", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, [E1]talin[/E1], and vinculin at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p4", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on [E1]fibronectin[/E1] confirmed the presence of paxillin, talin, and [E2]vinculin[/E2] at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[48, 59]], "entity_1_idx_in_text_with_entity_marker": [52, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p5", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of [E1]paxillin[/E1], talin, and [E2]vinculin[/E2] at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[86, 94]], "entity_1_idx_in_text_with_entity_marker": [90, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p6", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, [E1]talin[/E1], and [E2]vinculin[/E2] at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p7", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on [E1]fibronectin[/E1] confirmed the presence of [E2]paxillin[/E2], talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[48, 59]], "entity_1_idx_in_text_with_entity_marker": [52, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "paxillin", "entity_2_idx": [[86, 94]], "entity_2_idx_in_text_with_entity_marker": [99, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p8", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on [E1]fibronectin[/E1] confirmed the presence of paxillin, [E2]talin[/E2], and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[48, 59]], "entity_1_idx_in_text_with_entity_marker": [52, 63], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p9", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of [E1]paxillin[/E1], [E2]talin[/E2], and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[86, 94]], "entity_1_idx_in_text_with_entity_marker": [90, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p20", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, p27KIP1, and [E2]PCNA[/E2]; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PCNA", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p21", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and [E1]PCNA[/E1]; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p22", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and [E1]PCNA[/E1]; the cell-cell adhesion molecules of [E2]E-cadherin[/E2], alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[274, 284]], "entity_2_idx_in_text_with_entity_marker": [287, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p23", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and [E1]PCNA[/E1]; the cell-cell adhesion molecules of E-cadherin, [E2]alpha-catenin[/E2], and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[286, 299]], "entity_2_idx_in_text_with_entity_marker": [299, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p24", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, [E1]p27KIP1[/E1], and [E2]PCNA[/E2]; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p27KIP1", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PCNA", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p25", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], p16INK4, p27KIP1, and [E2]PCNA[/E2]; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PCNA", "entity_2_idx": [[232, 236]], "entity_2_idx_in_text_with_entity_marker": [245, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p26", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and [E1]PCNA[/E1]; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PCNA", "entity_1_idx": [[232, 236]], "entity_1_idx_in_text_with_entity_marker": [236, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p27", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, [E2]p16INK4[/E2], p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p16INK4", "entity_2_idx": [[210, 217]], "entity_2_idx_in_text_with_entity_marker": [223, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p28", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, [E1]p16INK4[/E1], p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16INK4", "entity_1_idx": [[210, 217]], "entity_1_idx_in_text_with_entity_marker": [214, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p29", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, [E1]p16INK4[/E1], p27KIP1, and PCNA; the cell-cell adhesion molecules of [E2]E-cadherin[/E2], alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16INK4", "entity_1_idx": [[210, 217]], "entity_1_idx_in_text_with_entity_marker": [214, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[274, 284]], "entity_2_idx_in_text_with_entity_marker": [287, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p30", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, [E1]p16INK4[/E1], p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, [E2]alpha-catenin[/E2], and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16INK4", "entity_1_idx": [[210, 217]], "entity_1_idx_in_text_with_entity_marker": [214, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[286, 299]], "entity_2_idx_in_text_with_entity_marker": [299, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p31", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, [E1]p16INK4[/E1], [E2]p27KIP1[/E2], and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16INK4", "entity_1_idx": [[210, 217]], "entity_1_idx_in_text_with_entity_marker": [214, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27KIP1", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p32", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, [E1]Rb[/E1], [E2]p16INK4[/E2], p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Rb", "entity_1_idx": [[206, 208]], "entity_1_idx_in_text_with_entity_marker": [210, 212], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p16INK4", "entity_2_idx": [[210, 217]], "entity_2_idx_in_text_with_entity_marker": [223, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p33", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, [E1]p16INK4[/E1], p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p16INK4", "entity_1_idx": [[210, 217]], "entity_1_idx_in_text_with_entity_marker": [214, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p34", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of [E2]HSP27[/E2] and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP27", "entity_2_idx": [[350, 355]], "entity_2_idx_in_text_with_entity_marker": [363, 368], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p35", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of [E2]E-cadherin[/E2], alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "E-cadherin", "entity_2_idx": [[274, 284]], "entity_2_idx_in_text_with_entity_marker": [287, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p36", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, [E2]alpha-catenin[/E2], and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[286, 299]], "entity_2_idx_in_text_with_entity_marker": [299, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p37", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, [E2]p27KIP1[/E2], and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p27KIP1", "entity_2_idx": [[219, 226]], "entity_2_idx_in_text_with_entity_marker": [232, 239], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p38", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], [E2]Rb[/E2], p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Rb", "entity_2_idx": [[206, 208]], "entity_2_idx_in_text_with_entity_marker": [219, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d422.s0_BioInfer.d422.s0.p39", "text": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of cyclin D1, Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and HSP70.", "text_with_entity_marker": "METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of [E1]cyclin D1[/E1], Rb, p16INK4, p27KIP1, and PCNA; the cell-cell adhesion molecules of E-cadherin, alpha-catenin, and beta-catenin; and the heat shock proteins of HSP27 and [E2]HSP70[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin D1", "entity_1_idx": [[195, 204]], "entity_1_idx_in_text_with_entity_marker": [199, 208], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HSP70", "entity_2_idx": [[360, 365]], "entity_2_idx_in_text_with_entity_marker": [373, 378], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p0", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive [E1]sarcomeric actin[/E1] and sarcomeric myosin heavy chain ([E2]SMHC[/E2]) normally seen after serum withdrawal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sarcomeric actin", "entity_1_idx": [[100, 116]], "entity_1_idx_in_text_with_entity_marker": [104, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMHC", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p1", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, [E1]EGF[/E1] inhibited increases in immunoreactive [E2]sarcomeric actin[/E2] and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EGF", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sarcomeric actin", "entity_2_idx": [[100, 116]], "entity_2_idx_in_text_with_entity_marker": [113, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p2", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive [E1]sarcomeric actin[/E1] and [E2]sarcomeric myosin heavy chain[/E2] (SMHC) normally seen after serum withdrawal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sarcomeric actin", "entity_1_idx": [[100, 116]], "entity_1_idx_in_text_with_entity_marker": [104, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sarcomeric myosin heavy chain", "entity_2_idx": [[121, 150]], "entity_2_idx_in_text_with_entity_marker": [134, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p3", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, [E1]EGF[/E1] inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain ([E2]SMHC[/E2]) normally seen after serum withdrawal.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EGF", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMHC", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p4", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and [E1]sarcomeric myosin heavy chain[/E1] ([E2]SMHC[/E2]) normally seen after serum withdrawal.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sarcomeric myosin heavy chain", "entity_1_idx": [[121, 150]], "entity_1_idx_in_text_with_entity_marker": [125, 154], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SMHC", "entity_2_idx": [[152, 156]], "entity_2_idx_in_text_with_entity_marker": [165, 169], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d333.s0_BioInfer.d333.s0.p5", "text": "In enriched cell lines and in a pure myocyte cell strain, EGF inhibited increases in immunoreactive sarcomeric actin and sarcomeric myosin heavy chain (SMHC) normally seen after serum withdrawal.", "text_with_entity_marker": "In enriched cell lines and in a pure myocyte cell strain, [E1]EGF[/E1] inhibited increases in immunoreactive sarcomeric actin and [E2]sarcomeric myosin heavy chain[/E2] (SMHC) normally seen after serum withdrawal.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EGF", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sarcomeric myosin heavy chain", "entity_2_idx": [[121, 150]], "entity_2_idx_in_text_with_entity_marker": [134, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p0", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the [E1]villin[/E1] and fimbrin from the cores but does not affect actin binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[201, 207]], "entity_1_idx_in_text_with_entity_marker": [205, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p1", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the [E1]villin[/E1] and [E2]fimbrin[/E2] from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[201, 207]], "entity_1_idx_in_text_with_entity_marker": [205, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p2", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the [E1]villin[/E1] and fimbrin from the cores but does not affect [E2]actin[/E2] binding by 110-kD calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "villin", "entity_1_idx": [[201, 207]], "entity_1_idx_in_text_with_entity_marker": [205, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p3", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the [E2]villin[/E2] and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[201, 207]], "entity_2_idx_in_text_with_entity_marker": [214, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p4", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the [E1]actin[/E1] of isolated cores, and can cause the dissociation of up to 30% of the [E2]villin[/E2] and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[201, 207]], "entity_2_idx_in_text_with_entity_marker": [214, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p5", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and [E1]fimbrin[/E1] from the cores but does not affect actin binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[212, 219]], "entity_1_idx_in_text_with_entity_marker": [216, 223], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p6", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect [E1]actin[/E1] binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[255, 260]], "entity_1_idx_in_text_with_entity_marker": [259, 264], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p7", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p8", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the [E1]actin[/E1] of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p9", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and [E1]fimbrin[/E1] from the cores but does not affect [E2]actin[/E2] binding by 110-kD calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[212, 219]], "entity_1_idx_in_text_with_entity_marker": [216, 223], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p10", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and [E2]fimbrin[/E2] from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p11", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the [E1]actin[/E1] of isolated cores, and can cause the dissociation of up to 30% of the villin and [E2]fimbrin[/E2] from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p12", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect [E2]actin[/E2] binding by 110-kD calmodulin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p13", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the [E1]actin[/E1] of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect [E2]actin[/E2] binding by 110-kD calmodulin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p14", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the [E2]actin[/E2] of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p10", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/[E1]CUB[/E1] and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CUB", "entity_1_idx": [[113, 116]], "entity_1_idx_in_text_with_entity_marker": [117, 120], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p11", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 ([E1]sNRP1[/E1]) isoform containing just the a/CUB and b/[E2]coagulation factor[/E2] homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sNRP1", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "coagulation factor", "entity_2_idx": [[123, 141]], "entity_2_idx_in_text_with_entity_marker": [136, 154], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p12", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 ([E1]sNRP1[/E1]) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sNRP1", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p13", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated [E1]NRP1[/E1] cDNA was cloned that encodes a 644-aa soluble NRP1 ([E2]sNRP1[/E2]) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "NRP1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "sNRP1", "entity_2_idx": [[76, 81]], "entity_2_idx_in_text_with_entity_marker": [89, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p14", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 ([E1]sNRP1[/E1]) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sNRP1", "entity_1_idx": [[76, 81]], "entity_1_idx_in_text_with_entity_marker": [80, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p15", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/[E1]coagulation factor[/E1] homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "coagulation factor", "entity_1_idx": [[123, 141]], "entity_1_idx_in_text_with_entity_marker": [127, 145], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p16", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated [E1]NRP1[/E1] cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/[E2]coagulation factor[/E2] homology extracellular domains of NRP1.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "coagulation factor", "entity_2_idx": [[123, 141]], "entity_2_idx_in_text_with_entity_marker": [136, 154], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p17", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/[E1]coagulation factor[/E1] homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "coagulation factor", "entity_1_idx": [[123, 141]], "entity_1_idx_in_text_with_entity_marker": [127, 145], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p18", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated [E1]NRP1[/E1] cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E2]NRP1[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d109.s1_BioInfer.d109.s1.p19", "text": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of NRP1.", "text_with_entity_marker": "A 2.2-kb truncated NRP1 cDNA was cloned that encodes a 644-aa soluble NRP1 (sNRP1) isoform containing just the a/CUB and b/coagulation factor homology extracellular domains of [E1-E2]NRP1[/E1-E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NRP1", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [183, 187], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NRP1", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [183, 187], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d662.s0_BioInfer.d662.s0.p0", "text": "The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.", "text_with_entity_marker": "The posttranslational metabolism of [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) and actin was regulated in parallel with the total contractile protein pool.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[56, 59]], "entity_2_idx_in_text_with_entity_marker": [69, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d662.s0_BioInfer.d662.s0.p1", "text": "The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.", "text_with_entity_marker": "The posttranslational metabolism of [E1]myosin heavy chain[/E1] (MHC) and [E2]actin[/E2] was regulated in parallel with the total contractile protein pool.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[36, 54]], "entity_1_idx_in_text_with_entity_marker": [40, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d662.s0_BioInfer.d662.s0.p2", "text": "The posttranslational metabolism of myosin heavy chain (MHC) and actin was regulated in parallel with the total contractile protein pool.", "text_with_entity_marker": "The posttranslational metabolism of myosin heavy chain ([E1]MHC[/E1]) and [E2]actin[/E2] was regulated in parallel with the total contractile protein pool.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[56, 59]], "entity_1_idx_in_text_with_entity_marker": [60, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d493.s0_BioInfer.d493.s0.p0", "text": "Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "text_with_entity_marker": "Previous studies have yielded conflicting results concerning the physiological role of [E1]profilin[/E1], a 12-15-kD [E2]actin[/E2]- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[87, 95]], "entity_1_idx_in_text_with_entity_marker": [91, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d493.s0_BioInfer.d493.s0.p1", "text": "Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "text_with_entity_marker": "Previous studies have yielded conflicting results concerning the physiological role of [E1]profilin[/E1], a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[87, 95]], "entity_1_idx_in_text_with_entity_marker": [91, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d493.s0_BioInfer.d493.s0.p2", "text": "Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "text_with_entity_marker": "Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD [E1]actin[/E1]- and phosphoinositide-binding protein, as a regulator of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[108, 113]], "entity_1_idx_in_text_with_entity_marker": [112, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p0", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated [E1]ATPase[/E1] than does [E2]beta myosin[/E2], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ATPase", "entity_1_idx": [[127, 133]], "entity_1_idx_in_text_with_entity_marker": [131, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p1", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, [E1]alpha Myosin[/E1] exhibits higher actin-activated [E2]ATPase[/E2] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha Myosin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[127, 133]], "entity_2_idx_in_text_with_entity_marker": [140, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p2", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated [E1]ATPase[/E1] than does beta myosin, and hearts expressing [E2]alpha myosin[/E2] exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[127, 133]], "entity_1_idx_in_text_with_entity_marker": [131, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha myosin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p3", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated [E1]ATPase[/E1] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ATPase", "entity_1_idx": [[127, 133]], "entity_1_idx_in_text_with_entity_marker": [131, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p4", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated [E2]ATPase[/E2] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [45, 50]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[127, 133]], "entity_2_idx_in_text_with_entity_marker": [140, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p5", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher [E1]actin[/E1]-activated [E2]ATPase[/E2] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[127, 133]], "entity_2_idx_in_text_with_entity_marker": [140, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p6", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two [E1]cardiac myosin heavy chain[/E1] isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated [E2]ATPase[/E2] than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cardiac myosin heavy chain", "entity_1_idx": [[8, 34], [55, 59]], "entity_1_idx_in_text_with_entity_marker": [12, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ATPase", "entity_2_idx": [[127, 133]], "entity_2_idx_in_text_with_entity_marker": [140, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p7", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, [E1]alpha Myosin[/E1] exhibits higher actin-activated ATPase than does [E2]beta myosin[/E2], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha Myosin", "entity_1_idx": [[82, 94]], "entity_1_idx_in_text_with_entity_marker": [86, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[144, 155]], "entity_2_idx_in_text_with_entity_marker": [157, 168], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p8", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does [E1]beta myosin[/E1], and hearts expressing [E2]alpha myosin[/E2] exhibit increased contractility relative to hearts expressing beta myosin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta myosin", "entity_1_idx": [[144, 155]], "entity_1_idx_in_text_with_entity_marker": [148, 159], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha myosin", "entity_2_idx": [[179, 191]], "entity_2_idx_in_text_with_entity_marker": [192, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d728.s0_BioInfer.d728.s0.p9", "text": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does beta myosin, and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing beta myosin.", "text_with_entity_marker": "The two cardiac myosin heavy chain isoforms, alpha and beta, differ functionally, alpha Myosin exhibits higher actin-activated ATPase than does [E1]beta myosin[/E1], and hearts expressing alpha myosin exhibit increased contractility relative to hearts expressing [E2]beta myosin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta myosin", "entity_1_idx": [[144, 155]], "entity_1_idx_in_text_with_entity_marker": [148, 159], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta myosin", "entity_2_idx": [[254, 265]], "entity_2_idx_in_text_with_entity_marker": [267, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p0", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the [E1]protein kinase[/E1] activity and stress fiber formation by [E2]LIMK2[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "protein kinase", "entity_1_idx": [[192, 206]], "entity_1_idx_in_text_with_entity_marker": [196, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p1", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for [E1]cofilin[/E1] phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the [E2]protein kinase[/E2] activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[192, 206]], "entity_2_idx_in_text_with_entity_marker": [205, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p2", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the [E2]protein kinase[/E2] activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[192, 206]], "entity_2_idx_in_text_with_entity_marker": [205, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p3", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and [E1]actin[/E1] cytoskeletal changes, whereas replacement by glutamate enhanced the [E2]protein kinase[/E2] activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[118, 123]], "entity_1_idx_in_text_with_entity_marker": [122, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[192, 206]], "entity_2_idx_in_text_with_entity_marker": [205, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p4", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished [E1]LIMK2[/E1] activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the [E2]protein kinase[/E2] activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "protein kinase", "entity_2_idx": [[192, 206]], "entity_2_idx_in_text_with_entity_marker": [205, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p5", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for [E1]cofilin[/E1] phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by [E2]LIMK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p6", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by [E2]LIMK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p7", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and [E1]actin[/E1] cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by [E2]LIMK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[118, 123]], "entity_1_idx_in_text_with_entity_marker": [122, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p8", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished [E1]LIMK2[/E1] activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by [E2]LIMK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[246, 251]], "entity_2_idx_in_text_with_entity_marker": [259, 264], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p9", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished LIMK2 activities for [E2]cofilin[/E2] phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p10", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for [E1]cofilin[/E1] phosphorylation and [E2]actin[/E2] cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[90, 97]], "entity_1_idx_in_text_with_entity_marker": [94, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p11", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished [E1]LIMK2[/E1] activities for [E2]cofilin[/E2] phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p12", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and [E2]actin[/E2] cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p13", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A [E1]LIMK2[/E1] mutant with replacement of threonine 505 by valine abolished [E2]LIMK2[/E2] activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK2", "entity_1_idx": [[2, 7]], "entity_1_idx_in_text_with_entity_marker": [6, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK2", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d36.s0_BioInfer.d36.s0.p14", "text": "A LIMK2 mutant with replacement of threonine 505 by valine abolished LIMK2 activities for cofilin phosphorylation and actin cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "text_with_entity_marker": "A LIMK2 mutant with replacement of threonine 505 by valine abolished [E1]LIMK2[/E1] activities for cofilin phosphorylation and [E2]actin[/E2] cytoskeletal changes, whereas replacement by glutamate enhanced the protein kinase activity and stress fiber formation by LIMK2.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK2", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d695.s0_BioInfer.d695.s0.p0", "text": "These data suggest that nuclear profilin can mediate a stimulus-response action on the actin cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.", "text_with_entity_marker": "These data suggest that nuclear [E1]profilin[/E1] can mediate a stimulus-response action on the [E2]actin[/E2] cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p0", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, RIP, and [E2]caspase-8[/E2], and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p1", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and [E1]caspase-8[/E1], and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caspase-8", "entity_1_idx": [[242, 251]], "entity_1_idx_in_text_with_entity_marker": [246, 255], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p2", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, [E1]RIP[/E1], and [E2]caspase-8[/E2], and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p3", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, TRADD, RIP, and [E2]caspase-8[/E2], and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p4", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and [E2]caspase-8[/E2], and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p5", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, [E1]TRADD[/E1], RIP, and [E2]caspase-8[/E2], and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[226, 231]], "entity_1_idx_in_text_with_entity_marker": [230, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p6", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, TRAIL, TRADD, RIP, and [E2]caspase-8[/E2], and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[242, 251]], "entity_2_idx_in_text_with_entity_marker": [255, 264], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p7", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and [E1]caspase-8[/E1], and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caspase-8", "entity_1_idx": [[242, 251]], "entity_1_idx_in_text_with_entity_marker": [246, 255], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p8", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and [E1]caspase-8[/E1], and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "caspase-8", "entity_1_idx": [[242, 251]], "entity_1_idx_in_text_with_entity_marker": [246, 255], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p9", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p15", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E2]FADD[/E2], TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p16", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, [E2]Fas ligand[/E2], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas ligand", "entity_2_idx": [[140, 150]], "entity_2_idx_in_text_with_entity_marker": [153, 163], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p17", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E2]TNFR-1[/E2], TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TNFR-1", "entity_2_idx": [[152, 158]], "entity_2_idx_in_text_with_entity_marker": [165, 171], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p18", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, [E1]ribonuclease[/E1] protection assay was used with specific antisense RNA probes for [E2]Fas[/E2], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonuclease", "entity_1_idx": [[57, 69]], "entity_1_idx_in_text_with_entity_marker": [61, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Fas", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p19", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, [E1]FAF[/E1], [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FAF", "entity_1_idx": [[185, 188]], "entity_1_idx_in_text_with_entity_marker": [189, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p20", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E1]TRADD[/E1], RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p21", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E1]RIP[/E1], [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RIP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p22", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, [E1]FAF[/E1], FAP, and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FAF", "entity_1_idx": [[185, 188]], "entity_1_idx_in_text_with_entity_marker": [189, 192], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p23", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p24", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p0", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by [E1]cyclin E[/E1]-cdk2, [E2]cyclin A[/E2]-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin A", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p1", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by [E1]cyclin E[/E1]-cdk2, cyclin A-cdk2, and [E2]cyclin D[/E2]-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p2", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by [E1]cyclin E[/E1]-cdk2, cyclin A-[E2]cdk2[/E2], and cyclin D-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p3", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by [E1]cyclin E[/E1]-cdk2, cyclin A-cdk2, and cyclin D-[E2]cdk4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin E", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p4", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by [E1]cyclin E[/E1]-[E2]cdk2[/E2], cyclin A-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[46, 54]], "entity_1_idx_in_text_with_entity_marker": [50, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p5", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by [E2]cyclin E[/E2]-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[46, 54]], "entity_2_idx_in_text_with_entity_marker": [59, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p6", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, [E1]cyclin A[/E1]-cdk2, and [E2]cyclin D[/E2]-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p7", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, [E1]cyclin A[/E1]-[E2]cdk2[/E2], and cyclin D-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin A", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p8", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, [E1]cyclin A[/E1]-cdk2, and cyclin D-[E2]cdk4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cyclin A", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p9", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-[E1]cdk2[/E1], [E2]cyclin A[/E2]-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin A", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p10", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, [E2]cyclin A[/E2]-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin A", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p11", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-[E1]cdk2[/E1], and [E2]cyclin D[/E2]-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p12", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and [E1]cyclin D[/E1]-[E2]cdk4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cyclin D", "entity_1_idx": [[80, 88]], "entity_1_idx_in_text_with_entity_marker": [84, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p13", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-[E1]cdk2[/E1], cyclin A-cdk2, and [E2]cyclin D[/E2]-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p14", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and [E2]cyclin D[/E2]-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin D", "entity_2_idx": [[80, 88]], "entity_2_idx_in_text_with_entity_marker": [93, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p15", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-[E1]cdk2[/E1], and cyclin D-[E2]cdk4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p16", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-[E1]cdk2[/E1], cyclin A-[E2]cdk2[/E2], and cyclin D-cdk4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p17", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-[E2]cdk2[/E2], and cyclin D-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p18", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "p27 binds to and inhibits complexes formed by cyclin E-[E1]cdk2[/E1], cyclin A-cdk2, and cyclin D-[E2]cdk4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cdk2", "entity_1_idx": [[55, 59]], "entity_1_idx_in_text_with_entity_marker": [59, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p19", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-[E2]cdk4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk4", "entity_2_idx": [[89, 93]], "entity_2_idx_in_text_with_entity_marker": [102, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d657.s0_BioInfer.d657.s0.p20", "text": "p27 binds to and inhibits complexes formed by cyclin E-cdk2, cyclin A-cdk2, and cyclin D-cdk4.", "text_with_entity_marker": "[E1]p27[/E1] binds to and inhibits complexes formed by cyclin E-[E2]cdk2[/E2], cyclin A-cdk2, and cyclin D-cdk4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p27", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[55, 59]], "entity_2_idx_in_text_with_entity_marker": [68, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d594.s0_BioInfer.d594.s0.p0", "text": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), cofilin and destrin.", "text_with_entity_marker": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors ([E1]ADF[/E1]), [E2]cofilin[/E2] and destrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[182, 185]], "entity_1_idx_in_text_with_entity_marker": [186, 189], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[188, 195]], "entity_2_idx_in_text_with_entity_marker": [201, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d594.s0_BioInfer.d594.s0.p1", "text": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), cofilin and destrin.", "text_with_entity_marker": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors ([E1]ADF[/E1]), cofilin and [E2]destrin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "ADF", "entity_1_idx": [[182, 185]], "entity_1_idx_in_text_with_entity_marker": [186, 189], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "destrin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d594.s0_BioInfer.d594.s0.p2", "text": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), cofilin and destrin.", "text_with_entity_marker": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal [E1]actin-depolymerizing factors[/E1] ([E2]ADF[/E2]), cofilin and destrin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-depolymerizing factors", "entity_1_idx": [[152, 180]], "entity_1_idx_in_text_with_entity_marker": [156, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ADF", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d594.s0_BioInfer.d594.s0.p3", "text": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), cofilin and destrin.", "text_with_entity_marker": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), [E1]cofilin[/E1] and [E2]destrin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[188, 195]], "entity_1_idx_in_text_with_entity_marker": [192, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "destrin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d594.s0_BioInfer.d594.s0.p4", "text": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), cofilin and destrin.", "text_with_entity_marker": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal [E1]actin-depolymerizing factors[/E1] (ADF), [E2]cofilin[/E2] and destrin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-depolymerizing factors", "entity_1_idx": [[152, 180]], "entity_1_idx_in_text_with_entity_marker": [156, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[188, 195]], "entity_2_idx_in_text_with_entity_marker": [201, 208], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d594.s0_BioInfer.d594.s0.p5", "text": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal actin-depolymerizing factors (ADF), cofilin and destrin.", "text_with_entity_marker": "The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal [E1]actin-depolymerizing factors[/E1] (ADF), cofilin and [E2]destrin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-depolymerizing factors", "entity_1_idx": [[152, 180]], "entity_1_idx_in_text_with_entity_marker": [156, 184], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "destrin", "entity_2_idx": [[200, 207]], "entity_2_idx_in_text_with_entity_marker": [213, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p10", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E1]H4[/E1] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[180, 182]], "entity_1_idx_in_text_with_entity_marker": [184, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p11", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones [E1]H2A[/E1], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[42, 45]], "entity_1_idx_in_text_with_entity_marker": [46, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p12", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, [E1]H3[/E1], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[52, 54]], "entity_1_idx_in_text_with_entity_marker": [56, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p13", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, [E1]H2B[/E1], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2B", "entity_1_idx": [[47, 50]], "entity_1_idx_in_text_with_entity_marker": [51, 54], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p14", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; [E1]histones[/E1] [E2]H2A[/E2] and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[387, 395]], "entity_1_idx_in_text_with_entity_marker": [391, 399], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[396, 399]], "entity_2_idx_in_text_with_entity_marker": [409, 412], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p15", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E1]H3[/E1]; [E2]histones[/E2] H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[383, 385]], "entity_1_idx_in_text_with_entity_marker": [387, 389], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[387, 395]], "entity_2_idx_in_text_with_entity_marker": [400, 408], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p16", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian [E2]histone[/E2] H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p17", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian [E1]histone[/E1] H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p18", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E1]histone[/E1] H4 shows five subfractions, analogous to the five subfractions of mammalian [E2]histone[/E2] H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[88, 95]], "entity_1_idx_in_text_with_entity_marker": [92, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p19", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian [E1]histone[/E1] H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p30", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian [E1]histone[/E1] H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone [E2]H3[/E2]; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[383, 385]], "entity_2_idx_in_text_with_entity_marker": [396, 398], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p31", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of [E2]histone[/E2] H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[375, 382]], "entity_2_idx_in_text_with_entity_marker": [388, 395], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p32", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; [E2]histone[/E2] H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[88, 95]], "entity_2_idx_in_text_with_entity_marker": [101, 108], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p33", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and [E2]H2B[/E2] show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[404, 407]], "entity_2_idx_in_text_with_entity_marker": [417, 420], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p34", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); [E2]histone[/E2] H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[245, 252]], "entity_2_idx_in_text_with_entity_marker": [258, 265], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p35", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, [E2]histones[/E2] H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histones", "entity_2_idx": [[33, 41]], "entity_2_idx_in_text_with_entity_marker": [46, 54], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p36", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone [E2]H4[/E2] shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[96, 98]], "entity_2_idx_in_text_with_entity_marker": [109, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p37", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and [E2]H4[/E2], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[60, 62]], "entity_2_idx_in_text_with_entity_marker": [73, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p38", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone [E2]H3[/E2] has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[253, 255]], "entity_2_idx_in_text_with_entity_marker": [266, 268], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p39", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core [E1]histones[/E1] from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone [E2]H4[/E2] (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p0", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of [E1]integrin[/E1] receptors, actin and cytoskeletal proteins such as vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrin", "entity_1_idx": [[182, 190]], "entity_1_idx_in_text_with_entity_marker": [186, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p1", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of [E1]integrin[/E1] receptors, actin and cytoskeletal proteins such as [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrin", "entity_1_idx": [[182, 190]], "entity_1_idx_in_text_with_entity_marker": [186, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[242, 250]], "entity_2_idx_in_text_with_entity_marker": [255, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p2", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a [E1]fibronectin[/E1]-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of [E2]integrin[/E2] receptors, actin and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "integrin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p3", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of [E2]integrin[/E2] receptors, actin and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrin", "entity_2_idx": [[182, 190]], "entity_2_idx_in_text_with_entity_marker": [195, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p4", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of [E1]integrin[/E1] receptors, [E2]actin[/E2] and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "integrin", "entity_1_idx": [[182, 190]], "entity_1_idx_in_text_with_entity_marker": [186, 194], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p5", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as [E1]vinculin[/E1] and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[242, 250]], "entity_1_idx_in_text_with_entity_marker": [246, 254], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p6", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a [E1]fibronectin[/E1]-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p7", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p8", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, [E1]actin[/E1] and cytoskeletal proteins such as vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[202, 207]], "entity_1_idx_in_text_with_entity_marker": [206, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p9", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a [E1]fibronectin[/E1]-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[242, 250]], "entity_2_idx_in_text_with_entity_marker": [255, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p10", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of integrin receptors, actin and cytoskeletal proteins such as [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[242, 250]], "entity_2_idx_in_text_with_entity_marker": [255, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p11", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, [E1]actin[/E1] and cytoskeletal proteins such as [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[202, 207]], "entity_1_idx_in_text_with_entity_marker": [206, 211], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[242, 250]], "entity_2_idx_in_text_with_entity_marker": [255, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p12", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a [E1]fibronectin[/E1]-coated glass surface, suggesting that the expression of a [E2]rac-1 GAP[/E2] alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rac-1 GAP", "entity_2_idx": [[149, 158]], "entity_2_idx_in_text_with_entity_marker": [162, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p13", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a [E1]fibronectin[/E1]-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, [E2]actin[/E2] and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fibronectin", "entity_1_idx": [[79, 90]], "entity_1_idx_in_text_with_entity_marker": [83, 94], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d734.s0_BioInfer.d734.s0.p14", "text": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a rac-1 GAP alters the assembly of integrin receptors, actin and cytoskeletal proteins such as vinculin and talin.", "text_with_entity_marker": "They had altered adhesive properties as measured by their ability to bind to a fibronectin-coated glass surface, suggesting that the expression of a [E1]rac-1 GAP[/E1] alters the assembly of integrin receptors, [E2]actin[/E2] and cytoskeletal proteins such as vinculin and talin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "rac-1 GAP", "entity_1_idx": [[149, 158]], "entity_1_idx_in_text_with_entity_marker": [153, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[202, 207]], "entity_2_idx_in_text_with_entity_marker": [215, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s0_BioInfer.d187.s0.p0", "text": "Effects of single amino acid substitutions in the actin-binding site on the biological activity of bovine profilin I.", "text_with_entity_marker": "Effects of single amino acid substitutions in the [E1]actin[/E1]-binding site on the biological activity of bovine [E2]profilin I[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[50, 55]], "entity_1_idx_in_text_with_entity_marker": [54, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[106, 116]], "entity_2_idx_in_text_with_entity_marker": [119, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s1_BioInfer.d187.s1.p0", "text": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "text_with_entity_marker": "However, these mutants displayed a lower affinity for [E1]actin[/E1] than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[184, 189]], "entity_2_idx_in_text_with_entity_marker": [197, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s1_BioInfer.d187.s1.p1", "text": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "text_with_entity_marker": "However, these mutants displayed a lower affinity for [E1]actin[/E1] than wild-type [E2]profilin[/E2], suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s1_BioInfer.d187.s1.p2", "text": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "text_with_entity_marker": "However, these mutants displayed a lower affinity for [E1]actin[/E1] than wild-type profilin, suggesting that additional putative bonds created this way cannot increase [E2]profilin[/E2]'s affinity for actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[54, 59]], "entity_1_idx_in_text_with_entity_marker": [58, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[160, 168]], "entity_2_idx_in_text_with_entity_marker": [173, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s1_BioInfer.d187.s1.p3", "text": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "text_with_entity_marker": "However, these mutants displayed a lower affinity for actin than wild-type [E1]profilin[/E1], suggesting that additional putative bonds created this way cannot increase profilin's affinity for [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[75, 83]], "entity_1_idx_in_text_with_entity_marker": [79, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[184, 189]], "entity_2_idx_in_text_with_entity_marker": [197, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s1_BioInfer.d187.s1.p4", "text": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "text_with_entity_marker": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase [E1]profilin[/E1]'s affinity for [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[160, 168]], "entity_1_idx_in_text_with_entity_marker": [164, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[184, 189]], "entity_2_idx_in_text_with_entity_marker": [197, 202], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s1_BioInfer.d187.s1.p5", "text": "However, these mutants displayed a lower affinity for actin than wild-type profilin, suggesting that additional putative bonds created this way cannot increase profilin's affinity for actin.", "text_with_entity_marker": "However, these mutants displayed a lower affinity for actin than wild-type [E1]profilin[/E1], suggesting that additional putative bonds created this way cannot increase [E2]profilin[/E2]'s affinity for actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[75, 83]], "entity_1_idx_in_text_with_entity_marker": [79, 87], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[160, 168]], "entity_2_idx_in_text_with_entity_marker": [173, 181], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d187.s2_BioInfer.d187.s2.p0", "text": "These results emphasize the highly conserved biological function of profilins with low sequence homology, and correlate specifically their actin-binding capacity with cell motility and proliferation.", "text_with_entity_marker": "These results emphasize the highly conserved biological function of [E1]profilins[/E1] with low sequence homology, and correlate specifically their [E2]actin[/E2]-binding capacity with cell motility and proliferation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilins", "entity_1_idx": [[68, 77]], "entity_1_idx_in_text_with_entity_marker": [72, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[139, 144]], "entity_2_idx_in_text_with_entity_marker": [152, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s0_BioInfer.d166.s0.p0", "text": "Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.", "text_with_entity_marker": "Deletion of both RAD50 and [E1]RAD51[/E1] produces a phenotype similar to that produced by deletion of [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s0_BioInfer.d166.s0.p1", "text": "Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.", "text_with_entity_marker": "Deletion of both [E1]RAD50[/E1] and [E2]RAD51[/E2] produces a phenotype similar to that produced by deletion of RAD52.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD50", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[27, 32]], "entity_2_idx_in_text_with_entity_marker": [40, 45], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s0_BioInfer.d166.s0.p2", "text": "Deletion of both RAD50 and RAD51 produces a phenotype similar to that produced by deletion of RAD52.", "text_with_entity_marker": "Deletion of both [E1]RAD50[/E1] and RAD51 produces a phenotype similar to that produced by deletion of [E2]RAD52[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD50", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD52", "entity_2_idx": [[94, 99]], "entity_2_idx_in_text_with_entity_marker": [107, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d166.s1_BioInfer.d166.s1.p0", "text": "rad59 mutations completely abolished the ability to generate type II survivors, while rad50 mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.", "text_with_entity_marker": "[E1]rad59[/E1] mutations completely abolished the ability to generate type II survivors, while [E2]rad50[/E2] mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "rad59", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "rad50", "entity_2_idx": [[86, 91]], "entity_2_idx_in_text_with_entity_marker": [99, 104], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p0", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone [E1]H3[/E1] and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[165, 167]], "entity_1_idx_in_text_with_entity_marker": [169, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p1", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the [E1]EF-1alpha[/E1] promoter involves increased physical interactions with acetylated histone H3 and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EF-1alpha", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "histone", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p2", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p3", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated [E1]histone[/E1] H3 and [E2]histone[/E2] H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[157, 164]], "entity_1_idx_in_text_with_entity_marker": [161, 168], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "histone", "entity_2_idx": [[172, 179]], "entity_2_idx_in_text_with_entity_marker": [185, 192], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p4", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and [E1]histone[/E1] [E2]H4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[172, 179]], "entity_1_idx_in_text_with_entity_marker": [176, 183], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p5", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the [E1]EF-1alpha[/E1] promoter involves increased physical interactions with acetylated histone [E2]H3[/E2] and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EF-1alpha", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "H3", "entity_2_idx": [[165, 167]], "entity_2_idx_in_text_with_entity_marker": [178, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p6", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone [E2]H3[/E2] and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[165, 167]], "entity_2_idx_in_text_with_entity_marker": [178, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p7", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated [E1]histone[/E1] [E2]H3[/E2] and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "histone", "entity_1_idx": [[157, 164]], "entity_1_idx_in_text_with_entity_marker": [161, 168], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[165, 167]], "entity_2_idx_in_text_with_entity_marker": [178, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p8", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone [E1]H3[/E1] and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[165, 167]], "entity_1_idx_in_text_with_entity_marker": [169, 171], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p9", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the [E2]EF-1alpha[/E2] promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "EF-1alpha", "entity_2_idx": [[81, 90]], "entity_2_idx_in_text_with_entity_marker": [94, 103], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p10", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the [E1]EF-1alpha[/E1] promoter involves increased physical interactions with acetylated [E2]histone[/E2] H3 and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "EF-1alpha", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "histone", "entity_2_idx": [[157, 164]], "entity_2_idx_in_text_with_entity_marker": [170, 177], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p11", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the [E1]EF-1alpha[/E1] promoter involves increased physical interactions with acetylated histone H3 and histone [E2]H4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "EF-1alpha", "entity_1_idx": [[81, 90]], "entity_1_idx_in_text_with_entity_marker": [85, 94], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p12", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated [E2]histone[/E2] H3 and histone H4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "histone", "entity_2_idx": [[157, 164]], "entity_2_idx_in_text_with_entity_marker": [170, 177], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p13", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that [E1]HRG[/E1] stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone [E2]H4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "HRG", "entity_1_idx": [[58, 61]], "entity_1_idx_in_text_with_entity_marker": [62, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d313.s0_BioInfer.d313.s0.p14", "text": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated histone H3 and histone H4.", "text_with_entity_marker": "In addition, we also provide new evidence to suggest that HRG stimulation of the EF-1alpha promoter involves increased physical interactions with acetylated [E1]histone[/E1] H3 and histone [E2]H4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[157, 164]], "entity_1_idx_in_text_with_entity_marker": [161, 168], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[180, 182]], "entity_2_idx_in_text_with_entity_marker": [193, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p0", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, [E1]alpha-catenin[/E1] and [E2]gamma-catenin[/E2] were seen in one case with abnormal beta-catenin immunoreactivity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[76, 89]], "entity_1_idx_in_text_with_entity_marker": [80, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p1", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of [E1]E-cadherin[/E1], alpha-catenin and [E2]gamma-catenin[/E2] were seen in one case with abnormal beta-catenin immunoreactivity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gamma-catenin", "entity_2_idx": [[94, 107]], "entity_2_idx_in_text_with_entity_marker": [107, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p2", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and [E1]gamma-catenin[/E1] were seen in one case with abnormal [E2]beta-catenin[/E2] immunoreactivity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p3", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of [E1]E-cadherin[/E1], [E2]alpha-catenin[/E2] and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[76, 89]], "entity_2_idx_in_text_with_entity_marker": [89, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p4", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, [E1]alpha-catenin[/E1] and gamma-catenin were seen in one case with abnormal [E2]beta-catenin[/E2] immunoreactivity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[76, 89]], "entity_1_idx_in_text_with_entity_marker": [80, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d418.s0_BioInfer.d418.s0.p5", "text": "Membranous staining and concomitant cytoplasmic localization of E-cadherin, alpha-catenin and gamma-catenin were seen in one case with abnormal beta-catenin immunoreactivity.", "text_with_entity_marker": "Membranous staining and concomitant cytoplasmic localization of [E1]E-cadherin[/E1], alpha-catenin and gamma-catenin were seen in one case with abnormal [E2]beta-catenin[/E2] immunoreactivity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[64, 74]], "entity_1_idx_in_text_with_entity_marker": [68, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[144, 156]], "entity_2_idx_in_text_with_entity_marker": [157, 169], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d567.s0_BioInfer.d567.s0.p0", "text": "The CREB binding domain of CBP is sufficient to contact to c-Jun in vitro.", "text_with_entity_marker": "The [E1]CREB[/E1] binding domain of [E2]CBP[/E2] is sufficient to contact to c-Jun in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CREB", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CBP", "entity_2_idx": [[27, 30]], "entity_2_idx_in_text_with_entity_marker": [40, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d567.s0_BioInfer.d567.s0.p1", "text": "The CREB binding domain of CBP is sufficient to contact to c-Jun in vitro.", "text_with_entity_marker": "The CREB binding domain of [E1]CBP[/E1] is sufficient to contact to [E2]c-Jun[/E2] in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "CBP", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[59, 64]], "entity_2_idx_in_text_with_entity_marker": [72, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d567.s0_BioInfer.d567.s0.p2", "text": "The CREB binding domain of CBP is sufficient to contact to c-Jun in vitro.", "text_with_entity_marker": "The [E1]CREB[/E1] binding domain of CBP is sufficient to contact to [E2]c-Jun[/E2] in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CREB", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-Jun", "entity_2_idx": [[59, 64]], "entity_2_idx_in_text_with_entity_marker": [72, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p70", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p71", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, TPM1, SPA2, BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p72", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, TPM1, [E2]SPA2[/E2], BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SPA2", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p73", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], [E2]SRV2[/E2], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SRV2", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p74", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, [E1]CDC55[/E1], SRV2, TPM1, SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CDC55", "entity_1_idx": [[243, 248]], "entity_1_idx_in_text_with_entity_marker": [247, 252], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p75", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], NAB1, DBR1, CDC55, SRV2, [E2]TPM1[/E2], SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TPM1", "entity_2_idx": [[256, 260]], "entity_2_idx_in_text_with_entity_marker": [269, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p76", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], NAB1, [E2]DBR1[/E2], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DBR1", "entity_2_idx": [[237, 241]], "entity_2_idx_in_text_with_entity_marker": [250, 254], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p77", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p78", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p79", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, [E1]WHI3[/E1], NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "WHI3", "entity_1_idx": [[225, 229]], "entity_1_idx_in_text_with_entity_marker": [229, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p90", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], [E2]TPM1[/E2], SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TPM1", "entity_2_idx": [[256, 260]], "entity_2_idx_in_text_with_entity_marker": [269, 273], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p91", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, [E1]TPM1[/E1], SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TPM1", "entity_1_idx": [[256, 260]], "entity_1_idx_in_text_with_entity_marker": [260, 264], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p92", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, SRV2, TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p93", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p94", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p95", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p96", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, SRV2, TPM1, [E2]SPA2[/E2], BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SPA2", "entity_2_idx": [[262, 266]], "entity_2_idx_in_text_with_entity_marker": [275, 279], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p97", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, [E2]SRV2[/E2], TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SRV2", "entity_2_idx": [[250, 254]], "entity_2_idx_in_text_with_entity_marker": [263, 267], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p98", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, [E1]DBR1[/E1], CDC55, SRV2, TPM1, SPA2, BNI1, [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DBR1", "entity_1_idx": [[237, 241]], "entity_1_idx_in_text_with_entity_marker": [241, 245], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p99", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E1]BNI1[/E1], DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[268, 272]], "entity_1_idx_in_text_with_entity_marker": [272, 276], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p100", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E1]BNI1[/E1], DFG5, DFG9, DFG10, BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[268, 272]], "entity_1_idx_in_text_with_entity_marker": [272, 276], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p101", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E1]BNI1[/E1], DFG5, [E2]DFG9[/E2], DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[268, 272]], "entity_1_idx_in_text_with_entity_marker": [272, 276], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG9", "entity_2_idx": [[280, 284]], "entity_2_idx_in_text_with_entity_marker": [293, 297], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p102", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E1]SPA2[/E1], [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SPA2", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p103", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, SPA2, [E2]BNI1[/E2], DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BNI1", "entity_2_idx": [[268, 272]], "entity_2_idx_in_text_with_entity_marker": [281, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p104", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, [E1]BNI1[/E1], [E2]DFG5[/E2], DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BNI1", "entity_1_idx": [[268, 272]], "entity_1_idx_in_text_with_entity_marker": [272, 276], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG5", "entity_2_idx": [[274, 278]], "entity_2_idx_in_text_with_entity_marker": [287, 291], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p105", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, [E1]DFG10[/E1], BUD8 and [E2]DFG16[/E2], mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG10", "entity_1_idx": [[286, 291]], "entity_1_idx_in_text_with_entity_marker": [290, 295], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG16", "entity_2_idx": [[302, 307]], "entity_2_idx_in_text_with_entity_marker": [315, 320], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p106", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, [E1]DFG9[/E1], [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG9", "entity_1_idx": [[280, 284]], "entity_1_idx_in_text_with_entity_marker": [284, 288], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p107", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, [E1]SPA2[/E1], BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SPA2", "entity_1_idx": [[262, 266]], "entity_1_idx_in_text_with_entity_marker": [266, 270], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p108", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, [E1]SRV2[/E1], TPM1, SPA2, BNI1, DFG5, DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SRV2", "entity_1_idx": [[250, 254]], "entity_1_idx_in_text_with_entity_marker": [254, 258], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d243.s0_BioInfer.d243.s0.p109", "text": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, DFG5, DFG9, DFG10, BUD8 and DFG16, mutations that block filamentous growth.", "text_with_entity_marker": "Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, CDC39, STE12, TEC1, WHI3, NAB1, DBR1, CDC55, SRV2, TPM1, SPA2, BNI1, [E1]DFG5[/E1], DFG9, [E2]DFG10[/E2], BUD8 and DFG16, mutations that block filamentous growth.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DFG5", "entity_1_idx": [[274, 278]], "entity_1_idx_in_text_with_entity_marker": [278, 282], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DFG10", "entity_2_idx": [[286, 291]], "entity_2_idx_in_text_with_entity_marker": [299, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p30", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to [E1]p55-R[/E1]; another, TRADD, binds to the p55 [E2]TNF receptor[/E2] but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55-R", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[100, 112]], "entity_2_idx_in_text_with_entity_marker": [113, 125], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p31", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to [E1]p55-R[/E1]; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, [E2]RIP[/E2], binds weakly to both receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p55-R", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p32", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to [E1]p55-R[/E1]; another, TRADD, binds to the p55 TNF receptor but not to [E2]Fas[/E2]/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55-R", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p33", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to [E1]p55-R[/E1]; another, TRADD, binds to the [E2]p55[/E2] TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p55-R", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p34", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to Fas/[E2]APO1[/E2] but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "APO1", "entity_2_idx": [[44, 48]], "entity_2_idx_in_text_with_entity_marker": [57, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p35", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to [E2]Fas[/E2]/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[40, 43]], "entity_2_idx_in_text_with_entity_marker": [53, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p36", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 [E2]TNF receptor[/E2] but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[100, 112]], "entity_2_idx_in_text_with_entity_marker": [113, 125], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p37", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, [E2]RIP[/E2], binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "RIP", "entity_2_idx": [[149, 152]], "entity_2_idx_in_text_with_entity_marker": [162, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p38", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to [E2]Fas[/E2]/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[124, 127]], "entity_2_idx_in_text_with_entity_marker": [137, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d461.s0_BioInfer.d461.s0.p39", "text": "One, MORT1 (also called FADD), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the p55 TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "text_with_entity_marker": "One, MORT1 (also called [E1]FADD[/E1]), binds to Fas/APO1 but not to p55-R; another, TRADD, binds to the [E2]p55[/E2] TNF receptor but not to Fas/APO1; and the third, RIP, binds weakly to both receptors.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "FADD", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d528.s0_BioInfer.d528.s0.p0", "text": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "text_with_entity_marker": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as [E1]actin[/E1] (43 kDa Mr), myosin heavy chain (195 kDa Mr), [E2]spectrin[/E2] (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "spectrin", "entity_2_idx": [[177, 185]], "entity_2_idx_in_text_with_entity_marker": [190, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d528.s0_BioInfer.d528.s0.p1", "text": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "text_with_entity_marker": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), [E1]spectrin[/E1] (235 and 240 kDa Mr), and [E2]tubulin[/E2] (51-54 kDa Mr).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "spectrin", "entity_1_idx": [[177, 185]], "entity_1_idx_in_text_with_entity_marker": [181, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d528.s0_BioInfer.d528.s0.p2", "text": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "text_with_entity_marker": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), [E1]myosin heavy chain[/E1] (195 kDa Mr), [E2]spectrin[/E2] (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[144, 162]], "entity_1_idx_in_text_with_entity_marker": [148, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "spectrin", "entity_2_idx": [[177, 185]], "entity_2_idx_in_text_with_entity_marker": [190, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d528.s0_BioInfer.d528.s0.p3", "text": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "text_with_entity_marker": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as [E1]actin[/E1] (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and [E2]tubulin[/E2] (51-54 kDa Mr).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d528.s0_BioInfer.d528.s0.p4", "text": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "text_with_entity_marker": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as [E1]actin[/E1] (43 kDa Mr), [E2]myosin heavy chain[/E2] (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[125, 130]], "entity_1_idx_in_text_with_entity_marker": [129, 134], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[144, 162]], "entity_2_idx_in_text_with_entity_marker": [157, 175], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d528.s0_BioInfer.d528.s0.p5", "text": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), myosin heavy chain (195 kDa Mr), spectrin (235 and 240 kDa Mr), and tubulin (51-54 kDa Mr).", "text_with_entity_marker": "SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as actin (43 kDa Mr), [E1]myosin heavy chain[/E1] (195 kDa Mr), spectrin (235 and 240 kDa Mr), and [E2]tubulin[/E2] (51-54 kDa Mr).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[144, 162]], "entity_1_idx_in_text_with_entity_marker": [148, 166], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tubulin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p0", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, [E1]beta-catenin[/E1], and gamma-catenin ([E2]plakoglobin[/E2]) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[83, 95]], "entity_1_idx_in_text_with_entity_marker": [87, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p1", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], and gamma-catenin (plakoglobin) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[83, 95]], "entity_2_idx_in_text_with_entity_marker": [96, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p2", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, [E1]beta-catenin[/E1], and [E2]gamma-catenin[/E2] (plakoglobin) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[83, 95]], "entity_1_idx_in_text_with_entity_marker": [87, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p3", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of [E1]alpha-catenin[/E1], beta-catenin, and gamma-catenin ([E2]plakoglobin[/E2]) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p4", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and [E1]gamma-catenin[/E1] ([E2]plakoglobin[/E2]) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[101, 114]], "entity_1_idx_in_text_with_entity_marker": [105, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d286.s0_BioInfer.d286.s0.p5", "text": "Immunoblot and Northern blot analyses also revealed the presence of alpha-catenin, beta-catenin, and gamma-catenin (plakoglobin) in these cell lines.", "text_with_entity_marker": "Immunoblot and Northern blot analyses also revealed the presence of [E1]alpha-catenin[/E1], beta-catenin, and [E2]gamma-catenin[/E2] (plakoglobin) in these cell lines.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[101, 114]], "entity_2_idx_in_text_with_entity_marker": [114, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p0", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, [E1]MyoD[/E1] and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[181, 185]], "entity_1_idx_in_text_with_entity_marker": [185, 189], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p1", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E1]sarcomeric actin[/E1], Myf-5, [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sarcomeric actin", "entity_1_idx": [[156, 172]], "entity_1_idx_in_text_with_entity_marker": [160, 176], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p2", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, [E1]Myf-5[/E1], [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[174, 179]], "entity_1_idx_in_text_with_entity_marker": [178, 183], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p3", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, sarcomeric actin, Myf-5, [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p4", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], sarcomeric actin, Myf-5, [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p5", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p6", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, sarcomeric actin, Myf-5, [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p7", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, [E2]MyoD[/E2] and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[181, 185]], "entity_2_idx_in_text_with_entity_marker": [194, 198], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p8", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E1]sarcomeric actin[/E1], Myf-5, MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "sarcomeric actin", "entity_1_idx": [[156, 172]], "entity_1_idx_in_text_with_entity_marker": [160, 176], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p9", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, [E1]Myf-5[/E1], MyoD and [E2]myogenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Myf-5", "entity_1_idx": [[174, 179]], "entity_1_idx_in_text_with_entity_marker": [178, 183], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myogenin", "entity_2_idx": [[190, 198]], "entity_2_idx_in_text_with_entity_marker": [203, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d543.s0_BioInfer.d543.s0.p0", "text": "Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.", "text_with_entity_marker": "[E1]Single-headed myosin[/E1], which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and [E2]actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Single-headed myosin", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d543.s0_BioInfer.d543.s0.p1", "text": "Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.", "text_with_entity_marker": "Single-headed myosin, which consists of a full length [E1]myosin heavy chain[/E1] and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and [E2]actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[54, 72]], "entity_1_idx_in_text_with_entity_marker": [58, 76], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[159, 164]], "entity_2_idx_in_text_with_entity_marker": [172, 177], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d543.s0_BioInfer.d543.s0.p2", "text": "Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.", "text_with_entity_marker": "[E1]Single-headed myosin[/E1], which consists of a full length [E2]myosin heavy chain[/E2] and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Single-headed myosin", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "myosin heavy chain", "entity_2_idx": [[54, 72]], "entity_2_idx_in_text_with_entity_marker": [67, 85], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p0", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme [E1]MluI[/E1]; the presence of [E2]MluI[/E2] restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MluI", "entity_1_idx": [[263, 267]], "entity_1_idx_in_text_with_entity_marker": [267, 271], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MluI", "entity_2_idx": [[285, 289]], "entity_2_idx_in_text_with_entity_marker": [298, 302], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p1", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of [E1]RAD54[/E1], an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme [E2]MluI[/E2]; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[118, 123]], "entity_1_idx_in_text_with_entity_marker": [122, 127], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[263, 267]], "entity_2_idx_in_text_with_entity_marker": [276, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p2", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the [E1]RAD54[/E1] transcript, and also contain two sites for restriction enzyme [E2]MluI[/E2]; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[195, 200]], "entity_1_idx_in_text_with_entity_marker": [199, 204], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[263, 267]], "entity_2_idx_in_text_with_entity_marker": [276, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p3", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for [E1]RAD51[/E1] protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme [E2]MluI[/E2]; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[263, 267]], "entity_2_idx_in_text_with_entity_marker": [276, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p4", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of [E1]RAD54[/E1], an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of [E2]MluI[/E2] restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[118, 123]], "entity_1_idx_in_text_with_entity_marker": [122, 127], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[285, 289]], "entity_2_idx_in_text_with_entity_marker": [298, 302], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p5", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the [E1]RAD54[/E1] transcript, and also contain two sites for restriction enzyme MluI; the presence of [E2]MluI[/E2] restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD54", "entity_1_idx": [[195, 200]], "entity_1_idx_in_text_with_entity_marker": [199, 204], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[285, 289]], "entity_2_idx_in_text_with_entity_marker": [298, 302], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p6", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for [E1]RAD51[/E1] protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of [E2]MluI[/E2] restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[285, 289]], "entity_2_idx_in_text_with_entity_marker": [298, 302], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p7", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of [E1]RAD54[/E1], an upstream activating sequence required for damage regulation of the [E2]RAD54[/E2] transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD54", "entity_1_idx": [[118, 123]], "entity_1_idx_in_text_with_entity_marker": [122, 127], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p8", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for [E1]RAD51[/E1] protein share homology with the damage response sequence element of [E2]RAD54[/E2], an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p9", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for [E1]RAD51[/E1] protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the [E2]RAD54[/E2] transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d597.s0_BioInfer.d597.s0.p0", "text": "The concentration of beta-catenin was constant during the follicular phase, whereas the content of alpha-catenin decreased in granulosa cells after treatment with diethylstilboestrol or hCG.", "text_with_entity_marker": "The concentration of [E1]beta-catenin[/E1] was constant during the follicular phase, whereas the content of [E2]alpha-catenin[/E2] decreased in granulosa cells after treatment with diethylstilboestrol or hCG.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[21, 33]], "entity_1_idx_in_text_with_entity_marker": [25, 37], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[99, 112]], "entity_2_idx_in_text_with_entity_marker": [112, 125], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d597.s1_BioInfer.d597.s1.p0", "text": "alpha- and beta-catenin were present in most ovarian cells at all stages of folliculogenesis.", "text_with_entity_marker": "[E1]alpha-[/E1] and [E2]beta-catenin[/E2] were present in most ovarian cells at all stages of folliculogenesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-", "entity_1_idx": [[0, 6], [16, 23]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[11, 23]], "entity_2_idx_in_text_with_entity_marker": [24, 36], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d352.s0_BioInfer.d352.s0.p0", "text": "In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.", "text_with_entity_marker": "In resting leukocytes, [E1]beta2 integrins[/E1] are constitutively linked to the [E2]actin[/E2] cytoskeleton via the protein talin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta2 integrins", "entity_1_idx": [[23, 38]], "entity_1_idx_in_text_with_entity_marker": [27, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d352.s0_BioInfer.d352.s0.p1", "text": "In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.", "text_with_entity_marker": "In resting leukocytes, beta2 integrins are constitutively linked to the [E1]actin[/E1] cytoskeleton via the protein [E2]talin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d352.s0_BioInfer.d352.s0.p2", "text": "In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.", "text_with_entity_marker": "In resting leukocytes, [E1]beta2 integrins[/E1] are constitutively linked to the actin cytoskeleton via the protein [E2]talin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta2 integrins", "entity_1_idx": [[23, 38]], "entity_1_idx_in_text_with_entity_marker": [27, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s0_BioInfer.d100.s0.p0", "text": "Biochemical complementation experiments also indicate that the PRP9 and PRP11 proteins interact.", "text_with_entity_marker": "Biochemical complementation experiments also indicate that the [E1]PRP9[/E1] and [E2]PRP11[/E2] proteins interact.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP9", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p0", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins ([E1]PRP5[/E1], PRP9, PRP11, and PRP21) interact to promote [E2]U2 snRNP[/E2] binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP5", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p1", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins ([E1]PRP5[/E1], PRP9, PRP11, and [E2]PRP21[/E2]) interact to promote U2 snRNP binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP5", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p2", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins ([E1]PRP5[/E1], [E2]PRP9[/E2], PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP5", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[40, 44]], "entity_2_idx_in_text_with_entity_marker": [53, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p3", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins ([E1]PRP5[/E1], PRP9, [E2]PRP11[/E2], and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP5", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p4", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and [E1]PRP21[/E1]) interact to promote [E2]U2 snRNP[/E2] binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP21", "entity_1_idx": [[57, 62]], "entity_1_idx_in_text_with_entity_marker": [61, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p5", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins (PRP5, [E1]PRP9[/E1], PRP11, and PRP21) interact to promote [E2]U2 snRNP[/E2] binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP9", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p6", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins (PRP5, PRP9, [E1]PRP11[/E1], and PRP21) interact to promote [E2]U2 snRNP[/E2] binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP11", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p7", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins (PRP5, [E1]PRP9[/E1], PRP11, and [E2]PRP21[/E2]) interact to promote U2 snRNP binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP9", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p8", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins (PRP5, PRP9, [E1]PRP11[/E1], and [E2]PRP21[/E2]) interact to promote U2 snRNP binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP11", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP21", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s1_BioInfer.d100.s1.p9", "text": "Four yeast spliceosomal proteins (PRP5, PRP9, PRP11, and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "text_with_entity_marker": "Four yeast spliceosomal proteins (PRP5, [E1]PRP9[/E1], [E2]PRP11[/E2], and PRP21) interact to promote U2 snRNP binding to pre-mRNA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP9", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p0", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that [E1]PRP5[/E1] (a DEAD box helicase-like protein), [E2]PRP9[/E2], and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP5", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p1", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that PRP5 (a DEAD box helicase-like protein), [E1]PRP9[/E1], and [E2]PRP11[/E2] are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP9", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p2", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that PRP5 (a DEAD box helicase-like protein), [E1]PRP9[/E1], and PRP11 are each required for the [E2]U2 snRNP[/E2] to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP9", "entity_1_idx": [[60, 64]], "entity_1_idx_in_text_with_entity_marker": [64, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p3", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that PRP5 (a [E1]DEAD box helicase[/E1]-like protein), [E2]PRP9[/E2], and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DEAD box helicase", "entity_1_idx": [[27, 44]], "entity_1_idx_in_text_with_entity_marker": [31, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP9", "entity_2_idx": [[60, 64]], "entity_2_idx_in_text_with_entity_marker": [73, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p4", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that [E1]PRP5[/E1] (a DEAD box helicase-like protein), PRP9, and [E2]PRP11[/E2] are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PRP5", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p5", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that [E1]PRP5[/E1] (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the [E2]U2 snRNP[/E2] to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP5", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p6", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that [E1]PRP5[/E1] (a [E2]DEAD box helicase[/E2]-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP5", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "DEAD box helicase", "entity_2_idx": [[27, 44]], "entity_2_idx_in_text_with_entity_marker": [40, 57], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p7", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and [E1]PRP11[/E1] are each required for the [E2]U2 snRNP[/E2] to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "PRP11", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p8", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that PRP5 (a [E1]DEAD box helicase[/E1]-like protein), PRP9, and [E2]PRP11[/E2] are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DEAD box helicase", "entity_1_idx": [[27, 44]], "entity_1_idx_in_text_with_entity_marker": [31, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PRP11", "entity_2_idx": [[70, 75]], "entity_2_idx_in_text_with_entity_marker": [83, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d100.s2_BioInfer.d100.s2.p9", "text": "Here, we show that PRP5 (a DEAD box helicase-like protein), PRP9, and PRP11 are each required for the U2 snRNP to bind to the pre-spliceosome during spliceosome assembly in vitro.", "text_with_entity_marker": "Here, we show that PRP5 (a [E1]DEAD box helicase[/E1]-like protein), PRP9, and PRP11 are each required for the [E2]U2 snRNP[/E2] to bind to the pre-spliceosome during spliceosome assembly in vitro.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DEAD box helicase", "entity_1_idx": [[27, 44]], "entity_1_idx_in_text_with_entity_marker": [31, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "U2 snRNP", "entity_2_idx": [[102, 110]], "entity_2_idx_in_text_with_entity_marker": [115, 123], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s0_BioInfer.d391.s0.p0", "text": "Isolation of profilin from embryonic chicken skeletal muscle and evaluation of its interaction with different actin isoforms.", "text_with_entity_marker": "Isolation of [E1]profilin[/E1] from embryonic chicken skeletal muscle and evaluation of its interaction with different [E2]actin[/E2] isoforms.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s1_BioInfer.d391.s1.p0", "text": "These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "text_with_entity_marker": "These results indicate that the assembly of cytoskeletal and [E1]sarcomeric actins[/E1] is regulated differently by [E2]profilin[/E2] in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "sarcomeric actins", "entity_1_idx": [[61, 78]], "entity_1_idx_in_text_with_entity_marker": [65, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s1_BioInfer.d391.s1.p1", "text": "These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "text_with_entity_marker": "These results indicate that the assembly of [E1]cytoskeletal[/E1] and sarcomeric actins is regulated differently by [E2]profilin[/E2] in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cytoskeletal", "entity_1_idx": [[44, 56], [72, 78]], "entity_1_idx_in_text_with_entity_marker": [48, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[107, 115]], "entity_2_idx_in_text_with_entity_marker": [120, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d391.s1_BioInfer.d391.s1.p2", "text": "These results indicate that the assembly of cytoskeletal and sarcomeric actins is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "text_with_entity_marker": "These results indicate that the assembly of [E1]cytoskeletal[/E1] and [E2]sarcomeric actins[/E2] is regulated differently by profilin in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cytoskeletal", "entity_1_idx": [[44, 56], [72, 78]], "entity_1_idx_in_text_with_entity_marker": [48, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "sarcomeric actins", "entity_2_idx": [[61, 78]], "entity_2_idx_in_text_with_entity_marker": [74, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p0", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, [E1]actin binding protein[/E1] (ABP), talin, and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin binding protein", "entity_1_idx": [[176, 197]], "entity_1_idx_in_text_with_entity_marker": [180, 201], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin heavy chain", "entity_2_idx": [[216, 234]], "entity_2_idx_in_text_with_entity_marker": [229, 247], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p1", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, [E1]actin binding protein[/E1] (ABP), [E2]talin[/E2], and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin binding protein", "entity_1_idx": [[176, 197]], "entity_1_idx_in_text_with_entity_marker": [180, 201], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p2", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, [E1]actin binding protein[/E1] ([E2]ABP[/E2]), talin, and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin binding protein", "entity_1_idx": [[176, 197]], "entity_1_idx_in_text_with_entity_marker": [180, 201], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "ABP", "entity_2_idx": [[199, 202]], "entity_2_idx_in_text_with_entity_marker": [212, 215], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p3", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), [E1]talin[/E1], and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[205, 210]], "entity_1_idx_in_text_with_entity_marker": [209, 214], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[216, 234]], "entity_2_idx_in_text_with_entity_marker": [229, 247], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p4", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein ([E1]ABP[/E1]), talin, and [E2]myosin heavy chain[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP", "entity_1_idx": [[199, 202]], "entity_1_idx_in_text_with_entity_marker": [203, 206], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin heavy chain", "entity_2_idx": [[216, 234]], "entity_2_idx_in_text_with_entity_marker": [229, 247], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d230.s0_BioInfer.d230.s0.p5", "text": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein (ABP), talin, and myosin heavy chain.", "text_with_entity_marker": "Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, actin binding protein ([E1]ABP[/E1]), [E2]talin[/E2], and myosin heavy chain.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ABP", "entity_1_idx": [[199, 202]], "entity_1_idx_in_text_with_entity_marker": [203, 206], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[205, 210]], "entity_2_idx_in_text_with_entity_marker": [218, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d455.s0_BioInfer.d455.s0.p0", "text": "Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.", "text_with_entity_marker": "Notably, the two pro-apoptotic adapter proteins [E1]TRADD[/E1] and [E2]FADD[/E2] are also involved in the activation of A-SMase.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TRADD", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[58, 62]], "entity_2_idx_in_text_with_entity_marker": [71, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d455.s0_BioInfer.d455.s0.p1", "text": "Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.", "text_with_entity_marker": "Notably, the two pro-apoptotic adapter proteins TRADD and [E1]FADD[/E1] are also involved in the activation of [E2]A-SMase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[58, 62]], "entity_1_idx_in_text_with_entity_marker": [62, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d455.s0_BioInfer.d455.s0.p2", "text": "Notably, the two pro-apoptotic adapter proteins TRADD and FADD are also involved in the activation of A-SMase.", "text_with_entity_marker": "Notably, the two pro-apoptotic adapter proteins [E1]TRADD[/E1] and FADD are also involved in the activation of [E2]A-SMase[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d411.s0_BioInfer.d411.s0.p0", "text": "Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, RAD51 and RAD54, have been isolated.", "text_with_entity_marker": "Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, [E1]RAD51[/E1] and [E2]RAD54[/E2], have been isolated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD51", "entity_1_idx": [[112, 117]], "entity_1_idx_in_text_with_entity_marker": [116, 121], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD54", "entity_2_idx": [[122, 127]], "entity_2_idx_in_text_with_entity_marker": [135, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d2.s0_BioInfer.d2.s0.p0", "text": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "text_with_entity_marker": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for [E1]alpha-catenin[/E1], in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for [E2]gamma-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[185, 198]], "entity_2_idx_in_text_with_entity_marker": [198, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d2.s0_BioInfer.d2.s0.p1", "text": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "text_with_entity_marker": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for [E1]E-cadherin[/E1], in 35 (66.0%) for [E2]alpha-catenin[/E2], in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[86, 96]], "entity_1_idx_in_text_with_entity_marker": [90, 100], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[116, 129]], "entity_2_idx_in_text_with_entity_marker": [129, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d2.s0_BioInfer.d2.s0.p2", "text": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "text_with_entity_marker": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for [E1]alpha-catenin[/E1], in 20 (37.7%) for [E2]beta-catenin[/E2], and in 37 (69.8%) for gamma-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[116, 129]], "entity_1_idx_in_text_with_entity_marker": [120, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[149, 161]], "entity_2_idx_in_text_with_entity_marker": [162, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d2.s0_BioInfer.d2.s0.p3", "text": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "text_with_entity_marker": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for [E1]E-cadherin[/E1], in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for [E2]gamma-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[86, 96]], "entity_1_idx_in_text_with_entity_marker": [90, 100], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[185, 198]], "entity_2_idx_in_text_with_entity_marker": [198, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d2.s0_BioInfer.d2.s0.p4", "text": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "text_with_entity_marker": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for [E1]beta-catenin[/E1], and in 37 (69.8%) for [E2]gamma-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[149, 161]], "entity_1_idx_in_text_with_entity_marker": [153, 165], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma-catenin", "entity_2_idx": [[185, 198]], "entity_2_idx_in_text_with_entity_marker": [198, 211], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d2.s0_BioInfer.d2.s0.p5", "text": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for E-cadherin, in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for beta-catenin, and in 37 (69.8%) for gamma-catenin.", "text_with_entity_marker": "Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for [E1]E-cadherin[/E1], in 35 (66.0%) for alpha-catenin, in 20 (37.7%) for [E2]beta-catenin[/E2], and in 37 (69.8%) for gamma-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[86, 96]], "entity_1_idx_in_text_with_entity_marker": [90, 100], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[149, 161]], "entity_2_idx_in_text_with_entity_marker": [162, 174], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d499.s0_BioInfer.d499.s0.p0", "text": "Protein phosphorylation of cofilin, an actin-binding protein that depolymerizes actin filaments, suppresses its function.", "text_with_entity_marker": "Protein phosphorylation of [E1]cofilin[/E1], an [E2]actin-binding protein[/E2] that depolymerizes actin filaments, suppresses its function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding protein", "entity_2_idx": [[39, 60]], "entity_2_idx_in_text_with_entity_marker": [52, 73], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d499.s0_BioInfer.d499.s0.p1", "text": "Protein phosphorylation of cofilin, an actin-binding protein that depolymerizes actin filaments, suppresses its function.", "text_with_entity_marker": "Protein phosphorylation of [E1]cofilin[/E1], an actin-binding protein that depolymerizes [E2]actin[/E2] filaments, suppresses its function.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[27, 34]], "entity_1_idx_in_text_with_entity_marker": [31, 38], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d499.s0_BioInfer.d499.s0.p2", "text": "Protein phosphorylation of cofilin, an actin-binding protein that depolymerizes actin filaments, suppresses its function.", "text_with_entity_marker": "Protein phosphorylation of cofilin, an [E1]actin-binding protein[/E1] that depolymerizes [E2]actin[/E2] filaments, suppresses its function.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[39, 60]], "entity_1_idx_in_text_with_entity_marker": [43, 64], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d412.s0_BioInfer.d412.s0.p0", "text": "Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Mammalian LIM-kinases ([E1]LIMKs[/E1]) phosphorylate cofilin and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMKs", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d412.s0_BioInfer.d412.s0.p1", "text": "Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Mammalian [E1]LIM-kinases[/E1] (LIMKs) phosphorylate cofilin and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinases", "entity_1_idx": [[10, 21]], "entity_1_idx_in_text_with_entity_marker": [14, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d412.s0_BioInfer.d412.s0.p2", "text": "Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Mammalian LIM-kinases (LIMKs) phosphorylate [E1]cofilin[/E1] and induce [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[44, 51]], "entity_1_idx_in_text_with_entity_marker": [48, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d412.s0_BioInfer.d412.s0.p3", "text": "Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Mammalian [E1]LIM-kinases[/E1] ([E2]LIMKs[/E2]) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIM-kinases", "entity_1_idx": [[10, 21]], "entity_1_idx_in_text_with_entity_marker": [14, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMKs", "entity_2_idx": [[23, 28]], "entity_2_idx_in_text_with_entity_marker": [36, 41], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d412.s0_BioInfer.d412.s0.p4", "text": "Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Mammalian LIM-kinases ([E1]LIMKs[/E1]) phosphorylate [E2]cofilin[/E2] and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMKs", "entity_1_idx": [[23, 28]], "entity_1_idx_in_text_with_entity_marker": [27, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[44, 51]], "entity_2_idx_in_text_with_entity_marker": [57, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d412.s0_BioInfer.d412.s0.p5", "text": "Mammalian LIM-kinases (LIMKs) phosphorylate cofilin and induce actin cytoskeletal reorganization.", "text_with_entity_marker": "Mammalian [E1]LIM-kinases[/E1] (LIMKs) phosphorylate [E2]cofilin[/E2] and induce actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinases", "entity_1_idx": [[10, 21]], "entity_1_idx_in_text_with_entity_marker": [14, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[44, 51]], "entity_2_idx_in_text_with_entity_marker": [57, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d189.s0_BioInfer.d189.s0.p0", "text": "Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing actin and talin.", "text_with_entity_marker": "Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing [E1]actin[/E1] and [E2]talin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[227, 232]], "entity_1_idx_in_text_with_entity_marker": [231, 236], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d354.s0_BioInfer.d354.s0.p0", "text": "Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.", "text_with_entity_marker": "[E1]Insulin-like growth factor-I[/E1], [E2]actin[/E2], and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin-like growth factor-I", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[30, 35]], "entity_2_idx_in_text_with_entity_marker": [43, 48], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d354.s0_BioInfer.d354.s0.p1", "text": "Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.", "text_with_entity_marker": "Insulin-like growth factor-I, [E1]actin[/E1], and [E2]myosin heavy chain[/E2] messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[41, 59]], "entity_2_idx_in_text_with_entity_marker": [54, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d354.s0_BioInfer.d354.s0.p2", "text": "Insulin-like growth factor-I, actin, and myosin heavy chain messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.", "text_with_entity_marker": "[E1]Insulin-like growth factor-I[/E1], actin, and [E2]myosin heavy chain[/E2] messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Insulin-like growth factor-I", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[41, 59]], "entity_2_idx_in_text_with_entity_marker": [54, 72], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p0", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and [E1]laminin[/E1]) and time in culture on the expression of genes encoding [E2]myosin heavy chain[/E2] (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "laminin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[115, 133]], "entity_2_idx_in_text_with_entity_marker": [128, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p1", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and [E1]laminin[/E1]) and time in culture on the expression of genes encoding myosin heavy chain ([E2]MHC[/E2]) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "laminin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p2", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and [E1]laminin[/E1]) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and [E2]alpha-skeletal actin[/E2] were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "laminin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-skeletal actin", "entity_2_idx": [[153, 173]], "entity_2_idx_in_text_with_entity_marker": [166, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p3", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[115, 133]], "entity_1_idx_in_text_with_entity_marker": [119, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p4", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding [E1]myosin heavy chain[/E1] (MHC) isoforms and [E2]alpha-skeletal actin[/E2] were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[115, 133]], "entity_1_idx_in_text_with_entity_marker": [119, 137], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-skeletal actin", "entity_2_idx": [[153, 173]], "entity_2_idx_in_text_with_entity_marker": [166, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d609.s0_BioInfer.d609.s0.p5", "text": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain (MHC) isoforms and alpha-skeletal actin were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "text_with_entity_marker": "The effects of two adhesion substrates (serum and laminin) and time in culture on the expression of genes encoding myosin heavy chain ([E1]MHC[/E1]) isoforms and [E2]alpha-skeletal actin[/E2] were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-skeletal actin", "entity_2_idx": [[153, 173]], "entity_2_idx_in_text_with_entity_marker": [166, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p30", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other [E1]glycoprotein 130[/E1] (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage [E2]collagen[/E2] breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycoprotein 130", "entity_1_idx": [[38, 54]], "entity_1_idx_in_text_with_entity_marker": [42, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagen", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p31", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M ([E1]OSM[/E1]) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage [E2]collagen[/E2] breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "OSM", "entity_1_idx": [[120, 123]], "entity_1_idx_in_text_with_entity_marker": [124, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagen", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p32", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 ([E1]gp130[/E1]) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage [E2]collagen[/E2] breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gp130", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "collagen", "entity_2_idx": [[207, 215]], "entity_2_idx_in_text_with_entity_marker": [220, 228], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p33", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other [E1]glycoprotein 130[/E1] (gp130) binding cytokines can mimic the effects of oncostatin M ([E2]OSM[/E2]) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycoprotein 130", "entity_1_idx": [[38, 54]], "entity_1_idx_in_text_with_entity_marker": [42, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "OSM", "entity_2_idx": [[120, 123]], "entity_2_idx_in_text_with_entity_marker": [133, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p34", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other [E1]glycoprotein 130[/E1] ([E2]gp130[/E2]) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "glycoprotein 130", "entity_1_idx": [[38, 54]], "entity_1_idx_in_text_with_entity_marker": [42, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[56, 61]], "entity_2_idx_in_text_with_entity_marker": [69, 74], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d456.s0_BioInfer.d456.s0.p35", "text": "OBJECTIVE: To determine whether other glycoprotein 130 (gp130) binding cytokines can mimic the effects of oncostatin M (OSM) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "text_with_entity_marker": "OBJECTIVE: To determine whether other glycoprotein 130 ([E1]gp130[/E1]) binding cytokines can mimic the effects of oncostatin M ([E2]OSM[/E2]) in acting synergistically with interleukin-1alpha (IL-1alpha) to induce cartilage collagen breakdown and collagenase expression, and to determine which receptors mediate these effects.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gp130", "entity_1_idx": [[56, 61]], "entity_1_idx_in_text_with_entity_marker": [60, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "OSM", "entity_2_idx": [[120, 123]], "entity_2_idx_in_text_with_entity_marker": [133, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p0", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1]cortexillin I[/E1] or II, two isoforms of the actin-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cortexillin I", "entity_1_idx": [[160, 173]], "entity_1_idx_in_text_with_entity_marker": [164, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p1", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of [E1]talin[/E1], a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p2", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1]cortexillin[/E1] I or II, two isoforms of the actin-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cortexillin", "entity_1_idx": [[160, 171], [177, 179]], "entity_1_idx_in_text_with_entity_marker": [164, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p3", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the [E1]actin[/E1]-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[201, 206]], "entity_1_idx_in_text_with_entity_marker": [205, 210], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p4", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the [E1]actin[/E1] network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein [E2]cortexillin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[104, 109]], "entity_1_idx_in_text_with_entity_marker": [108, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[224, 235]], "entity_2_idx_in_text_with_entity_marker": [237, 248], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p5", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of [E1]talin[/E1], a protein that couples the actin network to the plasma membrane, or by the lack of [E2]cortexillin I[/E2] or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin I", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p6", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1-E2]cortexillin[/E1] I[/E2] or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cortexillin", "entity_1_idx": [[160, 171], [177, 179]], "entity_1_idx_in_text_with_entity_marker": [167, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin[/E1] I", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [167, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p7", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1]cortexillin I[/E1] or II, two isoforms of the [E2]actin[/E2]-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cortexillin I", "entity_1_idx": [[160, 173]], "entity_1_idx_in_text_with_entity_marker": [164, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p8", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the [E1]actin[/E1] network to the plasma membrane, or by the lack of [E2]cortexillin I[/E2] or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[104, 109]], "entity_1_idx_in_text_with_entity_marker": [108, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin I", "entity_2_idx": [[160, 173]], "entity_2_idx_in_text_with_entity_marker": [173, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p9", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of [E1]talin[/E1], a protein that couples the actin network to the plasma membrane, or by the lack of [E2]cortexillin[/E2] I or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[160, 171], [177, 179]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p10", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of [E1]talin[/E1], a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the [E2]actin[/E2]-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p11", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of [E1]talin[/E1], a protein that couples the [E2]actin[/E2] network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "talin", "entity_1_idx": [[70, 75]], "entity_1_idx_in_text_with_entity_marker": [74, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[104, 109]], "entity_2_idx_in_text_with_entity_marker": [117, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p12", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of [E1]cortexillin[/E1] I or II, two isoforms of the [E2]actin[/E2]-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cortexillin", "entity_1_idx": [[160, 171], [177, 179]], "entity_1_idx_in_text_with_entity_marker": [164, 175], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p13", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the [E1]actin[/E1] network to the plasma membrane, or by the lack of [E2]cortexillin[/E2] I or II, two isoforms of the actin-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[104, 109]], "entity_1_idx_in_text_with_entity_marker": [108, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cortexillin", "entity_2_idx": [[160, 171], [177, 179]], "entity_2_idx_in_text_with_entity_marker": [173, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d747.s0_BioInfer.d747.s0.p14", "text": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the actin network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the actin-bundling protein cortexillin.", "text_with_entity_marker": "This technique was employed to quantify changes caused by the lack of talin, a protein that couples the [E1]actin[/E1] network to the plasma membrane, or by the lack of cortexillin I or II, two isoforms of the [E2]actin[/E2]-bundling protein cortexillin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[104, 109]], "entity_1_idx_in_text_with_entity_marker": [108, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[201, 206]], "entity_2_idx_in_text_with_entity_marker": [214, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s0_BioInfer.d580.s0.p0", "text": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "text_with_entity_marker": "The UL8 component of the herpes simplex virus [E1]helicase-primase[/E1] complex stimulates primer synthesis by a subassembly of the UL5 and [E2]UL52[/E2] components.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s0_BioInfer.d580.s0.p1", "text": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "text_with_entity_marker": "The [E1]UL8[/E1] component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and [E2]UL52[/E2] components.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s0_BioInfer.d580.s0.p2", "text": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "text_with_entity_marker": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the [E1]UL5[/E1] and [E2]UL52[/E2] components.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[123, 126]], "entity_1_idx_in_text_with_entity_marker": [127, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[131, 135]], "entity_2_idx_in_text_with_entity_marker": [144, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s0_BioInfer.d580.s0.p3", "text": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "text_with_entity_marker": "The [E1]UL8[/E1] component of the herpes simplex virus [E2]helicase-primase[/E2] complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "helicase-primase", "entity_2_idx": [[46, 62]], "entity_2_idx_in_text_with_entity_marker": [59, 75], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s0_BioInfer.d580.s0.p4", "text": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "text_with_entity_marker": "The UL8 component of the herpes simplex virus [E1]helicase-primase[/E1] complex stimulates primer synthesis by a subassembly of the [E2]UL5[/E2] and UL52 components.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s0_BioInfer.d580.s0.p5", "text": "The UL8 component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the UL5 and UL52 components.", "text_with_entity_marker": "The [E1]UL8[/E1] component of the herpes simplex virus helicase-primase complex stimulates primer synthesis by a subassembly of the [E2]UL5[/E2] and UL52 components.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[123, 126]], "entity_2_idx_in_text_with_entity_marker": [136, 139], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s1_BioInfer.d580.s1.p0", "text": "The herpes simplex virus type 1 (HSV) UL5, UL8, and UL52 proteins form a helicase-primase complex in infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV) UL5, [E1]UL8[/E1], and [E2]UL52[/E2] proteins form a helicase-primase complex in infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[43, 46]], "entity_1_idx_in_text_with_entity_marker": [47, 50], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s1_BioInfer.d580.s1.p1", "text": "The herpes simplex virus type 1 (HSV) UL5, UL8, and UL52 proteins form a helicase-primase complex in infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV) [E1]UL5[/E1], UL8, and [E2]UL52[/E2] proteins form a helicase-primase complex in infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d580.s1_BioInfer.d580.s1.p2", "text": "The herpes simplex virus type 1 (HSV) UL5, UL8, and UL52 proteins form a helicase-primase complex in infected cells.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV) [E1]UL5[/E1], [E2]UL8[/E2], and UL52 proteins form a helicase-primase complex in infected cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[43, 46]], "entity_2_idx_in_text_with_entity_marker": [56, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p0", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for [E1]fimbrin[/E1], the utrophin actin-binding domain appears to associate with [E2]actin[/E2] in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[55, 62]], "entity_1_idx_in_text_with_entity_marker": [59, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p1", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for fimbrin, the utrophin [E1]actin[/E1]-binding domain appears to associate with [E2]actin[/E2] in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p2", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for fimbrin, the [E1]utrophin[/E1] actin-binding domain appears to associate with [E2]actin[/E2] in an extended conformation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "utrophin", "entity_1_idx": [[68, 76]], "entity_1_idx_in_text_with_entity_marker": [72, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p3", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of [E1]actin[/E1] binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with [E2]actin[/E2] in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[124, 129]], "entity_2_idx_in_text_with_entity_marker": [137, 142], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p4", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for [E1]fimbrin[/E1], the utrophin [E2]actin[/E2]-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[55, 62]], "entity_1_idx_in_text_with_entity_marker": [59, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p5", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for [E1]fimbrin[/E1], the [E2]utrophin[/E2] actin-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[55, 62]], "entity_1_idx_in_text_with_entity_marker": [59, 66], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[68, 76]], "entity_2_idx_in_text_with_entity_marker": [81, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p6", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of [E1]actin[/E1] binding proposed for [E2]fimbrin[/E2], the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[55, 62]], "entity_2_idx_in_text_with_entity_marker": [68, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p7", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of actin binding proposed for fimbrin, the [E1]utrophin[/E1] [E2]actin[/E2]-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "utrophin", "entity_1_idx": [[68, 76]], "entity_1_idx_in_text_with_entity_marker": [72, 80], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p8", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of [E1]actin[/E1] binding proposed for fimbrin, the utrophin [E2]actin[/E2]-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d329.s0_BioInfer.d329.s0.p9", "text": "In contrast to the model of actin binding proposed for fimbrin, the utrophin actin-binding domain appears to associate with actin in an extended conformation.", "text_with_entity_marker": "In contrast to the model of [E1]actin[/E1] binding proposed for fimbrin, the [E2]utrophin[/E2] actin-binding domain appears to associate with actin in an extended conformation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "utrophin", "entity_2_idx": [[68, 76]], "entity_2_idx_in_text_with_entity_marker": [81, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d22.s0_BioInfer.d22.s0.p0", "text": "Additional studies demonstrated the gamma-catenin distribution to be remarkably similar to that of beta-catenin, whereas alpha-catenin staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "text_with_entity_marker": "Additional studies demonstrated the gamma-catenin distribution to be remarkably similar to that of [E1]beta-catenin[/E1], whereas [E2]alpha-catenin[/E2] staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[121, 134]], "entity_2_idx_in_text_with_entity_marker": [134, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d22.s0_BioInfer.d22.s0.p1", "text": "Additional studies demonstrated the gamma-catenin distribution to be remarkably similar to that of beta-catenin, whereas alpha-catenin staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "text_with_entity_marker": "Additional studies demonstrated the [E1]gamma-catenin[/E1] distribution to be remarkably similar to that of [E2]beta-catenin[/E2], whereas alpha-catenin staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "gamma-catenin", "entity_1_idx": [[36, 49]], "entity_1_idx_in_text_with_entity_marker": [40, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d22.s0_BioInfer.d22.s0.p2", "text": "Additional studies demonstrated the gamma-catenin distribution to be remarkably similar to that of beta-catenin, whereas alpha-catenin staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "text_with_entity_marker": "Additional studies demonstrated the [E1]gamma-catenin[/E1] distribution to be remarkably similar to that of beta-catenin, whereas [E2]alpha-catenin[/E2] staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "gamma-catenin", "entity_1_idx": [[36, 49]], "entity_1_idx_in_text_with_entity_marker": [40, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[121, 134]], "entity_2_idx_in_text_with_entity_marker": [134, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d682.s0_BioInfer.d682.s0.p0", "text": "The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit skeletal actin.", "text_with_entity_marker": "The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, [E1]actin[/E1]-nucleotide exchange rate and the Kd for rabbit [E2]skeletal actin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[147, 152]], "entity_1_idx_in_text_with_entity_marker": [151, 156], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "skeletal actin", "entity_2_idx": [[200, 214]], "entity_2_idx_in_text_with_entity_marker": [213, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d682.s0_BioInfer.d682.s0.p1", "text": "The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit skeletal actin.", "text_with_entity_marker": "The recombinant material is similar to authentic [E1]profilin[/E1] from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit [E2]skeletal actin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[49, 57]], "entity_1_idx_in_text_with_entity_marker": [53, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal actin", "entity_2_idx": [[200, 214]], "entity_2_idx_in_text_with_entity_marker": [213, 227], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d682.s0_BioInfer.d682.s0.p2", "text": "The recombinant material is similar to authentic profilin from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, actin-nucleotide exchange rate and the Kd for rabbit skeletal actin.", "text_with_entity_marker": "The recombinant material is similar to authentic [E1]profilin[/E1] from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, [E2]actin[/E2]-nucleotide exchange rate and the Kd for rabbit skeletal actin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[49, 57]], "entity_1_idx_in_text_with_entity_marker": [53, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p10", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2] which are independent from the cadherin-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[107, 118]], "entity_2_idx_in_text_with_entity_marker": [120, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p11", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and [E1]plakoglobin[/E1] which are independent from the cadherin-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[107, 118]], "entity_1_idx_in_text_with_entity_marker": [111, 122], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p12", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the [E2]cadherin[/E2]-catenin complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[150, 158]], "entity_2_idx_in_text_with_entity_marker": [163, 171], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p13", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the [E1]cadherin[/E1]-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cadherin", "entity_1_idx": [[150, 158]], "entity_1_idx_in_text_with_entity_marker": [154, 162], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d575.s2_BioInfer.d575.s2.p14", "text": "Thus, APC forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-catenin complexes.", "text_with_entity_marker": "Thus, [E1]APC[/E1] forms distinct heteromeric complexes containing combinations of alpha-catenin, beta-catenin, and plakoglobin which are independent from the cadherin-[E2]catenin[/E2] complexes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "APC", "entity_1_idx": [[6, 9]], "entity_1_idx_in_text_with_entity_marker": [10, 13], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[159, 166]], "entity_2_idx_in_text_with_entity_marker": [172, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p0", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an [E1]actin-depolymerizing factor[/E1], and regulates [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-depolymerizing factor", "entity_1_idx": [[48, 75]], "entity_1_idx_in_text_with_entity_marker": [52, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p1", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "LIM-kinase 1 (LIMK1) phosphorylates [E1]cofilin[/E1], an actin-depolymerizing factor, and regulates [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[36, 43]], "entity_1_idx_in_text_with_entity_marker": [40, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p2", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "LIM-kinase 1 ([E1]LIMK1[/E1]) phosphorylates cofilin, an actin-depolymerizing factor, and regulates [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK1", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p3", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]LIM-kinase 1[/E1] (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates [E2]actin[/E2] cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p4", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "LIM-kinase 1 (LIMK1) phosphorylates [E1]cofilin[/E1], an [E2]actin-depolymerizing factor[/E2], and regulates actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[36, 43]], "entity_1_idx_in_text_with_entity_marker": [40, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[48, 75]], "entity_2_idx_in_text_with_entity_marker": [61, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p5", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "LIM-kinase 1 ([E1]LIMK1[/E1]) phosphorylates cofilin, an [E2]actin-depolymerizing factor[/E2], and regulates actin cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIMK1", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[48, 75]], "entity_2_idx_in_text_with_entity_marker": [61, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p6", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]LIM-kinase 1[/E1] (LIMK1) phosphorylates cofilin, an [E2]actin-depolymerizing factor[/E2], and regulates actin cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIM-kinase 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-depolymerizing factor", "entity_2_idx": [[48, 75]], "entity_2_idx_in_text_with_entity_marker": [61, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p7", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "LIM-kinase 1 ([E1]LIMK1[/E1]) phosphorylates [E2]cofilin[/E2], an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIMK1", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[36, 43]], "entity_2_idx_in_text_with_entity_marker": [49, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p8", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]LIM-kinase 1[/E1] (LIMK1) phosphorylates [E2]cofilin[/E2], an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "LIM-kinase 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[36, 43]], "entity_2_idx_in_text_with_entity_marker": [49, 56], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d405.s0_BioInfer.d405.s0.p9", "text": "LIM-kinase 1 (LIMK1) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "text_with_entity_marker": "[E1]LIM-kinase 1[/E1] ([E2]LIMK1[/E2]) phosphorylates cofilin, an actin-depolymerizing factor, and regulates actin cytoskeletal reorganization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LIM-kinase 1", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LIMK1", "entity_2_idx": [[14, 19]], "entity_2_idx_in_text_with_entity_marker": [27, 32], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p13", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of [E1]actin[/E1] filaments; profilin inhibits the elongation of platelet actin much more strongly than [E2]muscle actin[/E2]; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle actin", "entity_2_idx": [[282, 294]], "entity_2_idx_in_text_with_entity_marker": [295, 307], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p14", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of [E1]actin[/E1] filaments; profilin inhibits the elongation of [E2]platelet actin[/E2] much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[190, 195]], "entity_1_idx_in_text_with_entity_marker": [194, 199], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "platelet actin", "entity_2_idx": [[243, 257]], "entity_2_idx_in_text_with_entity_marker": [256, 270], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p15", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of [E1]actin[/E1] with [E2]profilin[/E2] cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[337, 342]], "entity_1_idx_in_text_with_entity_marker": [341, 346], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[348, 356]], "entity_2_idx_in_text_with_entity_marker": [361, 369], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p16", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than [E1]muscle actin[/E1]; and simple formation of 1:1 complexes of actin with [E2]profilin[/E2] cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscle actin", "entity_1_idx": [[282, 294]], "entity_1_idx_in_text_with_entity_marker": [286, 298], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[348, 356]], "entity_2_idx_in_text_with_entity_marker": [361, 369], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p17", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of [E1]platelet actin[/E1] much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with [E2]profilin[/E2] cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "platelet actin", "entity_1_idx": [[243, 257]], "entity_1_idx_in_text_with_entity_marker": [247, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[348, 356]], "entity_2_idx_in_text_with_entity_marker": [361, 369], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p18", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than [E1]muscle actin[/E1]; and simple formation of 1:1 complexes of [E2]actin[/E2] with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "muscle actin", "entity_1_idx": [[282, 294]], "entity_1_idx_in_text_with_entity_marker": [286, 298], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[337, 342]], "entity_2_idx_in_text_with_entity_marker": [350, 355], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p19", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of [E1]platelet actin[/E1] much more strongly than muscle actin; and simple formation of 1:1 complexes of [E2]actin[/E2] with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "platelet actin", "entity_1_idx": [[243, 257]], "entity_1_idx_in_text_with_entity_marker": [247, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[337, 342]], "entity_2_idx_in_text_with_entity_marker": [350, 355], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d45.s2_BioInfer.d45.s2.p20", "text": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of platelet actin much more strongly than muscle actin; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "text_with_entity_marker": "On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: profilin has different effects on elongation at the two ends of actin filaments; profilin inhibits the elongation of [E1]platelet actin[/E1] much more strongly than [E2]muscle actin[/E2]; and simple formation of 1:1 complexes of actin with profilin cannot account for the strong inhibition of spontaneous polymerization.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "platelet actin", "entity_1_idx": [[243, 257]], "entity_1_idx_in_text_with_entity_marker": [247, 261], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "muscle actin", "entity_2_idx": [[282, 294]], "entity_2_idx_in_text_with_entity_marker": [295, 307], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s0_BioInfer.d52.s0.p0", "text": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "text_with_entity_marker": "[E1]Munc18-2[/E1] is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a [E2]t-SNARE[/E2] localized to the apical plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Munc18-2", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "t-SNARE", "entity_2_idx": [[97, 104]], "entity_2_idx_in_text_with_entity_marker": [110, 117], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s0_BioInfer.d52.s0.p1", "text": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "text_with_entity_marker": "Munc18-2 is a [E1]Sec1[/E1] homologue enriched in epithelial cells and forms a complex with syntaxin 3, a [E2]t-SNARE[/E2] localized to the apical plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Sec1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "t-SNARE", "entity_2_idx": [[97, 104]], "entity_2_idx_in_text_with_entity_marker": [110, 117], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s0_BioInfer.d52.s0.p2", "text": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "text_with_entity_marker": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with [E1]syntaxin 3[/E1], a [E2]t-SNARE[/E2] localized to the apical plasma membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntaxin 3", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "t-SNARE", "entity_2_idx": [[97, 104]], "entity_2_idx_in_text_with_entity_marker": [110, 117], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s0_BioInfer.d52.s0.p3", "text": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "text_with_entity_marker": "[E1]Munc18-2[/E1] is a [E2]Sec1[/E2] homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc18-2", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sec1", "entity_2_idx": [[14, 18]], "entity_2_idx_in_text_with_entity_marker": [27, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s0_BioInfer.d52.s0.p4", "text": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "text_with_entity_marker": "[E1]Munc18-2[/E1] is a Sec1 homologue enriched in epithelial cells and forms a complex with [E2]syntaxin 3[/E2], a t-SNARE localized to the apical plasma membrane.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc18-2", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[83, 93]], "entity_2_idx_in_text_with_entity_marker": [96, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s0_BioInfer.d52.s0.p5", "text": "Munc18-2 is a Sec1 homologue enriched in epithelial cells and forms a complex with syntaxin 3, a t-SNARE localized to the apical plasma membrane.", "text_with_entity_marker": "Munc18-2 is a [E1]Sec1[/E1] homologue enriched in epithelial cells and forms a complex with [E2]syntaxin 3[/E2], a t-SNARE localized to the apical plasma membrane.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Sec1", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[83, 93]], "entity_2_idx_in_text_with_entity_marker": [96, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s1_BioInfer.d52.s1.p0", "text": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "text_with_entity_marker": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the [E1]syntaxin[/E1] interaction is not the sole determinant of [E2]Sec1[/E2] protein membrane attachment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntaxin", "entity_1_idx": [[127, 135]], "entity_1_idx_in_text_with_entity_marker": [131, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sec1", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s1_BioInfer.d52.s1.p1", "text": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "text_with_entity_marker": "Even the Munc18-2 mutants that do not detectably bind [E1]syntaxin 3[/E1] were membrane associated in Caco-2 cells, suggesting that the [E2]syntaxin[/E2] interaction is not the sole determinant of Sec1 protein membrane attachment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntaxin 3", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s1_BioInfer.d52.s1.p2", "text": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "text_with_entity_marker": "Even the [E1]Munc18-2[/E1] mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the [E2]syntaxin[/E2] interaction is not the sole determinant of Sec1 protein membrane attachment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Munc18-2", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s1_BioInfer.d52.s1.p3", "text": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "text_with_entity_marker": "Even the Munc18-2 mutants that do not detectably bind [E1]syntaxin 3[/E1] were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of [E2]Sec1[/E2] protein membrane attachment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "syntaxin 3", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sec1", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s1_BioInfer.d52.s1.p4", "text": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "text_with_entity_marker": "Even the [E1]Munc18-2[/E1] mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of [E2]Sec1[/E2] protein membrane attachment.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Munc18-2", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Sec1", "entity_2_idx": [[179, 183]], "entity_2_idx_in_text_with_entity_marker": [192, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s1_BioInfer.d52.s1.p5", "text": "Even the Munc18-2 mutants that do not detectably bind syntaxin 3 were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "text_with_entity_marker": "Even the [E1]Munc18-2[/E1] mutants that do not detectably bind [E2]syntaxin 3[/E2] were membrane associated in Caco-2 cells, suggesting that the syntaxin interaction is not the sole determinant of Sec1 protein membrane attachment.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc18-2", "entity_1_idx": [[9, 17]], "entity_1_idx_in_text_with_entity_marker": [13, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[54, 64]], "entity_2_idx_in_text_with_entity_marker": [67, 77], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s2_BioInfer.d52.s2.p0", "text": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "text_with_entity_marker": "The in vitro and in vivo binding patterns were highly similar, and the association of the [E1]Munc18-2[/E1] variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from [E2]syntaxin 3[/E2] complexes when overexpressed in Caco-2 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc18-2", "entity_1_idx": [[90, 98]], "entity_1_idx_in_text_with_entity_marker": [94, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[184, 194]], "entity_2_idx_in_text_with_entity_marker": [197, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s2_BioInfer.d52.s2.p1", "text": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "text_with_entity_marker": "The in vitro and in vivo binding patterns were highly similar, and the association of the [E1]Munc18-2[/E1] variants with syntaxin 3 correlated well with their ability to displace [E2]SNAP-23[/E2] from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc18-2", "entity_1_idx": [[90, 98]], "entity_1_idx_in_text_with_entity_marker": [94, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAP-23", "entity_2_idx": [[171, 178]], "entity_2_idx_in_text_with_entity_marker": [184, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s2_BioInfer.d52.s2.p2", "text": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "text_with_entity_marker": "The in vitro and in vivo binding patterns were highly similar, and the association of the [E1]Munc18-2[/E1] variants with [E2]syntaxin 3[/E2] correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Munc18-2", "entity_1_idx": [[90, 98]], "entity_1_idx_in_text_with_entity_marker": [94, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[113, 123]], "entity_2_idx_in_text_with_entity_marker": [126, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s2_BioInfer.d52.s2.p3", "text": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "text_with_entity_marker": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace [E1]SNAP-23[/E1] from [E2]syntaxin 3[/E2] complexes when overexpressed in Caco-2 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SNAP-23", "entity_1_idx": [[171, 178]], "entity_1_idx_in_text_with_entity_marker": [175, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[184, 194]], "entity_2_idx_in_text_with_entity_marker": [197, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s2_BioInfer.d52.s2.p4", "text": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "text_with_entity_marker": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with [E1]syntaxin 3[/E1] correlated well with their ability to displace SNAP-23 from [E2]syntaxin 3[/E2] complexes when overexpressed in Caco-2 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntaxin 3", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[184, 194]], "entity_2_idx_in_text_with_entity_marker": [197, 207], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s2_BioInfer.d52.s2.p5", "text": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with syntaxin 3 correlated well with their ability to displace SNAP-23 from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "text_with_entity_marker": "The in vitro and in vivo binding patterns were highly similar, and the association of the Munc18-2 variants with [E1]syntaxin 3[/E1] correlated well with their ability to displace [E2]SNAP-23[/E2] from syntaxin 3 complexes when overexpressed in Caco-2 cells.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "syntaxin 3", "entity_1_idx": [[113, 123]], "entity_1_idx_in_text_with_entity_marker": [117, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAP-23", "entity_2_idx": [[171, 178]], "entity_2_idx_in_text_with_entity_marker": [184, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d52.s3_BioInfer.d52.s3.p0", "text": "This implies that Munc18-2 function in apical membrane trafficking involves aspects independent of the syntaxin 3 interaction.", "text_with_entity_marker": "This implies that [E1]Munc18-2[/E1] function in apical membrane trafficking involves aspects independent of the [E2]syntaxin 3[/E2] interaction.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Munc18-2", "entity_1_idx": [[18, 26]], "entity_1_idx_in_text_with_entity_marker": [22, 30], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "syntaxin 3", "entity_2_idx": [[103, 113]], "entity_2_idx_in_text_with_entity_marker": [116, 126], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d756.s0_BioInfer.d756.s0.p0", "text": "Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.", "text_with_entity_marker": "Thus, poly-L-proline binding, [E1]actin[/E1] binding, and [E2]actin[/E2] nucleotide exchange are each independent requirements for profilin function in fission yeast.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d756.s0_BioInfer.d756.s0.p1", "text": "Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.", "text_with_entity_marker": "Thus, poly-L-proline binding, [E1]actin[/E1] binding, and actin nucleotide exchange are each independent requirements for [E2]profilin[/E2] function in fission yeast.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[30, 35]], "entity_1_idx_in_text_with_entity_marker": [34, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[113, 121]], "entity_2_idx_in_text_with_entity_marker": [126, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d756.s0_BioInfer.d756.s0.p2", "text": "Thus, poly-L-proline binding, actin binding, and actin nucleotide exchange are each independent requirements for profilin function in fission yeast.", "text_with_entity_marker": "Thus, poly-L-proline binding, actin binding, and [E1]actin[/E1] nucleotide exchange are each independent requirements for [E2]profilin[/E2] function in fission yeast.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[113, 121]], "entity_2_idx_in_text_with_entity_marker": [126, 134], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p0", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin ([E1]alpha-SMA[/E1]), [E2]myosin heavy chain[/E2], and smoothelin, a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-SMA", "entity_1_idx": [[163, 172]], "entity_1_idx_in_text_with_entity_marker": [167, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p1", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin ([E1]alpha-SMA[/E1]), myosin heavy chain, and [E2]smoothelin[/E2], a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-SMA", "entity_1_idx": [[163, 172]], "entity_1_idx_in_text_with_entity_marker": [167, 176], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smoothelin", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p2", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to [E1]alpha-smooth muscle actin[/E1] ([E2]alpha-SMA[/E2]), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[136, 161]], "entity_1_idx_in_text_with_entity_marker": [140, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-SMA", "entity_2_idx": [[163, 172]], "entity_2_idx_in_text_with_entity_marker": [176, 185], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p3", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), [E1]myosin heavy chain[/E1], and [E2]smoothelin[/E2], a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[175, 193]], "entity_1_idx_in_text_with_entity_marker": [179, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p4", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to [E1]alpha-smooth muscle actin[/E1] (alpha-SMA), [E2]myosin heavy chain[/E2], and smoothelin, a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[136, 161]], "entity_1_idx_in_text_with_entity_marker": [140, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin heavy chain", "entity_2_idx": [[175, 193]], "entity_2_idx_in_text_with_entity_marker": [188, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d421.s0_BioInfer.d421.s0.p5", "text": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to alpha-smooth muscle actin (alpha-SMA), myosin heavy chain, and smoothelin, a novel marker for contractile VSMC phenotype.", "text_with_entity_marker": "METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to [E1]alpha-smooth muscle actin[/E1] (alpha-SMA), myosin heavy chain, and [E2]smoothelin[/E2], a novel marker for contractile VSMC phenotype.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[136, 161]], "entity_1_idx_in_text_with_entity_marker": [140, 165], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "smoothelin", "entity_2_idx": [[199, 209]], "entity_2_idx_in_text_with_entity_marker": [212, 222], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d463.s0_BioInfer.d463.s0.p0", "text": "One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "text_with_entity_marker": "One such protein is the yeast [E1]actin-binding protein[/E1] [E2]Sac6p[/E2], which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin-binding protein", "entity_1_idx": [[30, 51]], "entity_1_idx_in_text_with_entity_marker": [34, 55], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "Sac6p", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d463.s0_BioInfer.d463.s0.p1", "text": "One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "text_with_entity_marker": "One such protein is the yeast [E1]actin-binding protein[/E1] Sac6p, which is homologous to vertebrate [E2]fimbrin[/E2] (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[30, 51]], "entity_1_idx_in_text_with_entity_marker": [34, 55], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "fimbrin", "entity_2_idx": [[93, 100]], "entity_2_idx_in_text_with_entity_marker": [106, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d463.s0_BioInfer.d463.s0.p2", "text": "One such protein is the yeast actin-binding protein Sac6p, which is homologous to vertebrate fimbrin (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "text_with_entity_marker": "One such protein is the yeast actin-binding protein [E1]Sac6p[/E1], which is homologous to vertebrate [E2]fimbrin[/E2] (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Sac6p", "entity_1_idx": [[52, 57]], "entity_1_idx_in_text_with_entity_marker": [56, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[93, 100]], "entity_2_idx_in_text_with_entity_marker": [106, 113], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p70", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p71", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p72", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p73", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]), V protein, matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "P", "entity_1_idx": [[87, 88]], "entity_1_idx_in_text_with_entity_marker": [91, 92], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p74", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic ([E2]SH[/E2]) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SH", "entity_2_idx": [[161, 163]], "entity_2_idx_in_text_with_entity_marker": [174, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p75", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein ([E2]F[/E2]), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[138, 139]], "entity_2_idx_in_text_with_entity_marker": [151, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p76", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein ([E1]M[/E1]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large ([E2]L[/E2]) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "M", "entity_1_idx": [[118, 119]], "entity_1_idx_in_text_with_entity_marker": [122, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "L", "entity_2_idx": [[227, 228]], "entity_2_idx_in_text_with_entity_marker": [240, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p77", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p78", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, [E1]matrix protein[/E1] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "matrix protein", "entity_1_idx": [[102, 116]], "entity_1_idx_in_text_with_entity_marker": [106, 120], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p79", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E1]haemagglutinin-neuraminidase[/E1] ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "haemagglutinin-neuraminidase", "entity_1_idx": [[174, 202], [208, 215]], "entity_1_idx_in_text_with_entity_marker": [178, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p0", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, [E1]SIR1[/E1] and [E2]SIR4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR1", "entity_1_idx": [[195, 199]], "entity_1_idx_in_text_with_entity_marker": [199, 203], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR4", "entity_2_idx": [[204, 208]], "entity_2_idx_in_text_with_entity_marker": [217, 221], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p1", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the [E1]SIR[/E1] genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and [E2]SIR4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[204, 208]], "entity_2_idx_in_text_with_entity_marker": [217, 221], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p2", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the [E1]ADE2[/E1] assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and [E2]SIR4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADE2", "entity_1_idx": [[7, 11]], "entity_1_idx_in_text_with_entity_marker": [11, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR4", "entity_2_idx": [[204, 208]], "entity_2_idx_in_text_with_entity_marker": [217, 221], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p3", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two [E1]SIR[/E1] genes, SIR1 and [E2]SIR4[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SIR", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR4", "entity_2_idx": [[204, 208]], "entity_2_idx_in_text_with_entity_marker": [217, 221], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p4", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the [E1]SIR[/E1] genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, [E2]SIR1[/E2] and SIR4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p5", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the [E1]ADE2[/E1] assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, [E2]SIR1[/E2] and SIR4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADE2", "entity_1_idx": [[7, 11]], "entity_1_idx_in_text_with_entity_marker": [11, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p6", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two [E1]SIR[/E1] genes, [E2]SIR1[/E2] and SIR4.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "SIR", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SIR1", "entity_2_idx": [[195, 199]], "entity_2_idx_in_text_with_entity_marker": [208, 212], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p7", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the [E1]ADE2[/E1] assay system, silencing depends completely upon the function of the [E2]SIR[/E2] genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADE2", "entity_1_idx": [[7, 11]], "entity_1_idx_in_text_with_entity_marker": [11, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR", "entity_2_idx": [[80, 83]], "entity_2_idx_in_text_with_entity_marker": [93, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p8", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the ADE2 assay system, silencing depends completely upon the function of the [E1]SIR[/E1] genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two [E2]SIR[/E2] genes, SIR1 and SIR4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SIR", "entity_1_idx": [[80, 83]], "entity_1_idx_in_text_with_entity_marker": [84, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR", "entity_2_idx": [[184, 187]], "entity_2_idx_in_text_with_entity_marker": [197, 200], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d364.s0_BioInfer.d364.s0.p9", "text": "In the ADE2 assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two SIR genes, SIR1 and SIR4.", "text_with_entity_marker": "In the [E1]ADE2[/E1] assay system, silencing depends completely upon the function of the SIR genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two [E2]SIR[/E2] genes, SIR1 and SIR4.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ADE2", "entity_1_idx": [[7, 11]], "entity_1_idx_in_text_with_entity_marker": [11, 15], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SIR", "entity_2_idx": [[184, 187]], "entity_2_idx_in_text_with_entity_marker": [197, 200], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d420.s0_BioInfer.d420.s0.p0", "text": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.", "text_with_entity_marker": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, [E1]beta-catenin[/E1] and plakoglobin and a polyclonal antibody against [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[191, 203]], "entity_1_idx_in_text_with_entity_marker": [195, 207], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d420.s0_BioInfer.d420.s0.p1", "text": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.", "text_with_entity_marker": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against [E1]E-cadherin[/E1], [E2]beta-catenin[/E2] and plakoglobin and a polyclonal antibody against alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[179, 189]], "entity_1_idx_in_text_with_entity_marker": [183, 193], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[191, 203]], "entity_2_idx_in_text_with_entity_marker": [204, 216], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d420.s0_BioInfer.d420.s0.p2", "text": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.", "text_with_entity_marker": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, [E1]beta-catenin[/E1] and [E2]plakoglobin[/E2] and a polyclonal antibody against alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[191, 203]], "entity_1_idx_in_text_with_entity_marker": [195, 207], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[208, 219]], "entity_2_idx_in_text_with_entity_marker": [221, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d420.s0_BioInfer.d420.s0.p3", "text": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.", "text_with_entity_marker": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against [E1]E-cadherin[/E1], beta-catenin and plakoglobin and a polyclonal antibody against [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[179, 189]], "entity_1_idx_in_text_with_entity_marker": [183, 193], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d420.s0_BioInfer.d420.s0.p4", "text": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.", "text_with_entity_marker": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and [E1]plakoglobin[/E1] and a polyclonal antibody against [E2]alpha-catenin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[208, 219]], "entity_1_idx_in_text_with_entity_marker": [212, 223], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[254, 267]], "entity_2_idx_in_text_with_entity_marker": [267, 280], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d420.s0_BioInfer.d420.s0.p5", "text": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against E-cadherin, beta-catenin and plakoglobin and a polyclonal antibody against alpha-catenin.", "text_with_entity_marker": "METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against [E1]E-cadherin[/E1], beta-catenin and [E2]plakoglobin[/E2] and a polyclonal antibody against alpha-catenin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[179, 189]], "entity_1_idx_in_text_with_entity_marker": [183, 193], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[208, 219]], "entity_2_idx_in_text_with_entity_marker": [221, 232], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p10", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with [E1]LEF-1[/E1] and [E2]vinculin[/E2]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[127, 135]], "entity_2_idx_in_text_with_entity_marker": [140, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p11", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with [E2]LEF-1[/E2] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p12", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with [E1]LEF-1[/E1] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, [E2]cadherin[/E2] and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[265, 273]], "entity_2_idx_in_text_with_entity_marker": [278, 286], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p13", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with [E1]LEF-1[/E1] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by [E2]beta-catenin[/E2]; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "LEF-1", "entity_1_idx": [[117, 122]], "entity_1_idx_in_text_with_entity_marker": [121, 126], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[201, 213]], "entity_2_idx_in_text_with_entity_marker": [214, 226], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p14", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and [E1]beta-catenin[/E1] differ in their nuclear translocation and complexing with [E2]LEF-1[/E2] and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[46, 58]], "entity_1_idx_in_text_with_entity_marker": [50, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "LEF-1", "entity_2_idx": [[117, 122]], "entity_2_idx_in_text_with_entity_marker": [130, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p15", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of [E1]beta-catenin[/E1], cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[251, 263]], "entity_1_idx_in_text_with_entity_marker": [255, 267], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p16", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and [E1]vinculin[/E1]; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[127, 135]], "entity_1_idx_in_text_with_entity_marker": [131, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p17", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) [E1]plakoglobin[/E1] and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[30, 41]], "entity_1_idx_in_text_with_entity_marker": [34, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p18", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, [E1]cadherin[/E1] and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "cadherin", "entity_1_idx": [[265, 273]], "entity_1_idx_in_text_with_entity_marker": [269, 277], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d688.s0_BioInfer.d688.s0.p19", "text": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by beta-catenin; and (c) the cytoplasmic partners of beta-catenin, cadherin and alpha-catenin, can sequester it to the cytoplasm and inhibit its transcriptional activity.", "text_with_entity_marker": "The results indicate that (a) plakoglobin and beta-catenin differ in their nuclear translocation and complexing with LEF-1 and vinculin; (b) LEF-1-dependent transactivation is preferentially driven by [E1]beta-catenin[/E1]; and (c) the cytoplasmic partners of beta-catenin, cadherin and [E2]alpha-catenin[/E2], can sequester it to the cytoplasm and inhibit its transcriptional activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[201, 213]], "entity_1_idx_in_text_with_entity_marker": [205, 217], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[278, 291]], "entity_2_idx_in_text_with_entity_marker": [291, 304], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s0_BioInfer.d450.s0.p0", "text": "Neither can profilin I, in the presence of the peptide, promote actin polymerization during its early phase consistent with a lower affinity.", "text_with_entity_marker": "Neither can [E1]profilin I[/E1], in the presence of the peptide, promote [E2]actin[/E2] polymerization during its early phase consistent with a lower affinity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin I", "entity_1_idx": [[12, 22]], "entity_1_idx_in_text_with_entity_marker": [16, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s1_BioInfer.d450.s1.p0", "text": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "text_with_entity_marker": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and [E1]profilin II[/E1] to inhibit [E2]actin[/E2] nucleation and restores the extent of filament formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[96, 107]], "entity_1_idx_in_text_with_entity_marker": [100, 111], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s1_BioInfer.d450.s1.p1", "text": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "text_with_entity_marker": "The resulting profilin II-peptide complex overcomes the combined capacity of [E1]thymosin beta4[/E1] and profilin II to inhibit [E2]actin[/E2] nucleation and restores the extent of filament formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "thymosin beta4", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s1_BioInfer.d450.s1.p2", "text": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "text_with_entity_marker": "The resulting [E1]profilin II[/E1]-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit [E2]actin[/E2] nucleation and restores the extent of filament formation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin II", "entity_1_idx": [[14, 25]], "entity_1_idx_in_text_with_entity_marker": [18, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[119, 124]], "entity_2_idx_in_text_with_entity_marker": [132, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s1_BioInfer.d450.s1.p3", "text": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "text_with_entity_marker": "The resulting profilin II-peptide complex overcomes the combined capacity of [E1]thymosin beta4[/E1] and [E2]profilin II[/E2] to inhibit actin nucleation and restores the extent of filament formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymosin beta4", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[96, 107]], "entity_2_idx_in_text_with_entity_marker": [109, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s1_BioInfer.d450.s1.p4", "text": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "text_with_entity_marker": "The resulting [E1]profilin II[/E1]-peptide complex overcomes the combined capacity of thymosin beta4 and [E2]profilin II[/E2] to inhibit actin nucleation and restores the extent of filament formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[14, 25]], "entity_1_idx_in_text_with_entity_marker": [18, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin II", "entity_2_idx": [[96, 107]], "entity_2_idx_in_text_with_entity_marker": [109, 120], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d450.s1_BioInfer.d450.s1.p5", "text": "The resulting profilin II-peptide complex overcomes the combined capacity of thymosin beta4 and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "text_with_entity_marker": "The resulting [E1]profilin II[/E1]-peptide complex overcomes the combined capacity of [E2]thymosin beta4[/E2] and profilin II to inhibit actin nucleation and restores the extent of filament formation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[14, 25]], "entity_1_idx_in_text_with_entity_marker": [18, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta4", "entity_2_idx": [[77, 91]], "entity_2_idx_in_text_with_entity_marker": [90, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s0_BioInfer.d62.s0.p0", "text": "An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "text_with_entity_marker": "An assembly of the [E1]UL5[/E1] and [E2]UL52[/E2] subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[27, 31]], "entity_2_idx_in_text_with_entity_marker": [40, 44], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s0_BioInfer.d62.s0.p1", "text": "An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "text_with_entity_marker": "An assembly of the UL5 and [E1]UL52[/E1] subunits retains both enzymic activities, and the [E2]UL8[/E2] protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL52", "entity_1_idx": [[27, 31]], "entity_1_idx_in_text_with_entity_marker": [31, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s0_BioInfer.d62.s0.p2", "text": "An assembly of the UL5 and UL52 subunits retains both enzymic activities, and the UL8 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "text_with_entity_marker": "An assembly of the [E1]UL5[/E1] and UL52 subunits retains both enzymic activities, and the [E2]UL8[/E2] protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s1_BioInfer.d62.s1.p0", "text": "Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.", "text_with_entity_marker": "Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the [E1]UL5[/E1] and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "UL5", "entity_1_idx": [[170, 173]], "entity_1_idx_in_text_with_entity_marker": [174, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[178, 182]], "entity_2_idx_in_text_with_entity_marker": [191, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s1_BioInfer.d62.s1.p1", "text": "Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.", "text_with_entity_marker": "Deletion mutants of the herpes simplex virus type 1 [E1]UL8[/E1] protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[178, 182]], "entity_2_idx_in_text_with_entity_marker": [191, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s1_BioInfer.d62.s1.p2", "text": "Deletion mutants of the herpes simplex virus type 1 UL8 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the UL5 and UL52 proteins.", "text_with_entity_marker": "Deletion mutants of the herpes simplex virus type 1 [E1]UL8[/E1] protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the [E2]UL5[/E2] and UL52 proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[52, 55]], "entity_1_idx_in_text_with_entity_marker": [56, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL5", "entity_2_idx": [[170, 173]], "entity_2_idx_in_text_with_entity_marker": [183, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p0", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) [E1]helicase-primase[/E1], an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded [E2]UL5[/E2], UL8, and UL52 proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[40, 56]], "entity_1_idx_in_text_with_entity_marker": [44, 60], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[162, 165]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p1", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) [E1]helicase-primase[/E1], an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, [E2]UL8[/E2], and UL52 proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[40, 56]], "entity_1_idx_in_text_with_entity_marker": [44, 60], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p2", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) [E1]helicase-primase[/E1], an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[40, 56]], "entity_1_idx_in_text_with_entity_marker": [44, 60], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p3", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded [E1]UL5[/E1], [E2]UL8[/E2], and UL52 proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[162, 165]], "entity_1_idx_in_text_with_entity_marker": [166, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL8", "entity_2_idx": [[167, 170]], "entity_2_idx_in_text_with_entity_marker": [180, 183], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p4", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded [E1]UL5[/E1], UL8, and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL5", "entity_1_idx": [[162, 165]], "entity_1_idx_in_text_with_entity_marker": [166, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d62.s2_BioInfer.d62.s2.p5", "text": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, UL8, and UL52 proteins.", "text_with_entity_marker": "The herpes simplex virus type 1 (HSV-1) helicase-primase, an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded UL5, [E1]UL8[/E1], and [E2]UL52[/E2] proteins.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "UL8", "entity_1_idx": [[167, 170]], "entity_1_idx_in_text_with_entity_marker": [171, 174], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "UL52", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d794.s0_BioInfer.d794.s0.p0", "text": "Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "text_with_entity_marker": "[E1]Vimentin[/E1] and actin were also up-regulated, whereas an isoform of [E2]myosin heavy chain[/E2] was down-regulated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Vimentin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[65, 83]], "entity_2_idx_in_text_with_entity_marker": [78, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d794.s0_BioInfer.d794.s0.p1", "text": "Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "text_with_entity_marker": "Vimentin and [E1]actin[/E1] were also up-regulated, whereas an isoform of [E2]myosin heavy chain[/E2] was down-regulated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[13, 18]], "entity_1_idx_in_text_with_entity_marker": [17, 22], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[65, 83]], "entity_2_idx_in_text_with_entity_marker": [78, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d794.s0_BioInfer.d794.s0.p2", "text": "Vimentin and actin were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "text_with_entity_marker": "[E1]Vimentin[/E1] and [E2]actin[/E2] were also up-regulated, whereas an isoform of myosin heavy chain was down-regulated.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Vimentin", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[13, 18]], "entity_2_idx_in_text_with_entity_marker": [26, 31], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d740.s0_BioInfer.d740.s0.p0", "text": "This is consistent with cofilin activation being required for actin reorganization during exocytosis.", "text_with_entity_marker": "This is consistent with [E1]cofilin[/E1] activation being required for [E2]actin[/E2] reorganization during exocytosis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p0", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The E-cadherin-associated proteins [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2] were not significantly affected by treatment with TPA.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[35, 48]], "entity_1_idx_in_text_with_entity_marker": [39, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[53, 65]], "entity_2_idx_in_text_with_entity_marker": [66, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p1", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The E-cadherin-associated proteins [E1]alpha-catenin[/E1] and beta-catenin were not significantly affected by treatment with [E2]TPA[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[35, 48]], "entity_1_idx_in_text_with_entity_marker": [39, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TPA", "entity_2_idx": [[116, 119]], "entity_2_idx_in_text_with_entity_marker": [129, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p2", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The [E1]E-cadherin[/E1]-associated proteins [E2]alpha-catenin[/E2] and beta-catenin were not significantly affected by treatment with TPA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[35, 48]], "entity_2_idx_in_text_with_entity_marker": [48, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p3", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The E-cadherin-associated proteins alpha-catenin and [E1]beta-catenin[/E1] were not significantly affected by treatment with [E2]TPA[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[53, 65]], "entity_1_idx_in_text_with_entity_marker": [57, 69], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TPA", "entity_2_idx": [[116, 119]], "entity_2_idx_in_text_with_entity_marker": [129, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p4", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The [E1]E-cadherin[/E1]-associated proteins alpha-catenin and [E2]beta-catenin[/E2] were not significantly affected by treatment with TPA.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cadherin", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[53, 65]], "entity_2_idx_in_text_with_entity_marker": [66, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p5", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The [E1]E-cadherin[/E1]-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with [E2]TPA[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TPA", "entity_2_idx": [[116, 119]], "entity_2_idx_in_text_with_entity_marker": [129, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s1_BioInfer.d296.s1.p0", "text": "In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "text_with_entity_marker": "In CC, membranous expression of [E1]E-cad[/E1], alpha-catenin, and [E2]beta-catenin[/E2] was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[58, 70]], "entity_2_idx_in_text_with_entity_marker": [71, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s1_BioInfer.d296.s1.p1", "text": "In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "text_with_entity_marker": "In CC, membranous expression of [E1]E-cad[/E1], [E2]alpha-catenin[/E2], and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[39, 52]], "entity_2_idx_in_text_with_entity_marker": [52, 65], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s1_BioInfer.d296.s1.p2", "text": "In CC, membranous expression of E-cad, alpha-catenin, and beta-catenin was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "text_with_entity_marker": "In CC, membranous expression of E-cad, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[39, 52]], "entity_1_idx_in_text_with_entity_marker": [43, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[58, 70]], "entity_2_idx_in_text_with_entity_marker": [71, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p0", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and [E1]beta-catenin[/E1], but not [E2]CD44s[/E2], CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[43, 55]], "entity_1_idx_in_text_with_entity_marker": [47, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44s", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p1", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and [E1]beta-catenin[/E1], but not CD44s, CD44v5, CD44v6, CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[43, 55]], "entity_1_idx_in_text_with_entity_marker": [47, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p2", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and [E1]beta-catenin[/E1], but not CD44s, CD44v5, [E2]CD44v6[/E2], CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[43, 55]], "entity_1_idx_in_text_with_entity_marker": [47, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p3", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], alpha-catenin and [E2]beta-catenin[/E2], but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[43, 55]], "entity_2_idx_in_text_with_entity_marker": [56, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p4", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and [E1]beta-catenin[/E1], but not CD44s, [E2]CD44v5[/E2], CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[43, 55]], "entity_1_idx_in_text_with_entity_marker": [47, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v5", "entity_2_idx": [[72, 78]], "entity_2_idx_in_text_with_entity_marker": [85, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p5", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and [E2]beta-catenin[/E2], but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[43, 55]], "entity_2_idx_in_text_with_entity_marker": [56, 68], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p6", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and [E1]beta-catenin[/E1], but not CD44s, CD44v5, CD44v6, [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[43, 55]], "entity_1_idx_in_text_with_entity_marker": [47, 59], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p7", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not [E1]CD44s[/E1], CD44v5, CD44v6, CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44s", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p8", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not [E1]CD44s[/E1], CD44v5, [E2]CD44v6[/E2], CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44s", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v6", "entity_2_idx": [[80, 86]], "entity_2_idx_in_text_with_entity_marker": [93, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p9", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], alpha-catenin and beta-catenin, but not [E2]CD44s[/E2], CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44s", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p10", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not [E1]CD44s[/E1], [E2]CD44v5[/E2], CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44s", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v5", "entity_2_idx": [[72, 78]], "entity_2_idx_in_text_with_entity_marker": [85, 91], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p11", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not [E2]CD44s[/E2], CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44s", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p12", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not [E1]CD44s[/E1], CD44v5, CD44v6, [E2]CD44v7-8[/E2], and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44s", "entity_1_idx": [[65, 70]], "entity_1_idx_in_text_with_entity_marker": [69, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v7-8", "entity_2_idx": [[88, 96]], "entity_2_idx_in_text_with_entity_marker": [101, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p13", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, [E1]CD44v6[/E1], CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44v6", "entity_1_idx": [[80, 86]], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p14", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, [E1]E-cad[/E1], alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p15", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, [E1]CD44v5[/E1], CD44v6, CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "CD44v5", "entity_1_idx": [[72, 78]], "entity_1_idx_in_text_with_entity_marker": [76, 82], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s2_BioInfer.d296.s2.p16", "text": "In normal livers, E-cad, alpha-catenin and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and CD44v10, were expressed at the cell membrane of normal intrahepatic bile ducts.", "text_with_entity_marker": "In normal livers, E-cad, [E1]alpha-catenin[/E1] and beta-catenin, but not CD44s, CD44v5, CD44v6, CD44v7-8, and [E2]CD44v10[/E2], were expressed at the cell membrane of normal intrahepatic bile ducts.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[25, 38]], "entity_1_idx_in_text_with_entity_marker": [29, 42], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "CD44v10", "entity_2_idx": [[102, 109]], "entity_2_idx_in_text_with_entity_marker": [115, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p9", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E2]p53[/E2] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p10", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p11", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], [E2]alpha-catenin[/E2], and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[44, 57]], "entity_2_idx_in_text_with_entity_marker": [57, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p12", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of [E1]E-cad[/E1], alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, [E2]Ki-67[/E2] labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "E-cad", "entity_1_idx": [[37, 42]], "entity_1_idx_in_text_with_entity_marker": [41, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ki-67", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p13", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p14", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E2]p53[/E2] expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[179, 182]], "entity_2_idx_in_text_with_entity_marker": [192, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p15", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with [E2]c-erbB2[/E2] down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[308, 315]], "entity_2_idx_in_text_with_entity_marker": [321, 328], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p16", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[44, 57]], "entity_1_idx_in_text_with_entity_marker": [48, 61], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[63, 75]], "entity_2_idx_in_text_with_entity_marker": [76, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p17", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and [E1]beta-catenin[/E1] expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, [E2]Ki-67[/E2] labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Ki-67", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d296.s3_BioInfer.d296.s3.p18", "text": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, p53 expression, Ki-67 labeling, or c-erbB2 expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "text_with_entity_marker": "We found that the down-regulation of E-cad, alpha-catenin, and beta-catenin expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, [E1]p53[/E1] expression, Ki-67 labeling, or [E2]c-erbB2[/E2] expression, except for beta-catenin, the down-regulation of which was associated with c-erbB2 down-regulation.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "p53", "entity_1_idx": [[179, 182]], "entity_1_idx_in_text_with_entity_marker": [183, 186], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "c-erbB2", "entity_2_idx": [[214, 221]], "entity_2_idx_in_text_with_entity_marker": [227, 234], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p0", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, [E1]desmin[/E1], and SM myosin heavy chain isoforms, but not [E2]smoothelin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[145, 155]], "entity_2_idx_in_text_with_entity_marker": [158, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p1", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and [E1]SM myosin heavy chain[/E1] isoforms, but not [E2]smoothelin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "SM myosin heavy chain", "entity_1_idx": [[105, 126]], "entity_1_idx_in_text_with_entity_marker": [109, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[145, 155]], "entity_2_idx_in_text_with_entity_marker": [158, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p2", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed [E1]alpha-SM actin[/E1], desmin, and SM myosin heavy chain isoforms, but not [E2]smoothelin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-SM actin", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smoothelin", "entity_2_idx": [[145, 155]], "entity_2_idx_in_text_with_entity_marker": [158, 168], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p3", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, [E1]desmin[/E1], and [E2]SM myosin heavy chain[/E2] isoforms, but not smoothelin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[93, 99]], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[105, 126]], "entity_2_idx_in_text_with_entity_marker": [118, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p4", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed [E1]alpha-SM actin[/E1], [E2]desmin[/E2], and SM myosin heavy chain isoforms, but not smoothelin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-SM actin", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[93, 99]], "entity_2_idx_in_text_with_entity_marker": [106, 112], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d569.s0_BioInfer.d569.s0.p5", "text": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed alpha-SM actin, desmin, and SM myosin heavy chain isoforms, but not smoothelin.", "text_with_entity_marker": "The adventitial tissue underlying PTCA-induced lesions temporarily expressed [E1]alpha-SM actin[/E1], desmin, and [E2]SM myosin heavy chain[/E2] isoforms, but not smoothelin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-SM actin", "entity_1_idx": [[77, 91]], "entity_1_idx_in_text_with_entity_marker": [81, 95], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SM myosin heavy chain", "entity_2_idx": [[105, 126]], "entity_2_idx_in_text_with_entity_marker": [118, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d431.s0_BioInfer.d431.s0.p0", "text": "[Molecular functions of cofilin which regulates reorganization of actin cytoskeleton].", "text_with_entity_marker": "[Molecular functions of [E1]cofilin[/E1] which regulates reorganization of [E2]actin[/E2] cytoskeleton].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[24, 31]], "entity_1_idx_in_text_with_entity_marker": [28, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p10", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase ([E1]A-SMase[/E1]) through the p55 TNF receptor-associated proteins TRADD and [E2]FADD[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "A-SMase", "entity_1_idx": [[61, 68]], "entity_1_idx_in_text_with_entity_marker": [65, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[129, 133]], "entity_2_idx_in_text_with_entity_marker": [142, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p11", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the [E1]TNF[/E1]-dependent activation of acid SMase (A-SMase) through the [E2]p55[/E2] TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p12", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the [E1]TNF[/E1]-dependent activation of acid SMase (A-SMase) through the p55 [E2]TNF receptor[/E2]-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "TNF", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[86, 98]], "entity_2_idx_in_text_with_entity_marker": [99, 111], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p13", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the [E1]TNF[/E1]-dependent activation of [E2]acid SMase[/E2] (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "acid SMase", "entity_2_idx": [[49, 59]], "entity_2_idx_in_text_with_entity_marker": [62, 72], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p14", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the [E1]TNF[/E1]-dependent activation of acid SMase ([E2]A-SMase[/E2]) through the p55 TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TNF", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-SMase", "entity_2_idx": [[61, 68]], "entity_2_idx_in_text_with_entity_marker": [74, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p15", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the [E1]p55[/E1] [E2]TNF receptor[/E2]-associated proteins TRADD and FADD.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "p55", "entity_1_idx": [[82, 85]], "entity_1_idx_in_text_with_entity_marker": [86, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[86, 98]], "entity_2_idx_in_text_with_entity_marker": [99, 111], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p16", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of [E1]acid SMase[/E1] (A-SMase) through the [E2]p55[/E2] TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acid SMase", "entity_1_idx": [[49, 59]], "entity_1_idx_in_text_with_entity_marker": [53, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p17", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase ([E1]A-SMase[/E1]) through the [E2]p55[/E2] TNF receptor-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A-SMase", "entity_1_idx": [[61, 68]], "entity_1_idx_in_text_with_entity_marker": [65, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p55", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p18", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of [E1]acid SMase[/E1] (A-SMase) through the p55 [E2]TNF receptor[/E2]-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "acid SMase", "entity_1_idx": [[49, 59]], "entity_1_idx_in_text_with_entity_marker": [53, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[86, 98]], "entity_2_idx_in_text_with_entity_marker": [99, 111], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d242.s0_BioInfer.d242.s0.p19", "text": "Here we describe the TNF-dependent activation of acid SMase (A-SMase) through the p55 TNF receptor-associated proteins TRADD and FADD.", "text_with_entity_marker": "Here we describe the TNF-dependent activation of acid SMase ([E1]A-SMase[/E1]) through the p55 [E2]TNF receptor[/E2]-associated proteins TRADD and FADD.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A-SMase", "entity_1_idx": [[61, 68]], "entity_1_idx_in_text_with_entity_marker": [65, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TNF receptor", "entity_2_idx": [[86, 98]], "entity_2_idx_in_text_with_entity_marker": [99, 111], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p40", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked [E2]PKC1[/E2] as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "PKC1", "entity_2_idx": [[141, 145]], "entity_2_idx_in_text_with_entity_marker": [154, 158], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p41", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/[E2]SLG1[/E2] and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SLG1", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p42", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 ([E1]MEKK[/E1]) by the dominant [E2]BCK1-20[/E2] mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEKK", "entity_1_idx": [[37, 41]], "entity_1_idx_in_text_with_entity_marker": [41, 45], "entity_1_type": "DNA_family_or_group", "entity_1_type_id": 4, "entity_2": "BCK1-20", "entity_2_idx": [[59, 66]], "entity_2_idx_in_text_with_entity_marker": [72, 79], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p43", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 ([E2]MEK[/E2]) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MEK", "entity_2_idx": [[106, 109]], "entity_2_idx_in_text_with_entity_marker": [119, 122], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p44", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant [E1]BCK1-20[/E1] mutation nor increased dosage of MKK1 (MEK) or MPK1 ([E2]MAP kinase[/E2]) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "BCK1-20", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MAP kinase", "entity_2_idx": [[120, 130]], "entity_2_idx_in_text_with_entity_marker": [133, 143], "entity_2_type": "DNA_family_or_group", "entity_2_type_id": 4}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p45", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the [E1]Pkc1p[/E1] pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Pkc1p", "entity_1_idx": [[236, 241]], "entity_1_idx_in_text_with_entity_marker": [240, 245], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p46", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E1]HCS77[/E1]/[E2]WSC1[/E2]/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HCS77", "entity_1_idx": [[270, 275]], "entity_1_idx_in_text_with_entity_marker": [274, 279], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "WSC1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p47", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E1]HCS77[/E1]/WSC1/SLG1 and [E2]MID2[/E2] also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "HCS77", "entity_1_idx": [[270, 275]], "entity_1_idx_in_text_with_entity_marker": [274, 279], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MID2", "entity_2_idx": [[290, 294]], "entity_2_idx_in_text_with_entity_marker": [303, 307], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p48", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, [E1]RHO2[/E1], [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RHO2", "entity_1_idx": [[264, 268]], "entity_1_idx_in_text_with_entity_marker": [268, 272], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d44.s0_BioInfer.d44.s0.p49", "text": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or MPK1 (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, HCS77/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "text_with_entity_marker": "Although neither activation of BCK1 (MEKK) by the dominant BCK1-20 mutation nor increased dosage of MKK1 (MEK) or [E1]MPK1[/E1] (MAP kinase) mimicked PKC1 as a glc7-10 dosage suppressor, extra copies of genes encoding upstream components of the Pkc1p pathway such as ROM2, RHO2, [E2]HCS77[/E2]/WSC1/SLG1 and MID2 also suppressed glc7-10 effectively.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MPK1", "entity_1_idx": [[114, 118]], "entity_1_idx_in_text_with_entity_marker": [118, 122], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "HCS77", "entity_2_idx": [[270, 275]], "entity_2_idx_in_text_with_entity_marker": [283, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d741.s0_BioInfer.d741.s0.p0", "text": "This is the first report describing the coexistence of profilin with actin filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.", "text_with_entity_marker": "This is the first report describing the coexistence of profilin with [E1]actin[/E1] filaments in the division furrow, implying the possible involvement of [E2]profilin[/E2] in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[69, 74]], "entity_1_idx_in_text_with_entity_marker": [73, 78], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d741.s0_BioInfer.d741.s0.p1", "text": "This is the first report describing the coexistence of profilin with actin filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.", "text_with_entity_marker": "This is the first report describing the coexistence of [E1]profilin[/E1] with [E2]actin[/E2] filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[55, 63]], "entity_1_idx_in_text_with_entity_marker": [59, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d741.s0_BioInfer.d741.s0.p2", "text": "This is the first report describing the coexistence of profilin with actin filaments in the division furrow, implying the possible involvement of profilin in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.", "text_with_entity_marker": "This is the first report describing the coexistence of [E1]profilin[/E1] with actin filaments in the division furrow, implying the possible involvement of [E2]profilin[/E2] in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[55, 63]], "entity_1_idx_in_text_with_entity_marker": [59, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[146, 154]], "entity_2_idx_in_text_with_entity_marker": [159, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p0", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of [E1]profilin[/E1]-annexin I association on some properties of both [E2]profilin[/E2] and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[69, 77]], "entity_2_idx_in_text_with_entity_marker": [82, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p1", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-[E1]annexin I[/E1] association on some properties of both [E2]profilin[/E2] and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "annexin I", "entity_1_idx": [[20, 29]], "entity_1_idx_in_text_with_entity_marker": [24, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[69, 77]], "entity_2_idx_in_text_with_entity_marker": [82, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p2", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both [E1]profilin[/E1] and annexin I: modification of the inhibitory activity of [E2]profilin[/E2] on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[69, 77]], "entity_1_idx_in_text_with_entity_marker": [73, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p3", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both [E1]profilin[/E1] and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of [E2]annexin I[/E2] and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[69, 77]], "entity_1_idx_in_text_with_entity_marker": [73, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[211, 220]], "entity_2_idx_in_text_with_entity_marker": [224, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p4", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both [E1]profilin[/E1] and annexin I: modification of the inhibitory activity of profilin on [E2]actin[/E2] polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[69, 77]], "entity_1_idx_in_text_with_entity_marker": [73, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p5", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both [E1]profilin[/E1] and [E2]annexin I[/E2]: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[69, 77]], "entity_1_idx_in_text_with_entity_marker": [73, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[82, 91]], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p6", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of [E1]profilin[/E1]-[E2]annexin I[/E2] association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[20, 29]], "entity_2_idx_in_text_with_entity_marker": [33, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p7", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of [E1]profilin[/E1]-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of [E2]profilin[/E2] on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p8", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of [E1]profilin[/E1]-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of [E2]annexin I[/E2] and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[211, 220]], "entity_2_idx_in_text_with_entity_marker": [224, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p9", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of [E1]profilin[/E1]-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on [E2]actin[/E2] polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p10", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of [E1]profilin[/E1]-annexin I association on some properties of both profilin and [E2]annexin I[/E2]: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[11, 19]], "entity_1_idx_in_text_with_entity_marker": [15, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[82, 91]], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p11", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-[E1]annexin I[/E1] association on some properties of both profilin and annexin I: modification of the inhibitory activity of [E2]profilin[/E2] on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "annexin I", "entity_1_idx": [[20, 29]], "entity_1_idx_in_text_with_entity_marker": [24, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p12", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-[E1]annexin I[/E1] association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of [E2]annexin I[/E2] and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "annexin I", "entity_1_idx": [[20, 29]], "entity_1_idx_in_text_with_entity_marker": [24, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[211, 220]], "entity_2_idx_in_text_with_entity_marker": [224, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p13", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-[E1]annexin I[/E1] association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on [E2]actin[/E2] polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "annexin I", "entity_1_idx": [[20, 29]], "entity_1_idx_in_text_with_entity_marker": [24, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p14", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-[E1]annexin I[/E1] association on some properties of both profilin and [E2]annexin I[/E2]: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "annexin I", "entity_1_idx": [[20, 29]], "entity_1_idx_in_text_with_entity_marker": [24, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[82, 91]], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p15", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of [E1]profilin[/E1] on actin polymerization and inhibition of the self-association of [E2]annexin I[/E2] and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[136, 144]], "entity_1_idx_in_text_with_entity_marker": [140, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[211, 220]], "entity_2_idx_in_text_with_entity_marker": [224, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p16", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of [E1]profilin[/E1] on [E2]actin[/E2] polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[136, 144]], "entity_1_idx_in_text_with_entity_marker": [140, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p17", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both profilin and [E1]annexin I[/E1]: modification of the inhibitory activity of [E2]profilin[/E2] on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "annexin I", "entity_1_idx": [[82, 91]], "entity_1_idx_in_text_with_entity_marker": [86, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[136, 144]], "entity_2_idx_in_text_with_entity_marker": [149, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p18", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on [E1]actin[/E1] polymerization and inhibition of the self-association of [E2]annexin I[/E2] and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[148, 153]], "entity_1_idx_in_text_with_entity_marker": [152, 157], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[211, 220]], "entity_2_idx_in_text_with_entity_marker": [224, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p19", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both profilin and [E1]annexin I[/E1]: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of [E2]annexin I[/E2] and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "annexin I", "entity_1_idx": [[82, 91]], "entity_1_idx_in_text_with_entity_marker": [86, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "annexin I", "entity_2_idx": [[211, 220]], "entity_2_idx_in_text_with_entity_marker": [224, 233], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d184.s0_BioInfer.d184.s0.p20", "text": "Effects of profilin-annexin I association on some properties of both profilin and annexin I: modification of the inhibitory activity of profilin on actin polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "text_with_entity_marker": "Effects of profilin-annexin I association on some properties of both profilin and [E1]annexin I[/E1]: modification of the inhibitory activity of profilin on [E2]actin[/E2] polymerization and inhibition of the self-association of annexin I and its interactions with liposomes.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "annexin I", "entity_1_idx": [[82, 91]], "entity_1_idx_in_text_with_entity_marker": [86, 95], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[148, 153]], "entity_2_idx_in_text_with_entity_marker": [161, 166], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p0", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, [E1]smooth muscle myosin[/E1] (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin", "entity_1_idx": [[78, 98], [100, 111]], "entity_1_idx_in_text_with_entity_marker": [82, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p1", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, [E1]desmin[/E1], smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[70, 76]], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p2", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p3", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins [E1]vimentin[/E1] and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vimentin", "entity_1_idx": [[139, 147]], "entity_1_idx_in_text_with_entity_marker": [143, 151], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p4", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and [E2]cytokeratin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cytokeratin", "entity_2_idx": [[152, 163]], "entity_2_idx_in_text_with_entity_marker": [165, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p5", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, [E1]desmin[/E1], [E2]smooth muscle myosin[/E2] (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[70, 76]], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin", "entity_2_idx": [[78, 98], [100, 111]], "entity_2_idx_in_text_with_entity_marker": [91, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p6", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, desmin, [E2]smooth muscle myosin[/E2] (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin", "entity_2_idx": [[78, 98], [100, 111]], "entity_2_idx_in_text_with_entity_marker": [91, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p7", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, [E1]smooth muscle myosin[/E1] (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "smooth muscle myosin", "entity_1_idx": [[78, 98], [100, 111]], "entity_1_idx_in_text_with_entity_marker": [82, 102], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p8", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], desmin, [E2]smooth muscle myosin[/E2] (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "smooth muscle myosin", "entity_2_idx": [[78, 98], [100, 111]], "entity_2_idx_in_text_with_entity_marker": [91, 111], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p9", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, [E2]desmin[/E2], smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p10", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, [E1]desmin[/E1], smooth muscle myosin (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "desmin", "entity_1_idx": [[70, 76]], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p11", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], [E2]desmin[/E2], smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p12", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p13", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of [E1]alpha-smooth muscle actin[/E1], [E2]tropomyosin[/E2], desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[30, 55]], "entity_1_idx_in_text_with_entity_marker": [34, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "tropomyosin", "entity_2_idx": [[57, 68]], "entity_2_idx_in_text_with_entity_marker": [70, 81], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d826.s0_BioInfer.d826.s0.p14", "text": "We tested for the presence of alpha-smooth muscle actin, tropomyosin, desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins vimentin and cytokeratin.", "text_with_entity_marker": "We tested for the presence of alpha-smooth muscle actin, [E1]tropomyosin[/E1], desmin, smooth muscle myosin (heavy chain) and cytoskeletal proteins [E2]vimentin[/E2] and cytokeratin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[57, 68]], "entity_1_idx_in_text_with_entity_marker": [61, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vimentin", "entity_2_idx": [[139, 147]], "entity_2_idx_in_text_with_entity_marker": [152, 160], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d18.s0_BioInfer.d18.s0.p0", "text": "Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.", "text_with_entity_marker": "[E1]Actin[/E1] isoforms from different species were also compared, and the effect of profilin on the thermal stability of [E2]actin[/E2] was studied.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actin", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d18.s0_BioInfer.d18.s0.p1", "text": "Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.", "text_with_entity_marker": "[E1]Actin[/E1] isoforms from different species were also compared, and the effect of [E2]profilin[/E2] on the thermal stability of actin was studied.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Actin", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[76, 84]], "entity_2_idx_in_text_with_entity_marker": [89, 97], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d18.s0_BioInfer.d18.s0.p2", "text": "Actin isoforms from different species were also compared, and the effect of profilin on the thermal stability of actin was studied.", "text_with_entity_marker": "Actin isoforms from different species were also compared, and the effect of [E1]profilin[/E1] on the thermal stability of [E2]actin[/E2] was studied.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[113, 118]], "entity_2_idx_in_text_with_entity_marker": [126, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p8", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "[E1]beta-catenin[/E1] or [E2]plakoglobin[/E2] is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[16, 27]], "entity_2_idx_in_text_with_entity_marker": [29, 40], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p9", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the [E2]cadherin[/E2]/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p10", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/[E2]catenin[/E2] complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p11", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the cadherin; [E2]alpha-catenin[/E2] binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[70, 83]], "entity_2_idx_in_text_with_entity_marker": [83, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p12", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the cadherin; alpha-catenin binds to beta-catenin/[E2]plakoglobin[/E2] and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[106, 117]], "entity_2_idx_in_text_with_entity_marker": [119, 130], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p13", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[173, 178]], "entity_2_idx_in_text_with_entity_marker": [186, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p14", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "beta-catenin or [E1]plakoglobin[/E1] is associated directly with the cadherin; alpha-catenin binds to [E2]beta-catenin[/E2]/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[16, 27]], "entity_1_idx_in_text_with_entity_marker": [20, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[93, 105]], "entity_2_idx_in_text_with_entity_marker": [106, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p15", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "[E1]beta-catenin[/E1] or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the [E2]cadherin[/E2]/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherin", "entity_2_idx": [[141, 149]], "entity_2_idx_in_text_with_entity_marker": [154, 162], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p16", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "[E1]beta-catenin[/E1] or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/[E2]catenin[/E2] complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "catenin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d140.s2_BioInfer.d140.s2.p17", "text": "beta-catenin or plakoglobin is associated directly with the cadherin; alpha-catenin binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "text_with_entity_marker": "[E1]beta-catenin[/E1] or plakoglobin is associated directly with the cadherin; [E2]alpha-catenin[/E2] binds to beta-catenin/plakoglobin and serves to link the cadherin/catenin complex to the actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[70, 83]], "entity_2_idx_in_text_with_entity_marker": [83, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s0_BioInfer.d28.s0.p0", "text": "After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "text_with_entity_marker": "After 24 or 48 hours of shear, staining for [E1]VE-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[44, 55]], "entity_1_idx_in_text_with_entity_marker": [48, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s0_BioInfer.d28.s0.p1", "text": "After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "text_with_entity_marker": "After 24 or 48 hours of shear, staining for VE-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[57, 70]], "entity_1_idx_in_text_with_entity_marker": [61, 74], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s0_BioInfer.d28.s0.p2", "text": "After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "text_with_entity_marker": "After 24 or 48 hours of shear, staining for [E1]VE-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "VE-cadherin", "entity_1_idx": [[44, 55]], "entity_1_idx_in_text_with_entity_marker": [48, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[57, 70]], "entity_2_idx_in_text_with_entity_marker": [70, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p0", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to [E1]vascular endothelial[/E1] (VE) cadherin, alpha-catenin, [E2]beta-catenin[/E2], or plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial", "entity_1_idx": [[48, 68], [74, 82]], "entity_1_idx_in_text_with_entity_marker": [52, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p1", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to [E1]vascular endothelial[/E1] (VE) cadherin, [E2]alpha-catenin[/E2], beta-catenin, or plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial", "entity_1_idx": [[48, 68], [74, 82]], "entity_1_idx_in_text_with_entity_marker": [52, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[84, 97]], "entity_2_idx_in_text_with_entity_marker": [97, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p2", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to [E1]vascular endothelial[/E1] (VE) cadherin, alpha-catenin, beta-catenin, or [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "vascular endothelial", "entity_1_idx": [[48, 68], [74, 82]], "entity_1_idx_in_text_with_entity_marker": [52, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p3", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], or plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[84, 97]], "entity_1_idx_in_text_with_entity_marker": [88, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p4", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, [E1]beta-catenin[/E1], or [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p5", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, [E1]alpha-catenin[/E1], beta-catenin, or [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[84, 97]], "entity_1_idx_in_text_with_entity_marker": [88, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d202.s0_BioInfer.d202.s0.p0", "text": "Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.", "text_with_entity_marker": "Expression of [E1]alpha-catenin[/E1] was generally weak and did not correlate with the expression of either beta-catenin or [E2]E-cadherin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[14, 27]], "entity_1_idx_in_text_with_entity_marker": [18, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[115, 125]], "entity_2_idx_in_text_with_entity_marker": [128, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d202.s0_BioInfer.d202.s0.p1", "text": "Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.", "text_with_entity_marker": "Expression of alpha-catenin was generally weak and did not correlate with the expression of either [E1]beta-catenin[/E1] or [E2]E-cadherin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[115, 125]], "entity_2_idx_in_text_with_entity_marker": [128, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d202.s0_BioInfer.d202.s0.p2", "text": "Expression of alpha-catenin was generally weak and did not correlate with the expression of either beta-catenin or E-cadherin.", "text_with_entity_marker": "Expression of [E1]alpha-catenin[/E1] was generally weak and did not correlate with the expression of either [E2]beta-catenin[/E2] or E-cadherin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "alpha-catenin", "entity_1_idx": [[14, 27]], "entity_1_idx_in_text_with_entity_marker": [18, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p10", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases ([E1]MEK[/E1]1/2) and [E2]ERK[/E2]1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[198, 201], [203, 204]], "entity_1_idx_in_text_with_entity_marker": [202, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ERK", "entity_2_idx": [[210, 213], [215, 216]], "entity_2_idx_in_text_with_entity_marker": [223, 226], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p11", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases ([E1-E2]MEK[/E1]1[/E2]/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[198, 201], [203, 204]], "entity_1_idx_in_text_with_entity_marker": [205, 208], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MEK[/E1]1", "entity_2_idx": [[198, 202]], "entity_2_idx_in_text_with_entity_marker": [205, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p12", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by [E1]PDGF-AB[/E1], inhibited activation of mitogen-activated protein kinase (ERK) kinases ([E2]MEK[/E2]1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF-AB", "entity_1_idx": [[117, 124]], "entity_1_idx_in_text_with_entity_marker": [121, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MEK", "entity_2_idx": [[198, 201], [203, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p13", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases ([E1]MEK[/E1]1/2) and [E2]ERK1[/E2]/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK", "entity_1_idx": [[198, 201], [203, 204]], "entity_1_idx_in_text_with_entity_marker": [202, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ERK1", "entity_2_idx": [[210, 214]], "entity_2_idx_in_text_with_entity_marker": [223, 227], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p14", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of [E1]mitogen-activated protein kinase[/E1] (ERK) kinases ([E2]MEK[/E2]1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "mitogen-activated protein kinase", "entity_1_idx": [[150, 182], [189, 196]], "entity_1_idx_in_text_with_entity_marker": [154, 186], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "MEK", "entity_2_idx": [[198, 201], [203, 204]], "entity_2_idx_in_text_with_entity_marker": [211, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p15", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase ([E1]ERK[/E1]) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor [E2]AP-1[/E2] DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK", "entity_1_idx": [[184, 187]], "entity_1_idx_in_text_with_entity_marker": [188, 191], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AP-1", "entity_2_idx": [[253, 257]], "entity_2_idx_in_text_with_entity_marker": [266, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p16", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and [E1]ERK[/E1]1/2, and abrogated transcription factor [E2]AP-1[/E2] DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK", "entity_1_idx": [[210, 213], [215, 216]], "entity_1_idx_in_text_with_entity_marker": [214, 217], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AP-1", "entity_2_idx": [[253, 257]], "entity_2_idx_in_text_with_entity_marker": [266, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p17", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases ([E1]MEK1[/E1]/2) and ERK1/2, and abrogated transcription factor [E2]AP-1[/E2] DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "MEK1", "entity_1_idx": [[198, 202]], "entity_1_idx_in_text_with_entity_marker": [202, 206], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[253, 257]], "entity_2_idx_in_text_with_entity_marker": [266, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p18", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by [E1]PDGF-AB[/E1], inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor [E2]AP-1[/E2] DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PDGF-AB", "entity_1_idx": [[117, 124]], "entity_1_idx_in_text_with_entity_marker": [121, 128], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "AP-1", "entity_2_idx": [[253, 257]], "entity_2_idx_in_text_with_entity_marker": [266, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d387.s0_BioInfer.d387.s0.p19", "text": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and ERK1/2, and abrogated transcription factor AP-1 DNA-binding activity.", "text_with_entity_marker": "In vitro studies indicated that suramin completely blocked PDGF receptor activation or phosphorylation stimulated by PDGF-AB, inhibited activation of mitogen-activated protein kinase (ERK) kinases (MEK1/2) and [E1]ERK1[/E1]/2, and abrogated transcription factor [E2]AP-1[/E2] DNA-binding activity.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ERK1", "entity_1_idx": [[210, 214]], "entity_1_idx_in_text_with_entity_marker": [214, 218], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AP-1", "entity_2_idx": [[253, 257]], "entity_2_idx_in_text_with_entity_marker": [266, 270], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s0_BioInfer.d419.s0.p0", "text": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "text_with_entity_marker": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of [E1]adenosine kinase[/E1]), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the [E2]A1 adenosine receptor[/E2] binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine kinase", "entity_1_idx": [[93, 109]], "entity_1_idx_in_text_with_entity_marker": [97, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[283, 304]], "entity_2_idx_in_text_with_entity_marker": [296, 317], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s0_BioInfer.d419.s0.p1", "text": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "text_with_entity_marker": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of [E1]adenosine deaminase[/E1]), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the [E2]A1 adenosine receptor[/E2] binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[172, 191]], "entity_1_idx_in_text_with_entity_marker": [176, 195], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[283, 304]], "entity_2_idx_in_text_with_entity_marker": [296, 317], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s0_BioInfer.d419.s0.p2", "text": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of adenosine kinase), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of adenosine deaminase), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "text_with_entity_marker": "METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of [E1]adenosine kinase[/E1]), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of [E2]adenosine deaminase[/E2]), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the A1 adenosine receptor binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine kinase", "entity_1_idx": [[93, 109]], "entity_1_idx_in_text_with_entity_marker": [97, 113], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "adenosine deaminase", "entity_2_idx": [[172, 191]], "entity_2_idx_in_text_with_entity_marker": [185, 204], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s1_BioInfer.d419.s1.p0", "text": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the A1 adenosine receptor.", "text_with_entity_marker": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the [E1]A1 adenosine receptor[/E1] antagonist 8-cyclopentyltheophylline and [E2]adenosine deaminase[/E2], implicating endogenous adenosine acting at the A1 adenosine receptor.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A1 adenosine receptor", "entity_1_idx": [[81, 102]], "entity_1_idx_in_text_with_entity_marker": [85, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "adenosine deaminase", "entity_2_idx": [[144, 163]], "entity_2_idx_in_text_with_entity_marker": [157, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s1_BioInfer.d419.s1.p1", "text": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the A1 adenosine receptor.", "text_with_entity_marker": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and [E1]adenosine deaminase[/E1], implicating endogenous adenosine acting at the [E2]A1 adenosine receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "adenosine deaminase", "entity_1_idx": [[144, 163]], "entity_1_idx_in_text_with_entity_marker": [148, 167], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[212, 233]], "entity_2_idx_in_text_with_entity_marker": [225, 246], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d419.s1_BioInfer.d419.s1.p2", "text": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the A1 adenosine receptor antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the A1 adenosine receptor.", "text_with_entity_marker": "The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the [E1]A1 adenosine receptor[/E1] antagonist 8-cyclopentyltheophylline and adenosine deaminase, implicating endogenous adenosine acting at the [E2]A1 adenosine receptor[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "A1 adenosine receptor", "entity_1_idx": [[81, 102]], "entity_1_idx_in_text_with_entity_marker": [85, 106], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "A1 adenosine receptor", "entity_2_idx": [[212, 233]], "entity_2_idx_in_text_with_entity_marker": [225, 246], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p100", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E1]PNR[/E1]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "PNR", "entity_1_idx": [[144, 147]], "entity_1_idx_in_text_with_entity_marker": [148, 151], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p101", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p102", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p103", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), [E1]ribonucleotide reductase[/E1] (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "ribonucleotide reductase", "entity_1_idx": [[118, 142]], "entity_1_idx_in_text_with_entity_marker": [122, 146], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p104", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone [E1]H2A[/E1] + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H2A", "entity_1_idx": [[213, 216]], "entity_1_idx_in_text_with_entity_marker": [217, 220], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p105", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone [E1]H1[/E1], histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H1", "entity_1_idx": [[201, 203]], "entity_1_idx_in_text_with_entity_marker": [205, 207], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p106", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), [E1]proliferating cell nuclear antigen[/E1] (PCNA), histone H1, histone H2A + 2B, histone H3, and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "proliferating cell nuclear antigen", "entity_1_idx": [[150, 184]], "entity_1_idx_in_text_with_entity_marker": [154, 188], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p107", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone [E1]H3[/E1], and histone [E2]H4[/E2], was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[231, 233]], "entity_1_idx_in_text_with_entity_marker": [235, 237], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[247, 249]], "entity_2_idx_in_text_with_entity_marker": [260, 262], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p108", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including [E1]thymidylate synthase[/E1] (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase ([E2]PNR[/E2]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "thymidylate synthase", "entity_1_idx": [[59, 79]], "entity_1_idx_in_text_with_entity_marker": [63, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PNR", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d806.s0_BioInfer.d806.s0.p109", "text": "We found that the expression of all these genes, including thymidylate synthase (TS), dihydrofolate reductase (DHFR), ribonucleotide reductase (PNR), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "text_with_entity_marker": "We found that the expression of all these genes, including thymidylate synthase (TS), [E1]dihydrofolate reductase[/E1] (DHFR), ribonucleotide reductase ([E2]PNR[/E2]), proliferating cell nuclear antigen (PCNA), histone H1, histone H2A + 2B, histone H3, and histone H4, was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "dihydrofolate reductase", "entity_1_idx": [[86, 109]], "entity_1_idx_in_text_with_entity_marker": [90, 113], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "PNR", "entity_2_idx": [[144, 147]], "entity_2_idx_in_text_with_entity_marker": [157, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s0_BioInfer.d288.s0.p0", "text": "Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.", "text_with_entity_marker": "Immunofluorescence experiments showed that, like [E1]Abp1p[/E1], cofilin is associated with the membrane [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s0_BioInfer.d288.s0.p1", "text": "Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.", "text_with_entity_marker": "Immunofluorescence experiments showed that, like [E1]Abp1p[/E1], [E2]cofilin[/E2] is associated with the membrane actin cytoskeleton.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "Abp1p", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[56, 63]], "entity_2_idx_in_text_with_entity_marker": [69, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s0_BioInfer.d288.s0.p2", "text": "Immunofluorescence experiments showed that, like Abp1p, cofilin is associated with the membrane actin cytoskeleton.", "text_with_entity_marker": "Immunofluorescence experiments showed that, like Abp1p, [E1]cofilin[/E1] is associated with the membrane [E2]actin[/E2] cytoskeleton.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "cofilin", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s1_BioInfer.d288.s1.p0", "text": "In this study, we demonstrate using viscosity, sedimentation, and actin assembly rate assays that yeast cofilin (16 kD) possesses all of these properties.", "text_with_entity_marker": "In this study, we demonstrate using viscosity, sedimentation, and [E1]actin[/E1] assembly rate assays that yeast [E2]cofilin[/E2] (16 kD) possesses all of these properties.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[66, 71]], "entity_1_idx_in_text_with_entity_marker": [70, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "cofilin", "entity_2_idx": [[104, 111]], "entity_2_idx_in_text_with_entity_marker": [117, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s2_BioInfer.d288.s2.p0", "text": "The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.", "text_with_entity_marker": "The NH2-terminal 16kD of [E1]Abp1p[/E1], a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abp1p", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[134, 141]], "entity_2_idx_in_text_with_entity_marker": [147, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s2_BioInfer.d288.s2.p1", "text": "The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.", "text_with_entity_marker": "The NH2-terminal 16kD of [E1]Abp1p[/E1], a 65-kD yeast protein identified by its ability to bind to [E2]actin[/E2] filaments, is 23% identical to yeast cofilin.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "Abp1p", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[91, 96]], "entity_2_idx_in_text_with_entity_marker": [104, 109], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s2_BioInfer.d288.s2.p2", "text": "The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to actin filaments, is 23% identical to yeast cofilin.", "text_with_entity_marker": "The NH2-terminal 16kD of Abp1p, a 65-kD yeast protein identified by its ability to bind to [E1]actin[/E1] filaments, is 23% identical to yeast [E2]cofilin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[91, 96]], "entity_1_idx_in_text_with_entity_marker": [95, 100], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[134, 141]], "entity_2_idx_in_text_with_entity_marker": [147, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d288.s3_BioInfer.d288.s3.p0", "text": "We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian actin binding protein cofilin.", "text_with_entity_marker": "We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian [E1]actin binding protein[/E1] [E2]cofilin[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin binding protein", "entity_1_idx": [[89, 110]], "entity_1_idx_in_text_with_entity_marker": [93, 114], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "cofilin", "entity_2_idx": [[111, 118]], "entity_2_idx_in_text_with_entity_marker": [124, 131], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d351.s0_BioInfer.d351.s0.p0", "text": "In reconstitution experiments, actin filaments incubated in EGTA with purified fimbrin and villin form smooth-sided bundles containing an apparently random number of filaments.", "text_with_entity_marker": "In reconstitution experiments, [E1]actin[/E1] filaments incubated in EGTA with purified [E2]fimbrin[/E2] and villin form smooth-sided bundles containing an apparently random number of filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[79, 86]], "entity_2_idx_in_text_with_entity_marker": [92, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d351.s0_BioInfer.d351.s0.p1", "text": "In reconstitution experiments, actin filaments incubated in EGTA with purified fimbrin and villin form smooth-sided bundles containing an apparently random number of filaments.", "text_with_entity_marker": "In reconstitution experiments, actin filaments incubated in EGTA with purified [E1]fimbrin[/E1] and [E2]villin[/E2] form smooth-sided bundles containing an apparently random number of filaments.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "fimbrin", "entity_1_idx": [[79, 86]], "entity_1_idx_in_text_with_entity_marker": [83, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[91, 97]], "entity_2_idx_in_text_with_entity_marker": [104, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d351.s0_BioInfer.d351.s0.p2", "text": "In reconstitution experiments, actin filaments incubated in EGTA with purified fimbrin and villin form smooth-sided bundles containing an apparently random number of filaments.", "text_with_entity_marker": "In reconstitution experiments, [E1]actin[/E1] filaments incubated in EGTA with purified fimbrin and [E2]villin[/E2] form smooth-sided bundles containing an apparently random number of filaments.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "actin", "entity_1_idx": [[31, 36]], "entity_1_idx_in_text_with_entity_marker": [35, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[91, 97]], "entity_2_idx_in_text_with_entity_marker": [104, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d492.s0_BioInfer.d492.s0.p0", "text": "Previously, we have shown that in the absence of RAD52, repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking RAD51, gene conversion is absent but cells can repair the DSB by BIR.", "text_with_entity_marker": "Previously, we have shown that in the absence of [E1]RAD52[/E1], repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking [E2]RAD51[/E2], gene conversion is absent but cells can repair the DSB by BIR.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d385.s0_BioInfer.d385.s0.p0", "text": "Introduction of high concentrations of profilin (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of actin tail elongation and bacterial migration.", "text_with_entity_marker": "Introduction of high concentrations of [E1]profilin[/E1] (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of [E2]actin[/E2] tail elongation and bacterial migration.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "profilin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[162, 167]], "entity_2_idx_in_text_with_entity_marker": [175, 180], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d371.s0_BioInfer.d371.s0.p0", "text": "In the present work we have used profilin and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "text_with_entity_marker": "In the present work we have used [E1]profilin[/E1] and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb [E2]actin[/E2] microfilament structure and assembly in an attempt to answer this question.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d371.s0_BioInfer.d371.s0.p1", "text": "In the present work we have used profilin and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "text_with_entity_marker": "In the present work we have used [E1]profilin[/E1] and [E2]DNAse I[/E2] injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNAse I", "entity_2_idx": [[46, 53]], "entity_2_idx_in_text_with_entity_marker": [59, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d371.s0_BioInfer.d371.s0.p2", "text": "In the present work we have used profilin and DNAse I injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb actin microfilament structure and assembly in an attempt to answer this question.", "text_with_entity_marker": "In the present work we have used profilin and [E1]DNAse I[/E1] injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb [E2]actin[/E2] microfilament structure and assembly in an attempt to answer this question.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DNAse I", "entity_1_idx": [[46, 53]], "entity_1_idx_in_text_with_entity_marker": [50, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p0", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "[E1]DR3[/E1] signal transduction is mediated by a complex of intracellular signaling molecules including [E2]TRADD[/E2], TRAF2, FADD, and FLICE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRADD", "entity_2_idx": [[96, 101]], "entity_2_idx_in_text_with_entity_marker": [109, 114], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p1", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including [E1]TRADD[/E1], TRAF2, FADD, and [E2]FLICE[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p2", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including [E1]TRADD[/E1], TRAF2, [E2]FADD[/E2], and FLICE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p3", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including [E1]TRADD[/E1], [E2]TRAF2[/E2], FADD, and FLICE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRADD", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF2", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p4", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "[E1]DR3[/E1] signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and [E2]FLICE[/E2].", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p5", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "[E1]DR3[/E1] signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, [E2]FADD[/E2], and FLICE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p6", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "[E1]DR3[/E1] signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, [E2]TRAF2[/E2], FADD, and FLICE.", "relation": [{"relation_type": "negative", "relation_id": 1, "entity_1": "DR3", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TRAF2", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p7", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, [E1]FADD[/E1], and [E2]FLICE[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "FADD", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p8", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, [E1]TRAF2[/E1], FADD, and [E2]FLICE[/E2].", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRAF2", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FLICE", "entity_2_idx": [[120, 125]], "entity_2_idx_in_text_with_entity_marker": [133, 138], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d180.s0_BioInfer.d180.s0.p9", "text": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, TRAF2, FADD, and FLICE.", "text_with_entity_marker": "DR3 signal transduction is mediated by a complex of intracellular signaling molecules including TRADD, [E1]TRAF2[/E1], [E2]FADD[/E2], and FLICE.", "relation": [{"relation_type": "positive", "relation_id": 0, "entity_1": "TRAF2", "entity_1_idx": [[103, 108]], "entity_1_idx_in_text_with_entity_marker": [107, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "FADD", "entity_2_idx": [[110, 114]], "entity_2_idx_in_text_with_entity_marker": [123, 127], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
